name,pdb_id,pubmed_id,resolution,uniprot,PFAM,CATH,receptor_chain,receptor_length,peptide_chain,peptide_length,sequence_alignment,stride,percent_exposed_alignment,cluster_number,binding_mode,size_of_binding_mode,core_ecr_alignment,longest_continuous_core,longest_continuous_ecr,corebinding_aa,exosite_aa,surface_aa,interior_aa,corebinding_ss,exosite_ss,surface_ss,interior_ss,unique_id,COREBINDING_aa,COREBINDING_ss,EXOSITE_aa,EXOSITE_ss,bfact,bs_loc_type,full_peptide_sequece,mean_seq_iden_in_bm,mean_seq_iden_not_bm,min_dist_E_C_diff_bm,occupancy,pep_loc_type,title
1A3R_LH_P_4_15.pdb,1A3R,8194515,2.10,Q52L64_Q505N9,PF07654_PF07686,2.60.40.10,LH,432,P,15,V-K--AETRLNPDLQPTE--,C-C--CTTTTCGGGTTTC--,2-2--1000001210204--,4,15,2,d-C--CCCCCDDDDDDDD--,6,8,D:0;H:0;K:0;L:0;N:0;Q:0;R:0;S:0;T:0;W:0;Y:0,D:1;H:0;K:1;L:0;N:0;Q:0;R:0;S:0;T:0;W:0;Y:0,A:4;C:1;D:4;E:6;G:7;K:10;N:2;P:4;Q:6;R:2;S:23;T:4;V:1;W:1;Y:1,A:17;C:9;D:12;E:10;F:11;G:20;H:5;I:14;K:13;L:30;M:4;N:12;P:20;Q:12;R:7;S:36;T:43;V:30;W:7;Y:15,C:0;E:0;G:0;T:0,C:0;E:0;G:2;T:0,C:15;E:14;G:8;H:4;T:35,B:6;C:51;E:204;G:9;H:7;T:48;b:2,4_15,D:3;H:1;K:0;L:2;N:1;Q:1;R:1;S:1;T:1;W:1;Y:6,C:2;E:11;G:2;T:3,D:1;H:0;K:1;L:0;N:3;Q:0;R:1;S:0;T:0;W:0;Y:3,C:1;E:2;G:0;T:6,7-6--5444445668999--,ARG_33_L_EXOSITE;ARG_49_H_COREBINDING;ASN_31_L_EXOSITE;ASN_54_H_EXOSITE;ASN_97_L_COREBINDING;ASN_99_L_EXOSITE;ASP_103_H_COREBINDING;ASP_105_H_COREBINDING;ASP_30_H_exosite;ASP_51_H_EXOSITE;ASP_96_H_COREBINDING;GLN_95_L_COREBINDING;HIS_34_H_COREBINDING;LEU_102_L_COREBINDING;LEU_52_L_COREBINDING;LYS_29_H_exosite;LYS_58_H_EXOSITE;SER_100_H_COREBINDING;THR_40_L_COREBINDING;TRP_56_L_COREBINDING;TYR_100_L_EXOSITE;TYR_101_H_COREBINDING;TYR_32_H_COREBINDING;TYR_38_L_COREBINDING;TYR_42_L_COREBINDING;TYR_55_L_COREBINDING;TYR_56_H_EXOSITE;TYR_98_H_COREBINDING;TYR_98_L_EXOSITE,VKAETRLNPDLQPTE,0.625,0.480296689521484,0.412815939614738,9-9--9999999999999--,VAL_1_P_e;LYS_2_P_C;ALA_3_P_C;GLU_4_P_C;THR_5_P_C;ARG_6_P_C;LEU_7_P_C;ASN_8_P_E;PRO_9_P_E;ASP_10_P_E;LEU_11_P_E;GLN_12_P_E;PRO_13_P_E;THR_14_P_E;GLU_15_P_E,"FAB FRAGMENT ANTIBODY 8F5 COMPLEXED WITH PEPTIDE FROM 2 HUMAN RHINOVIRUS SEROTYPE 2 VIRAL CAPSID PROTEIN VP2 3 RESIDUES 156170"
1EJO_LH_P_4_29.pdb,1EJO,10811933,2.30,P01660_Q6PF95,PF07686_PF07654,2.60.40.10,LH,430,P,13,YTTSTRGDLAHVT,CCCTTTTTTTTTC,3100220001004,4,29,1,CCCCCCCCCCCCC,13,0,A:0;D:0;E:0;F:0;L:0;N:0;R:0;S:0;T:0;W:0;Y:0,A:0;D:0;E:0;F:0;L:0;N:0;R:0;S:0;T:0;W:0;Y:0,A:8;D:8;E:4;G:9;H:1;K:9;M:1;N:2;P:4;Q:3;R:5;S:21;T:4;V:1,A:21;C:9;D:11;E:12;F:13;G:18;H:5;I:13;K:10;L:31;M:5;N:10;P:20;Q:12;R:11;S:38;T:35;V:30;W:7;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,B:1;C:21;E:9;G:4;H:5;T:39;b:1,B:4;C:50;E:206;G:8;H:7;T:49;b:3,4_29,A:1;D:3;E:1;F:2;L:1;N:2;R:2;S:5;T:2;W:1;Y:3,C:3;E:9;T:11,A:0;D:0;E:0;F:0;L:0;N:0;R:0;S:0;T:0;W:0;Y:0,C:0;E:0;T:0,6544443334567,ALA_99_H_COREBINDING;ARG_54_L_COREBINDING;ARG_98_H_COREBINDING;ASN_34_L_COREBINDING;ASN_96_L_COREBINDING;ASP_101_H_COREBINDING;ASP_103_H_COREBINDING;ASP_98_L_COREBINDING;GLU_97_L_COREBINDING;LEU_100_L_COREBINDING;PHE_100_H_COREBINDING;PHE_36_L_COREBINDING;SER_102_H_COREBINDING;SER_31_L_COREBINDING;SER_51_H_COREBINDING;SER_52_H_COREBINDING;SER_95_L_COREBINDING;THR_32_H_COREBINDING;THR_49_H_COREBINDING;TRP_46_H_COREBINDING;TYR_32_L_COREBINDING;TYR_56_H_COREBINDING;TYR_58_H_COREBINDING,YTTSTRGDLAHVTTT,-1,0.487460746738803,,9999999999999,TYR_1_P_C;THR_2_P_C;THR_3_P_C;SER_4_P_C;THR_5_P_C;ARG_6_P_C;GLY_7_P_C;ASP_8_P_C;LEU_9_P_C;ALA_10_P_C;HIS_11_P_C;VAL_12_P_C;THR_13_P_C,"FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 2 COMPLEXED WITH GH LOOP FROM FMDV"
1KC5_LH_P_4_40.pdb,1KC5,11859128,2.50,P01837_P01869,PF07654,2.60.40.10,LH,431,P,8,HQLDPAFG,CCCTTTTC,43001003,4,40,1,CCCCCCCC,8,0,A:0;D:0;F:0;G:0;L:0;N:0;S:0;T:0;Y:0,A:0;D:0;F:0;G:0;L:0;N:0;S:0;T:0;Y:0,A:9;C:1;D:4;E:4;G:5;K:13;M:1;N:4;P:6;Q:2;R:1;S:18;T:5;V:1,A:20;C:8;D:14;E:11;F:12;G:20;H:5;I:13;K:8;L:28;M:4;N:12;P:21;Q:15;R:11;S:40;T:42;V:31;W:9;Y:17,C:0;E:0;T:0,C:0;E:0;T:0,C:22;E:7;G:5;H:2;T:38,B:6;C:57;E:199;G:7;H:8;T:60;b:4,4_40,A:1;D:1;F:1;G:3;L:1;N:1;S:2;T:1;Y:5,C:3;E:4;T:9,A:0;D:0;F:0;G:0;L:0;N:0;S:0;T:0;Y:0,C:0;E:0;T:0,99645479,ALA_34_H_COREBINDING;ASN_36_H_COREBINDING;ASP_32_H_COREBINDING;GLY_100_H_COREBINDING;GLY_102_H_COREBINDING;GLY_99_H_COREBINDING;LEU_96_L_COREBINDING;PHE_103_H_COREBINDING;SER_91_L_COREBINDING;SER_93_L_COREBINDING;THR_101_H_COREBINDING;TYR_32_L_COREBINDING;TYR_33_H_COREBINDING;TYR_51_H_COREBINDING;TYR_92_L_COREBINDING;TYR_94_L_COREBINDING,HQLDPAFGANSTNPD,-1,0.484491220140946,,99999999,HIS_1_P_C;GLN_2_P_C;LEU_3_P_C;ASP_4_P_C;PRO_5_P_C;ALA_6_P_C;PHE_7_P_C;GLY_8_P_C,"CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 2 PEPTIDE"
1KCS_LH_P_4_43.pdb,1KCS,11859128,2.50,P01837_P18532,PF07654_PF07686,2.60.40.10,LH,431,P,7,QLDPAFG,CCCGGGC,3101004,4,43,1,CCCCCCC,7,0,A:0;D:0;F:0;G:0;L:0;N:0;S:0;T:0;Y:0,A:0;D:0;F:0;G:0;L:0;N:0;S:0;T:0;Y:0,A:11;C:1;D:6;E:4;G:7;K:7;L:1;N:2;P:1;Q:2;R:1;S:23;T:3,A:23;C:8;D:11;E:7;F:12;G:23;H:3;I:11;K:14;L:26;M:5;N:13;P:21;Q:14;R:9;S:44;T:44;V:32;W:9;Y:17,C:0;E:0;T:0,C:0;E:0;T:0,C:15;E:8;G:6;H:3;T:37,B:2;C:59;E:204;G:12;H:8;T:57;b:4,4_43,A:1;D:1;F:1;G:3;L:1;N:1;S:3;T:1;Y:4,C:3;E:4;T:9,A:0;D:0;F:0;G:0;L:0;N:0;S:0;T:0;Y:0,C:0;E:0;T:0,7633356,ALA_34_H_COREBINDING;ASN_36_H_COREBINDING;ASP_32_H_COREBINDING;GLY_100_H_COREBINDING;GLY_102_H_COREBINDING;GLY_99_H_COREBINDING;LEU_96_L_COREBINDING;PHE_103_H_COREBINDING;SER_91_L_COREBINDING;SER_93_L_COREBINDING;SER_94_L_COREBINDING;THR_101_H_COREBINDING;TYR_32_L_COREBINDING;TYR_33_H_COREBINDING;TYR_51_H_COREBINDING;TYR_92_L_COREBINDING,HQLDPAFGANSTNPD,-1,0.451515025753367,,9999999,GLN_1_P_C;LEU_2_P_C;ASP_3_P_C;PRO_4_P_C;ALA_5_P_C;PHE_6_P_C;GLY_7_P_C,"CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 2 PEPTIDE"
1N64_LH_P_4_25.pdb,1N64,12574359,2.34,,,2.60.40.10,LH,438,P,16,PGGGQIVGGVYLLPRR,CCCCCCCCGGGCCCCC,3242010001303245,4,25,1,CCCCCCCCCCCCCCCC,16,0,A:0;D:0;E:0;F:0;H:0;I:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;D:0;E:0;F:0;H:0;I:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:6;D:7;E:3;G:6;K:10;M:1;N:3;P:4;Q:4;R:3;S:20;T:6;V:2,A:22;C:9;D:10;E:14;F:15;G:21;H:4;I:11;K:17;L:27;M:5;N:13;P:21;Q:14;R:9;S:37;T:37;V:30;W:9;Y:16,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:17;E:11;G:4;H:5;T:38,B:4;C:54;E:207;G:12;H:7;T:53;b:4,4_25,A:1;D:1;E:1;F:2;H:1;I:1;L:2;N:2;P:1;Q:1;R:1;S:1;T:3;V:1;W:1;Y:2,C:2;E:7;G:2;T:11,A:0;D:0;E:0;F:0;H:0;I:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,9998654323345799,ALA_97_L_COREBINDING;ARG_33_L_COREBINDING;ASN_31_L_COREBINDING;ASN_52_H_COREBINDING;ASP_31_H_COREBINDING;GLN_103_H_COREBINDING;GLU_54_H_COREBINDING;HIS_35_H_COREBINDING;ILE_99_L_COREBINDING;LEU_101_H_COREBINDING;LEU_102_L_COREBINDING;PHE_32_H_COREBINDING;PHE_99_H_COREBINDING;PRO_100_L_COREBINDING;SER_33_H_COREBINDING;THR_30_H_COREBINDING;THR_34_L_COREBINDING;THR_53_H_COREBINDING;TRP_50_H_COREBINDING;TYR_38_L_COREBINDING;TYR_98_L_COREBINDING;VAL_51_H_COREBINDING,PGGGQIVGGVYLLPRR,-1,0.485641218311087,,9999999999999999,PRO_1_P_C;GLY_2_P_C;GLY_3_P_C;GLY_4_P_C;GLN_5_P_C;ILE_6_P_C;VAL_7_P_C;GLY_8_P_C;GLY_9_P_C;VAL_10_P_C;TYR_11_P_C;LEU_12_P_C;LEU_13_P_C;PRO_14_P_C;ARG_15_P_C;ARG_16_P_C,"CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON 2 HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6"
1PZ5_AB_C_4_41.pdb,1PZ5,14645714,1.80,A2NHM3_P01801,PF07654_PF07686,2.60.40.10,AB,435,C,8,MDWNMHAA,CCCTTTTC,31100102,4,41,1,CCCCCCCC,8,0,A:0;D:0;E:0;G:0;H:0;K:0;N:0;P:0;R:0;T:0;V:0;W:0;Y:0,A:0;D:0;E:0;G:0;H:0;K:0;N:0;P:0;R:0;T:0;V:0;W:0;Y:0,A:3;C:1;D:5;E:5;G:9;K:9;L:2;N:4;P:4;Q:4;R:4;S:19;T:4;Y:1,A:15;C:8;D:13;E:13;F:14;G:25;H:4;I:14;K:13;L:30;M:5;N:10;P:17;Q:11;R:11;S:45;T:31;V:37;W:8;Y:16,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,B:1;C:20;E:12;G:11;H:2;T:28,B:6;C:61;E:211;G:18;H:4;T:35;b:5,4_41,A:1;D:1;E:1;G:3;H:3;K:1;N:2;P:1;R:1;T:2;V:2;W:1;Y:2,C:3;E:5;G:1;T:12,A:0;D:0;E:0;G:0;H:0;K:0;N:0;P:0;R:0;T:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,87655556,ALA_103_B_COREBINDING;ARG_52_B_COREBINDING;ASN_31_B_COREBINDING;ASN_35_A_COREBINDING;ASP_33_A_COREBINDING;GLU_50_B_COREBINDING;GLY_101_B_COREBINDING;GLY_102_B_COREBINDING;GLY_105_B_COREBINDING;HIS_31_A_COREBINDING;HIS_61_B_COREBINDING;HIS_98_A_COREBINDING;LYS_55_A_COREBINDING;PRO_100_A_COREBINDING;THR_96_A_COREBINDING;THR_97_A_COREBINDING;TRP_33_B_COREBINDING;TYR_32_B_COREBINDING;TYR_37_A_COREBINDING;VAL_104_B_COREBINDING;VAL_99_A_COREBINDING,MDWNMHAA,-1,0.480014953093389,,99999999,MET_1_C_C;ASP_2_C_C;TRP_3_C_C;ASN_4_C_C;MET_5_C_C;HIS_6_C_C;ALA_7_C_C;ALA_8_C_C,"STRUCTURAL BASIS OF PEPTIDECARBOHYDRATE MIMICRY IN AN ANTIBODY 2 COMBINING SITE"
1Q1J_HL_P_4_6.pdb,1Q1J,14962380,2.50,,,2.60.40.10,HL,446,P,10,KRIHIGPGRA---,CEEEETTTTC---,4210000114---,4,6,3,CCCCCCCCCd---,9,1,A:0;D:0;E:0;K:0;R:0;W:0;Y:0,A:0;D:0;E:0;K:0;R:0;W:0;Y:0,A:4;D:2;E:5;G:12;K:12;L:2;N:2;P:6;Q:3;R:4;S:19;T:11;V:1,A:24;C:9;D:14;E:9;F:13;G:30;H:4;I:10;K:12;L:31;M:3;N:13;P:20;Q:13;R:7;S:42;T:35;V:39;W:7;Y:14,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:23;E:12;G:10;H:4;I:1;T:33,B:10;C:61;E:203;G:13;H:7;I:4;T:47;b:4,4_6,A:1;D:2;E:1;K:1;R:1;W:3;Y:5,C:2;E:9;G:1;T:2,A:0;D:0;E:0;K:0;R:0;W:0;Y:0,C:0;E:0;G:0;T:0,7765544556---,ALA_98_L_COREBINDING;ARG_50_H_COREBINDING;ASP_112_H_COREBINDING;ASP_56_H_COREBINDING;GLU_111_H_COREBINDING;LYS_52_H_COREBINDING;TRP_100_L_COREBINDING;TRP_33_H_COREBINDING;TRP_92_L_COREBINDING;TYR_113_H_COREBINDING;TYR_114_H_COREBINDING;TYR_115_H_COREBINDING;TYR_116_H_COREBINDING;TYR_33_L_COREBINDING,CKRIHIGPGRAFYTTC,0.99218991880312,0.394213071621263,1.27604506190025,9999999999---,LYS_1_P_C;ARG_2_P_C;ILE_3_P_C;HIS_4_P_C;ILE_5_P_C;GLY_6_P_C;PRO_7_P_C;GLY_8_P_C;ARG_9_P_C;ALA_10_P_e,"CRYSTAL STRUCTURE ANALYSIS OF ANTIHIV1 FAB 44752D IN 2 COMPLEX WITH V3 PEPTIDE"
1SM3_HL_P_4_38.pdb,1SM3,9826510,1.95,P01801_P01723,PF07686,2.60.40.10,HL,421,P,9,SAPDTRPAP,CCCCCCCCC,410021312,4,38,1,CCCCCCCCC,9,0,F:0;G:0;N:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,F:0;G:0;N:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,A:2;D:4;E:9;G:10;H:1;K:6;M:1;N:4;P:5;Q:3;R:3;S:16;T:5,A:25;C:8;D:7;E:12;F:11;G:24;H:7;I:10;K:12;L:29;M:5;N:11;P:17;Q:12;R:8;S:33;T:46;V:39;W:8;Y:14,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:17;E:12;G:10;H:4;T:26,B:5;C:49;E:221;G:16;H:8;T:36;b:3,4_38,F:1;G:1;N:1;P:1;Q:1;R:1;S:1;V:1;W:3;Y:3,C:3;E:4;G:1;T:6,F:0;G:0;N:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,643344456,ARG_52_H_COREBINDING;ASN_31_H_COREBINDING;GLN_103_H_COREBINDING;GLY_102_H_COREBINDING;PHE_27_H_COREBINDING;PRO_57_L_COREBINDING;SER_94_L_COREBINDING;TRP_33_H_COREBINDING;TRP_92_L_COREBINDING;TRP_97_L_COREBINDING;TYR_106_H_COREBINDING;TYR_32_H_COREBINDING;TYR_33_L_COREBINDING;VAL_101_H_COREBINDING,TSAPDTRPAPGST,-1,0.345619862020633,,999999999,SER_1_P_C;ALA_2_P_C;PRO_3_P_C;ASP_4_P_C;THR_5_P_C;ARG_6_P_C;PRO_7_P_C;ALA_8_P_C;PRO_9_P_C,"CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 2 COMPLEX WITH ITS PEPTIDE EPITOPE"
1TET_LH_P_4_32.pdb,1TET,7690406,2.30,,,2.60.40.10,LH,425,P,12,VPGSQHIDSQKK,TTTTCCCCCCCC,100010313335,4,32,1,CCCCCCCCCCCC,12,0,F:0;G:0;H:0;I:0;K:0;N:0;R:0;S:0;T:0;W:0;Y:0,F:0;G:0;H:0;I:0;K:0;N:0;R:0;S:0;T:0;W:0;Y:0,A:1;D:7;E:2;G:6;K:11;L:2;M:1;N:3;P:5;Q:3;R:3;S:17;T:6;W:1,A:18;C:8;D:11;E:13;F:19;G:21;H:5;I:13;K:14;L:25;M:4;N:10;P:22;Q:12;R:8;S:40;T:36;V:33;W:7;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,C:17;E:14;G:5;H:4;T:28,B:4;C:50;E:205;G:13;H:7;T:52;b:4,4_32,F:1;G:3;H:1;I:2;K:1;N:2;R:1;S:3;T:3;W:2;Y:3,C:3;E:5;T:14,F:0;G:0;H:0;I:0;K:0;N:0;R:0;S:0;T:0;W:0;Y:0,C:0;E:0;T:0,543446556777,ARG_99_H_COREBINDING;ASN_35_L_COREBINDING;ASN_52_H_COREBINDING;GLY_33_H_COREBINDING;GLY_34_L_COREBINDING;GLY_96_L_COREBINDING;HIS_31_L_COREBINDING;ILE_51_H_COREBINDING;ILE_99_L_COREBINDING;LYS_55_L_COREBINDING;PHE_101_L_COREBINDING;SER_100_H_COREBINDING;SER_33_L_COREBINDING;SER_97_L_COREBINDING;THR_30_H_COREBINDING;THR_31_H_COREBINDING;THR_53_H_COREBINDING;TRP_101_H_COREBINDING;TRP_50_H_COREBINDING;TYR_32_H_COREBINDING;TYR_37_L_COREBINDING;TYR_54_H_COREBINDING,VEVPGSQHIDSQKKA,-1,0.494589553070039,,999999999999,VAL_1_P_C;PRO_2_P_C;GLY_3_P_C;SER_4_P_C;GLN_5_P_C;HIS_6_P_C;ILE_7_P_C;ASP_8_P_C;SER_9_P_C;GLN_10_P_C;LYS_11_P_C;LYS_12_P_C,"CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX 2 AT 23 ANGSTROMS"
1TJG_HL_P_4_1.pdb,1TJG,15367639,2.00,,,2.60.40.10,HL,449,P,7,---------ELDKWAS--,---------CBTTTTC--,---------3201014--,4,1,18,---------eCCCCCC--,6,1,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:0;R:1;V:0;Y:0,A:2;D:4;E:3;F:1;G:9;I:1;K:11;L:1;N:2;P:6;Q:3;R:3;S:21;T:7;V:1,A:23;C:8;D:13;E:11;F:14;G:23;H:5;I:13;K:13;L:35;M:2;N:10;P:24;Q:16;R:12;S:42;T:39;V:37;W:6;Y:13,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:0,C:16;E:9;G:8;H:3;T:39,B:5;C:55;E:214;G:15;H:8;T:56;b:6,4_1,D:2;F:2;G:1;H:2;L:1;P:1;R:2;V:1;Y:2,B:1;C:5;E:2;G:1;T:5,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0,---------5444469--,ARG_100_H_COREBINDING;ARG_113_H_COREBINDING;ARG_60_H_exosite;ASP_56_H_COREBINDING;ASP_58_H_COREBINDING;GLY_33_H_COREBINDING;HIS_92_L_COREBINDING;HIS_96_L_COREBINDING;LEU_91_L_COREBINDING;PHE_32_H_COREBINDING;PHE_93_L_COREBINDING;PRO_103_H_COREBINDING;TYR_54_H_COREBINDING;TYR_94_L_COREBINDING;VAL_116_H_COREBINDING,ELDKWAS,0.97091576051356,0.328582034149963,3.04786449830041,---------9999999--,GLU_1_P_e;LEU_2_P_C;ASP_3_P_C;LYS_4_P_C;TRP_5_P_C;ALA_6_P_C;SER_7_P_C,"CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTIHIV1 2 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE"
1TJH_HL_P_4_1.pdb,1TJH,15367639,2.10,,,2.60.40.10,HL,449,P,11,-------LLELDKWASLW,-------CCEETTTTTTC,-------50220100404,4,1,18,-------eeeCCCCCCdd,6,3,A:0;D:0;F:0;G:0;H:0;I:0;L:0;P:0;Q:0;R:0;V:0;Y:0,A:2;D:0;F:0;G:0;H:0;I:1;L:1;P:1;Q:1;R:1;V:0;Y:0,A:1;D:4;E:4;F:1;G:9;K:12;L:1;N:2;P:8;Q:3;R:4;S:23;T:7;V:1,A:22;C:8;D:13;E:10;F:14;G:23;H:5;I:13;K:12;L:34;M:2;N:10;P:21;Q:15;R:11;S:40;T:39;V:37;W:6;Y:13,C:0;E:0;G:0;T:0,C:2;E:4;G:0;T:1,C:19;E:11;G:6;H:3;T:41,B:5;C:56;E:208;G:11;H:8;T:54;b:6,4_1,A:0;D:2;F:2;G:1;H:2;I:0;L:1;P:1;Q:0;R:2;V:1;Y:2,C:5;E:4;G:1;T:4,A:0;D:0;F:0;G:0;H:0;I:0;L:0;P:0;Q:0;R:0;V:0;Y:0,C:0;E:0;G:0;T:0,-------86543333443,ALA_1_L_exosite;ALA_112_H_exosite;ARG_100_H_COREBINDING;ARG_113_H_COREBINDING;ARG_60_H_exosite;ASP_56_H_COREBINDING;ASP_58_H_COREBINDING;GLN_27_L_exosite;GLY_33_H_COREBINDING;HIS_92_L_COREBINDING;HIS_96_L_COREBINDING;ILE_111_H_exosite;LEU_2_L_exosite;LEU_91_L_COREBINDING;PHE_32_H_COREBINDING;PHE_93_L_COREBINDING;PRO_103_H_COREBINDING;PRO_110_H_exosite;TYR_54_H_COREBINDING;TYR_94_L_COREBINDING;VAL_116_H_COREBINDING,LLELDKWASLW,0.97091576051356,0.328641425389755,1.28435392318473,-------99999999999,LEU_1_P_e;LEU_2_P_e;GLU_3_P_e;LEU_4_P_C;ASP_5_P_C;LYS_6_P_C;TRP_7_P_C;ALA_8_P_C;SER_9_P_C;LEU_10_P_e;TRP_11_P_e,"CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTIHIV1 2 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE"
1TJI_HL_P_4_1.pdb,1TJI,15367639,2.20,,,2.60.40.10,HL,449,P,14,E----QELLELDKWASLW,C----CCCCEETTTTTTC,4----3240220100404,4,1,18,E----EEEEECCCCCCdd,6,6,A:0;D:0;F:0;G:0;H:0;I:0;L:0;P:0;Q:0;R:0;V:0;Y:0,A:1;D:0;F:0;G:0;H:0;I:1;L:0;P:0;Q:0;R:0;V:0;Y:0,A:1;D:4;E:4;F:1;G:9;K:11;L:1;N:2;P:7;Q:3;R:2;S:22;T:6;V:1,A:22;C:8;D:13;E:10;F:14;G:23;H:5;I:13;K:13;L:34;M:2;N:10;P:23;Q:15;R:13;S:41;T:40;V:37;W:6;Y:13,C:0;E:0;G:0;T:0,C:0;E:2;G:0;T:0,C:14;E:8;G:6;H:4;T:42,B:5;C:54;E:214;G:11;H:8;T:57;b:6,4_1,A:0;D:2;F:2;G:1;H:2;I:0;L:1;P:1;Q:0;R:2;V:1;Y:2,C:5;E:4;G:1;T:4,A:1;D:0;F:0;G:0;H:0;I:0;L:1;P:0;Q:1;R:1;V:0;Y:0,C:2;E:1;G:0;T:1,9----9998543434543,ALA_1_L_EXOSITE;ALA_112_H_exosite;ARG_100_H_COREBINDING;ARG_113_H_COREBINDING;ARG_60_H_EXOSITE;ASP_56_H_COREBINDING;ASP_58_H_COREBINDING;GLN_27_L_EXOSITE;GLY_33_H_COREBINDING;HIS_92_L_COREBINDING;HIS_96_L_COREBINDING;ILE_111_H_exosite;LEU_2_L_EXOSITE;LEU_91_L_COREBINDING;PHE_32_H_COREBINDING;PHE_93_L_COREBINDING;PRO_103_H_COREBINDING;TYR_54_H_COREBINDING;TYR_94_L_COREBINDING;VAL_116_H_COREBINDING,EKNEQELLELDKWASLW,0.97091576051356,0.328433556050483,1.11774147279234,9----9999999999999,GLU_1_P_E;GLN_2_P_E;GLU_3_P_E;LEU_4_P_E;LEU_5_P_E;GLU_6_P_E;LEU_7_P_C;ASP_8_P_C;LYS_9_P_C;TRP_10_P_C;ALA_11_P_C;SER_12_P_C;LEU_13_P_e;TRP_14_P_e,"CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTIHIV1 2 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE"
1U8H_BA_C_4_1.pdb,1U8H,19740978,2.10,,,2.60.40.10,BA,441,C,7,----A-----LDKWAS--,----C-----BTTTTC--,----4-----101004--,4,1,18,----e-----CCCCCC--,6,1,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,A:3;C:2;D:2;E:3;F:1;G:9;K:11;L:1;N:2;P:8;Q:5;R:4;S:20;T:6;V:1,A:23;C:8;D:14;E:12;F:14;G:20;H:5;I:13;K:10;L:35;M:2;N:10;P:22;Q:14;R:13;S:39;T:38;V:37;W:6;Y:13,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:22;E:10;G:7;H:4;T:35,B:6;C:50;E:211;G:13;H:8;T:54;b:6,4_1,D:2;F:2;G:2;H:2;L:1;P:1;R:2;V:1;Y:2,B:1;C:6;E:2;G:1;T:5,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0,----5-----444457--,ARG_100_B_COREBINDING;ARG_113_B_COREBINDING;ASP_56_B_COREBINDING;ASP_58_B_COREBINDING;GLY_102_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_32_B_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,ALDKWAS,0.987334531443646,0.326642499190438,3.14857761536856,----9-----999999--,ALA_1_C_e;LEU_2_C_C;ASP_3_C_C;LYS_4_C_C;TRP_5_C_C;ALA_6_C_C;SER_7_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS"
1U8I_BA_C_4_1.pdb,1U8I,19740978,2.00,,,2.60.40.10,BA,441,C,7,----E-----LDKWAN--,----C-----BTTTTC--,----2-----101014--,4,1,18,----e-----CCCCCC--,6,1,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:0;R:1;V:0;Y:0,A:3;C:2;D:2;E:3;F:2;G:9;K:11;L:1;N:2;P:8;Q:5;R:5;S:20;T:6;V:1,A:23;C:8;D:15;E:12;F:14;G:20;H:5;I:13;K:10;L:35;M:2;N:10;P:22;Q:14;R:10;S:39;T:38;V:37;W:6;Y:13,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:0,C:23;E:10;G:7;H:4;T:36,B:6;C:49;E:210;G:13;H:8;T:54;b:6,4_1,D:1;F:1;G:2;H:2;L:1;P:1;R:3;V:1;Y:2,B:1;C:6;E:2;G:1;T:4,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0,----4-----433458--,ARG_100_B_COREBINDING;ARG_101_B_COREBINDING;ARG_113_B_COREBINDING;ARG_60_B_exosite;ASP_56_B_COREBINDING;GLY_102_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,ELDKWAN,0.987334531443646,0.326733202138284,3.23982360630945,----9-----999999--,GLU_1_C_e;LEU_2_C_C;ASP_3_C_C;LYS_4_C_C;TRP_5_C_C;ALA_6_C_C;ASN_7_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN"
1U8J_BA_C_4_1.pdb,1U8J,19740978,2.24,,,2.60.40.10,BA,441,C,7,----E-----LDKWAG--,----C-----BTTTTC--,----4-----101014--,4,1,18,----e-----CCCCCC--,6,1,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,A:3;C:2;D:2;E:3;F:1;G:9;K:11;L:1;N:2;P:8;Q:5;R:4;S:20;T:6;V:1,A:23;C:8;D:15;E:12;F:14;G:20;H:5;I:13;K:10;L:35;M:2;N:10;P:22;Q:14;R:13;S:39;T:38;V:37;W:6;Y:13,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:22;E:10;G:7;H:4;T:35,B:6;C:51;E:211;G:13;H:8;T:54;b:6,4_1,D:1;F:2;G:2;H:2;L:1;P:1;R:2;V:1;Y:2,B:1;C:5;E:2;G:1;T:5,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0,----6-----645679--,ARG_100_B_COREBINDING;ARG_113_B_COREBINDING;ASP_56_B_COREBINDING;GLY_102_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_32_B_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,ELDKWAG,0.987334531443646,0.326612264874489,3.30553429871783,----9-----999999--,GLU_1_C_e;LEU_2_C_C;ASP_3_C_C;LYS_4_C_C;TRP_5_C_C;ALA_6_C_C;GLY_7_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG"
1U8K_BA_C_4_1.pdb,1U8K,,2.24,,,2.60.40.10,BA,442,C,9,---LE-----LDKWASL-,---CE-----ETTTTCC-,---41-----2010042-,4,1,18,---ee-----CCCCCCd-,6,2,D:0;F:0;G:0;H:0;L:0;P:0;Q:0;R:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:1;Q:1;R:1;V:0;Y:0,A:1;C:1;D:2;E:4;F:2;G:9;K:10;L:1;N:2;P:8;Q:2;R:5;S:21;T:7;V:1,A:23;C:9;D:15;E:10;F:14;G:20;H:5;I:13;K:11;L:35;M:2;N:10;P:21;Q:16;R:11;S:39;T:39;V:37;W:6;Y:13,C:0;E:0;G:0;T:0,C:0;E:2;G:0;T:1,C:18;E:10;G:8;H:3;T:37,B:5;C:52;E:212;G:15;H:8;T:51;b:6,4_1,D:1;F:1;G:2;H:2;L:1;P:1;Q:0;R:3;V:1;Y:2,C:6;E:4;G:1;T:3,D:0;F:0;G:0;H:0;L:0;P:0;Q:0;R:0;V:0;Y:0,C:0;E:0;G:0;T:0,---76-----4444699-,ARG_100_B_COREBINDING;ARG_101_B_COREBINDING;ARG_113_B_COREBINDING;ARG_60_B_exosite;ASP_56_B_COREBINDING;GLN_27_A_exosite;GLY_102_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;PRO_110_B_exosite;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,LELDKWASL,0.981740098512472,0.32830318703843,0.924033008068432,---99-----9999999-,LEU_1_C_e;GLU_2_C_e;LEU_3_C_C;ASP_4_C_C;LYS_5_C_C;TRP_6_C_C;ALA_7_C_C;SER_8_C_C;LEU_9_C_e,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL"
1U8M_BA_C_4_1.pdb,1U8M,19740978,2.40,,,2.60.40.10,BA,441,C,7,----E-----LDKYAS--,----C-----BTTTTC--,----2-----201005--,4,1,18,----e-----CCCCCC--,6,1,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:0;R:1;V:0;Y:0,A:3;C:2;D:2;E:3;F:2;G:9;K:11;L:1;N:2;P:8;Q:5;R:4;S:20;T:6;V:1,A:23;C:8;D:15;E:12;F:14;G:20;H:5;I:13;K:10;L:35;M:2;N:10;P:22;Q:14;R:11;S:39;T:38;V:37;W:6;Y:13,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:0,C:22;E:10;G:7;H:4;T:36,B:6;C:50;E:210;G:13;H:8;T:54;b:6,4_1,D:1;F:1;G:2;H:2;L:1;P:1;R:3;V:1;Y:2,B:1;C:6;E:2;G:1;T:4,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0,----5-----555555--,ARG_100_B_COREBINDING;ARG_101_B_COREBINDING;ARG_113_B_COREBINDING;ARG_60_B_exosite;ASP_56_B_COREBINDING;GLY_102_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,ELDKYAS,0.987334531443646,0.326642499190438,3.31879948174035,----9-----999999--,GLU_1_C_e;LEU_2_C_C;ASP_3_C_C;LYS_4_C_C;TYR_5_C_C;ALA_6_C_C;SER_7_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS"
1U8Q_BA_C_4_1.pdb,1U8Q,19740978,2.24,,,2.60.40.10,BA,441,C,7,----E-----LEKWAS--,----C-----BTTTTC--,----3-----201013--,4,1,18,----e-----CCCCCC--,6,1,D:0;F:0;G:0;H:0;L:0;P:0;R:0;T:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:0;R:1;T:0;V:0;Y:0,A:3;C:2;D:2;E:3;F:1;G:9;K:11;L:1;N:2;P:8;Q:5;R:5;S:20;T:6;V:1,A:23;C:8;D:14;E:12;F:14;G:21;H:5;I:13;K:10;L:35;M:2;N:10;P:22;Q:14;R:11;S:39;T:37;V:37;W:6;Y:13,B:0;C:0;E:0;G:0;T:0;b:0,B:0;C:0;E:1;G:0;T:0;b:0,C:23;E:10;G:7;H:4;T:35,B:6;C:50;E:210;G:13;H:8;T:54;b:5,4_1,D:2;F:2;G:1;H:2;L:1;P:1;R:2;T:1;V:1;Y:2,B:1;C:5;E:2;G:1;T:5;b:1,D:0;F:0;G:0;H:0;L:0;P:0;R:0;T:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0;b:0,----9-----999999--,ARG_100_B_COREBINDING;ARG_113_B_COREBINDING;ARG_60_B_exosite;ASP_56_B_COREBINDING;ASP_58_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_32_B_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;THR_30_A_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,ELEKWAS,0.987334531443646,0.326612264874489,3.45923850001702,----9-----999999--,GLU_1_C_e;LEU_2_C_C;GLU_3_C_C;LYS_4_C_C;TRP_5_C_C;ALA_6_C_C;SER_7_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS"
1U91_BA_C_4_1.pdb,1U91,19740978,2.24,,,2.60.40.10,BA,441,C,7,----E-----NDKWAS--,----C-----BTTTTC--,----2-----101014--,4,1,18,----e-----CCCCCC--,6,1,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:0;R:1;V:0;Y:0,A:3;C:2;D:2;E:3;F:2;G:9;K:11;L:1;N:2;P:8;Q:5;R:4;S:20;T:6;V:1,A:23;C:8;D:15;E:12;F:14;G:20;H:5;I:13;K:10;L:35;M:2;N:10;P:22;Q:14;R:11;S:39;T:38;V:37;W:6;Y:13,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:0,C:22;E:10;G:7;H:4;T:36,B:6;C:50;E:210;G:13;H:8;T:54;b:6,4_1,D:1;F:1;G:2;H:2;L:1;P:1;R:3;V:1;Y:2,B:1;C:6;E:2;G:1;T:4,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0,----4-----433347--,ARG_100_B_COREBINDING;ARG_101_B_COREBINDING;ARG_113_B_COREBINDING;ARG_60_B_exosite;ASP_56_B_COREBINDING;GLY_102_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,ENDKWAS,0.987334531443646,0.326672733506386,3.2901130679659,----9-----999999--,GLU_1_C_e;ASN_2_C_C;ASP_3_C_C;LYS_4_C_C;TRP_5_C_C;ALA_6_C_C;SER_7_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW 3 DAPS CYCLIC"
1U92_BA_C_4_1.pdb,1U92,19740978,2.24,,,2.60.40.10,BA,438,C,7,----E-----ADKWQS--,----C-----BTTTTC--,----2-----201005--,4,1,18,----e-----CCCCCC--,6,1,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:0;R:1;V:0;Y:0,A:3;C:1;D:2;E:3;F:2;G:8;K:11;L:1;N:2;P:8;Q:5;R:4;S:21;T:5;V:1,A:22;C:8;D:15;E:12;F:14;G:20;H:5;I:13;K:10;L:35;M:2;N:10;P:22;Q:14;R:11;S:38;T:39;V:37;W:6;Y:13,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:0,C:19;E:8;G:7;H:4;T:39,B:6;C:49;E:210;G:13;H:8;T:54;b:6,4_1,D:1;F:1;G:2;H:2;L:1;P:1;R:3;V:1;Y:2,B:1;C:6;E:2;G:1;T:4,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0,----5-----544489--,ARG_100_B_COREBINDING;ARG_101_B_COREBINDING;ARG_113_B_COREBINDING;ARG_60_B_exosite;ASP_56_B_COREBINDING;GLY_102_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,EADKWQS,0.984795622438505,0.327370697975828,2.85965819635844,----9-----999999--,GLU_1_C_e;ALA_2_C_C;ASP_3_C_C;LYS_4_C_C;TRP_5_C_C;GLN_6_C_C;SER_7_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EDAP 3 DKWQS CYCLIC"
1U93_BA_C_4_1.pdb,1U93,19740978,2.37,,,2.60.40.10,BA,441,C,7,----E-----QDKWAS--,----C-----BTTTTC--,----3-----201014--,4,1,18,----e-----CCCCCC--,6,1,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,A:3;C:2;D:2;E:3;F:1;G:9;K:11;L:1;N:2;P:8;Q:5;R:4;S:20;T:6;V:1,A:23;C:8;D:15;E:12;F:14;G:21;H:5;I:13;K:10;L:35;M:2;N:10;P:22;Q:14;R:13;S:39;T:38;V:37;W:6;Y:13,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:22;E:10;G:7;H:4;T:35,B:6;C:52;E:211;G:13;H:8;T:54;b:6,4_1,D:1;F:2;G:1;H:2;L:1;P:1;R:2;V:1;Y:2,B:1;C:4;E:2;G:1;T:5,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0,----6-----644589--,ARG_100_B_COREBINDING;ARG_113_B_COREBINDING;ASP_56_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_32_B_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,EQDKWAS,0.987334531443646,0.326672733506386,2.92444815307093,----9-----999999--,GLU_1_C_e;GLN_2_C_C;ASP_3_C_C;LYS_4_C_C;TRP_5_C_C;ALA_6_C_C;SER_7_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW 3 DAPS CYCLIC"
1U95_BA_C_4_1.pdb,1U95,19740978,2.24,,,2.60.40.10,BA,441,C,7,----E-----LDHWAS--,----C-----BTTTTC--,----3-----101014--,4,1,18,----e-----CCCCCC--,6,1,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:0;R:1;V:0;Y:0,A:3;C:2;D:2;E:3;F:1;G:9;K:11;L:1;N:2;P:8;Q:5;R:4;S:20;T:6;V:1,A:23;C:8;D:14;E:12;F:14;G:20;H:5;I:13;K:10;L:35;M:2;N:10;P:22;Q:14;R:12;S:39;T:38;V:37;W:6;Y:13,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:0,C:22;E:10;G:7;H:4;T:35,B:6;C:50;E:210;G:13;H:8;T:54;b:6,4_1,D:2;F:2;G:2;H:2;L:1;P:1;R:2;V:1;Y:2,B:1;C:6;E:2;G:1;T:5,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0,----5-----543458--,ARG_100_B_COREBINDING;ARG_113_B_COREBINDING;ARG_60_B_exosite;ASP_56_B_COREBINDING;ASP_58_B_COREBINDING;GLY_102_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_32_B_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,ELDHWAS,0.987334531443646,0.326642499190438,3.28108198617468,----9-----999999--,GLU_1_C_e;LEU_2_C_C;ASP_3_C_C;HIS_4_C_C;TRP_5_C_C;ALA_6_C_C;SER_7_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS"
2B1A_HL_P_4_5.pdb,2B1A,16731948,2.35,,,2.60.40.10,HL,441,P,16,--TRKSIHLGPGR-AFYAT---,--TTTTEEEETTE-EETTC---,--20000000233-11125---,4,5,3,--CCCCCCCCCCC-CDDED---,12,4,A:0;D:0;E:0;G:0;I:0;L:0;N:0;P:0;R:0;S:0;W:0;Y:0,A:0;D:0;E:0;G:0;I:0;L:0;N:0;P:0;R:0;S:0;W:0;Y:0,A:5;D:2;E:6;G:11;K:12;N:2;P:7;Q:2;R:2;S:23;T:6;V:1,A:26;C:8;D:13;E:11;F:12;G:22;H:7;I:10;K:13;L:29;M:3;N:8;P:22;Q:16;R:6;S:45;T:29;V:30;W:9;Y:16,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:24;E:13;G:3;H:4;T:35,B:5;C:54;E:196;G:6;H:8;T:62;b:4,4_5,A:1;D:5;E:1;G:3;I:1;L:1;N:2;P:1;R:1;S:1;W:2;Y:4,B:1;C:5;E:8;T:9,A:0;D:0;E:0;G:2;I:0;L:0;N:0;P:0;R:1;S:1;W:0;Y:0,B:0;C:1;E:2;T:1,--97544442456-68999---,ALA_108_H_COREBINDING;ARG_59_H_EXOSITE;ARG_98_H_COREBINDING;ASN_31_L_COREBINDING;ASN_32_L_COREBINDING;ASP_102_H_COREBINDING;ASP_109_H_COREBINDING;ASP_31_H_COREBINDING;ASP_55_H_COREBINDING;ASP_57_H_COREBINDING;GLU_104_H_COREBINDING;GLY_100_H_COREBINDING;GLY_101_H_COREBINDING;GLY_107_H_COREBINDING;GLY_97_L_EXOSITE;GLY_98_L_EXOSITE;ILE_50_H_COREBINDING;LEU_99_H_COREBINDING;PRO_99_L_COREBINDING;SER_106_H_COREBINDING;SER_58_H_EXOSITE;TRP_33_H_COREBINDING;TRP_92_L_COREBINDING;TYR_32_H_COREBINDING;TYR_33_L_COREBINDING;TYR_35_L_COREBINDING;TYR_52_H_COREBINDING,NNTRKSIHLGPGRAFYATGDIIG,0.888888888888889,0.397880955277947,0.998631563691034,--99999999999-99999---,THR_1_P_C;ARG_2_P_C;LYS_3_P_C;SER_4_P_C;ILE_5_P_C;HIS_6_P_C;LEU_7_P_C;GLY_8_P_C;PRO_9_P_C;GLY_10_P_C;ARG_11_P_C;ALA_12_P_C;PHE_13_P_E;TYR_14_P_E;ALA_15_P_E;THR_16_P_E,"CRYSTAL STRUCTURE ANALYSIS OF ANTIHIV1 V3 FAB 2219 IN COMPLEX WITH 2 UG1033 PEPTIDE"
2B1H_HL_P_4_5.pdb,2B1H,16731948,2.00,,,2.60.40.10,HL,441,P,16,--TKKSIKIRPRQ-AFYAT---,--TTTTEEEETTE-EETTC---,--20000101241-11134---,4,5,3,--CCCCCCCCCCC-CDDDE---,12,4,A:0;D:0;E:0;G:0;I:0;L:0;N:0;P:0;R:0;S:0;W:0;Y:0,A:0;D:0;E:0;G:0;I:0;L:0;N:0;P:0;R:0;S:0;W:0;Y:0,A:5;D:1;E:5;G:12;K:12;N:2;P:8;Q:4;R:2;S:24;T:7;V:2,A:26;C:8;D:12;E:12;F:12;G:23;H:7;I:10;K:13;L:29;M:3;N:8;P:21;Q:14;R:7;S:45;T:28;V:29;W:9;Y:17,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,B:1;C:25;E:11;G:7;H:5;T:35,B:5;C:51;E:206;G:10;H:7;T:50;b:4,4_5,A:1;D:7;E:1;G:1;I:1;L:1;N:2;P:1;R:0;S:1;W:2;Y:3,B:1;C:4;E:5;T:11,A:0;D:0;E:0;G:2;I:0;L:0;N:0;P:0;R:1;S:0;W:0;Y:0,B:0;C:1;E:1;T:1,--99653323333-34579---,ALA_108_H_COREBINDING;ARG_59_H_EXOSITE;ASN_31_L_COREBINDING;ASN_32_L_COREBINDING;ASP_102_H_COREBINDING;ASP_105_H_COREBINDING;ASP_109_H_COREBINDING;ASP_31_H_COREBINDING;ASP_55_H_COREBINDING;ASP_57_H_COREBINDING;ASP_94_L_COREBINDING;GLU_104_H_COREBINDING;GLY_107_H_COREBINDING;GLY_97_L_EXOSITE;GLY_98_L_EXOSITE;ILE_50_H_COREBINDING;LEU_99_H_COREBINDING;PRO_99_L_COREBINDING;SER_106_H_COREBINDING;TRP_33_H_COREBINDING;TRP_92_L_COREBINDING;TYR_32_H_COREBINDING;TYR_33_L_COREBINDING;TYR_52_H_COREBINDING,NNTKKSIKIRPRQAFYATNGIIG,0.888888888888889,0.398107997661852,1.13010795944458,--99999999999-99999---,THR_1_P_C;LYS_2_P_C;LYS_3_P_C;SER_4_P_C;ILE_5_P_C;LYS_6_P_C;ILE_7_P_C;ARG_8_P_C;PRO_9_P_C;ARG_10_P_C;GLN_11_P_C;ALA_12_P_C;PHE_13_P_E;TYR_14_P_E;ALA_15_P_E;THR_16_P_E,"CRYSTAL STRUCTURE ANALYSIS OF ANTIHIV1 V3 FAB 2219 IN COMPLEX WITH 2 UG29 PEPTIDE"
2CK0_LH_P_4_35.pdb,2CK0,,2.20,P01837,PF07654,2.60.40.10,LH,427,P,11,CKEWLSTAPCG,CCTTTTCCCCC,14210022224,4,35,1,CCCCCCCCCCC,11,0,D:0;F:0;G:0;H:0;L:0;N:0;R:0;S:0;Y:0,D:0;F:0;G:0;H:0;L:0;N:0;R:0;S:0;Y:0,A:1;D:8;E:4;G:6;I:1;K:10;M:1;N:2;P:3;Q:4;R:3;S:20;T:7;V:1,A:23;C:8;D:12;E:10;F:13;G:23;H:4;I:12;K:14;L:31;M:6;N:15;P:19;Q:15;R:14;S:35;T:34;V:30;W:8;Y:17,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:17;E:8;G:7;H:4;T:35,B:7;C:54;E:209;G:9;H:7;T:53;b:4,4_35,D:1;F:1;G:2;H:1;L:1;N:2;R:1;S:1;Y:3,C:1;E:1;G:2;T:9,D:0;F:0;G:0;H:0;L:0;N:0;R:0;S:0;Y:0,C:0;E:0;G:0;T:0,67665676689,ARG_52_H_COREBINDING;ASN_57_H_COREBINDING;ASN_99_L_COREBINDING;ASP_103_H_COREBINDING;GLY_104_H_COREBINDING;GLY_55_H_COREBINDING;HIS_31_L_COREBINDING;LEU_100_L_COREBINDING;PHE_56_H_COREBINDING;SER_97_L_COREBINDING;TYR_38_L_COREBINDING;TYR_61_H_COREBINDING;TYR_98_L_COREBINDING,CKEWLSTAPCG,-1,0.492957809948292,,99999999999,CYS_1_P_C;LYS_2_P_C;GLU_3_P_C;TRP_4_P_C;LEU_5_P_C;SER_6_P_C;THR_7_P_C;ALA_8_P_C;PRO_9_P_C;CYS_10_P_C;GLY_11_P_C,"ANTIANTIIDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II 2 COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE"
2FX7_HL_P_4_9.pdb,2FX7,17125793,1.76,,,2.60.40.10,HL,442,P,16,NWFDITNWLWYIKKKK,CGGGHHHHHHHHHHHC,1001100300112234,4,9,2,CCCCCCCCCCCCCCCe,15,1,A:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:2;D:4;E:5;G:12;K:9;L:1;N:2;P:6;Q:3;R:7;S:20;T:7;W:1,A:28;C:8;D:8;E:13;F:14;G:25;H:5;I:7;K:11;L:31;M:1;N:9;P:19;Q:20;R:11;S:39;T:30;V:37;W:6;Y:15,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:21;E:11;G:5;H:3;T:39,B:7;C:56;E:199;G:13;H:8;T:50;b:4,4_9,A:1;E:1;G:3;I:3;K:2;L:3;N:2;P:1;Q:1;S:3;T:2;V:1;W:1;Y:2,C:2;E:11;G:3;T:10,A:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,4444444667889999,ALA_33_H_COREBINDING;ASN_31_L_COREBINDING;ASN_59_H_COREBINDING;GLN_94_L_COREBINDING;GLU_99_H_COREBINDING;GLY_108_H_COREBINDING;GLY_50_H_COREBINDING;GLY_93_L_COREBINDING;ILE_111_H_COREBINDING;ILE_52_H_COREBINDING;ILE_57_H_COREBINDING;LEU_107_H_COREBINDING;LEU_54_H_COREBINDING;LEU_55_H_COREBINDING;LYS_109_H_COREBINDING;LYS_33_L_COREBINDING;PRO_110_H_COREBINDING;SER_35_H_COREBINDING;SER_95_L_COREBINDING;SER_97_L_COREBINDING;THR_31_H_COREBINDING;THR_58_H_COREBINDING;TRP_47_H_COREBINDING;TYR_32_H_COREBINDING;TYR_92_L_COREBINDING;VAL_51_H_COREBINDING,NWFDITNWLWYIKKKK,0.97737556561086,0.41078773648324,10.6123817307898,9999999999999999,ASN_1_P_C;TRP_2_P_C;PHE_3_P_C;ASP_4_P_C;ILE_5_P_C;THR_6_P_C;ASN_7_P_C;TRP_8_P_C;LEU_9_P_C;TRP_10_P_C;TYR_11_P_C;ILE_12_P_C;LYS_13_P_C;LYS_14_P_C;LYS_15_P_C;LYS_16_P_e,"CRYSTAL STRUCTURE OF HIV1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH 2 A 16RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41"
2G5B_AB_I_4_20.pdb,2G5B,16946732,2.30,,,2.60.40.10,AB,433,I,7,PTSSE--QI----,CGGGC--CC----,20010--21----,4,20,2,dCCCC--CC----,6,1,D:0;F:0;G:0;K:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,D:0;F:0;G:0;K:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:3;D:6;E:4;G:8;K:10;M:1;N:3;P:6;Q:3;R:3;S:19;T:7;V:2;Y:1,A:17;C:8;D:12;E:13;F:14;G:22;H:4;I:13;K:11;L:29;M:5;N:13;P:18;Q:12;R:14;S:40;T:36;V:32;W:9;Y:16,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:18;E:11;G:7;H:5;T:35,B:5;C:49;E:220;G:9;H:7;T:44;b:4,4_20,D:1;F:1;G:1;K:1;L:1;N:4;R:1;S:2;T:1;V:1;W:1;Y:4,C:4;E:3;G:5;T:7,D:0;F:0;G:0;K:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,66465--67----,ARG_52_B_COREBINDING;ASN_31_A_COREBINDING;ASN_53_B_COREBINDING;ASN_56_B_COREBINDING;ASN_99_A_COREBINDING;ASP_31_B_COREBINDING;GLY_103_B_COREBINDING;LEU_100_A_COREBINDING;LYS_33_A_COREBINDING;PHE_50_B_COREBINDING;SER_104_B_COREBINDING;SER_97_A_COREBINDING;THR_34_A_COREBINDING;TRP_108_B_COREBINDING;TYR_106_B_COREBINDING;TYR_33_B_COREBINDING;TYR_38_A_COREBINDING;TYR_98_A_COREBINDING;VAL_55_B_COREBINDING,PTSSEQI,0.778290993071594,0.494346449375193,1.27353445183081,99999--99----,PRO_1_I_e;THR_2_I_C;SER_3_I_C;SER_4_I_C;GLU_5_I_C;GLN_6_I_C;ILE_7_I_C,"CRYSTAL STRUCTURE OF THE ANTIBAX MONOCLONAL ANTIBODY 6A7 AND A BAX 2 PEPTIDE"
2HKF_LH_P_4_37.pdb,2HKF,18041760,2.01,,,2.60.40.10,LH,429,P,9,LPGEEDLPG,CCCCTTTCC,201201014,4,37,1,CCCCCCCCC,9,0,A:0;F:0;G:0;H:0;K:0;N:0;R:0;S:0;T:0;V:0;Y:0,A:0;F:0;G:0;H:0;K:0;N:0;R:0;S:0;T:0;V:0;Y:0,A:3;C:1;D:7;E:3;G:7;K:9;L:1;N:4;P:5;Q:4;R:3;S:19;T:5;V:1,A:16;C:9;D:11;E:12;F:13;G:20;H:7;I:11;K:12;L:30;M:7;N:13;P:19;Q:13;R:8;S:41;T:34;V:36;W:8;Y:17,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:19;E:10;G:8;H:4;T:31,B:6;C:50;E:211;G:9;H:8;T:49;b:4,4_37,A:1;F:1;G:2;H:1;K:1;N:4;R:2;S:2;T:2;V:1;Y:3,C:5;E:4;G:1;T:10,A:0;F:0;G:0;H:0;K:0;N:0;R:0;S:0;T:0;V:0;Y:0,C:0;E:0;G:0;T:0,753432347,ALA_33_H_COREBINDING;ARG_50_H_COREBINDING;ARG_52_H_COREBINDING;ASN_103_H_COREBINDING;ASN_31_H_COREBINDING;ASN_33_L_COREBINDING;ASN_56_H_COREBINDING;GLY_102_H_COREBINDING;GLY_26_H_COREBINDING;HIS_31_L_COREBINDING;LYS_55_L_COREBINDING;PHE_101_L_COREBINDING;SER_27_H_COREBINDING;SER_96_L_COREBINDING;THR_100_H_COREBINDING;THR_28_H_COREBINDING;TYR_101_H_COREBINDING;TYR_32_H_COREBINDING;TYR_37_L_COREBINDING;VAL_2_H_COREBINDING,LPGEEDLPG,-1,0.495562917124717,,999999999,LEU_1_P_C;PRO_2_P_C;GLY_3_P_C;GLU_4_P_C;GLU_5_P_C;ASP_6_P_C;LEU_7_P_C;PRO_8_P_C;GLY_9_P_C,"CRYSTAL STRUCTURE OF THE COMPLEX FAB M75 PEPTIDE"
2P8L_BA_C_4_1.pdb,2P8L,18824005,2.44,,,2.60.40.10,BA,436,C,11,--E----LLELDKWASL-,--C----CCEETTTTCC-,--3----3021010032-,4,1,18,--E----EEECCCCCCd-,6,4,A:0;D:0;F:0;G:0;H:0;L:0;P:0;Q:0;R:0;V:0;Y:0,A:0;D:0;F:0;G:0;H:0;L:0;P:1;Q:0;R:0;V:0;Y:0,A:1;C:1;D:2;E:4;F:2;G:8;K:11;L:1;N:2;P:10;Q:4;R:4;S:21;T:7;V:1,A:22;C:8;D:14;E:11;F:14;G:20;H:5;I:13;K:9;L:34;M:2;N:10;P:19;Q:14;R:11;S:37;T:38;V:37;W:6;Y:13,C:0;E:0;G:0;T:0,C:0;E:1;G:0;T:0,C:18;E:11;G:3;H:3;T:44,B:6;C:42;E:205;G:8;H:8;T:62;b:6,4_1,A:0;D:2;F:1;G:2;H:2;L:1;P:1;Q:0;R:3;V:1;Y:2,C:5;E:4;G:1;T:5,A:1;D:0;F:0;G:0;H:0;L:1;P:0;Q:1;R:1;V:0;Y:0,C:2;E:1;G:0;T:1,--9----9765444699-,ALA_1_A_EXOSITE;ARG_100_B_COREBINDING;ARG_101_B_COREBINDING;ARG_113_B_COREBINDING;ARG_60_B_EXOSITE;ASP_56_B_COREBINDING;ASP_58_B_COREBINDING;GLN_27_A_EXOSITE;GLY_102_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_2_A_EXOSITE;LEU_91_A_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;PRO_110_B_exosite;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,ELLELDKWASLNW,0.981604087244166,0.328269687610262,1.02530239441835,--9----9999999999-,GLU_1_C_E;LEU_2_C_E;LEU_3_C_E;GLU_4_C_E;LEU_5_C_C;ASP_6_C_C;LYS_7_C_C;TRP_8_C_C;ALA_9_C_C;SER_10_C_C;LEU_11_C_e,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN"
2R0W_LH_Q_4_3.pdb,2R0W,17895381,2.50,A2NHM3_Q811U5,PF07686_PF07654,2.60.40.10,LH,435,Q,7,-AEFRH-DS,-CBCCC-CC,-42010-14,4,3,5,-CCCCC-Cd,6,1,D:0;G:0;H:0;L:0;N:0;R:0;S:0;V:0;W:0;Y:0,D:0;G:0;H:0;L:0;N:0;R:0;S:0;V:0;W:0;Y:0,A:4;D:6;E:2;G:5;K:8;L:1;N:3;P:4;Q:7;R:5;S:23;T:4;V:2,A:16;C:8;D:12;E:12;F:14;G:24;H:5;I:16;K:17;L:36;M:3;N:12;P:20;Q:10;R:8;S:38;T:38;V:31;W:10;Y:15,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:18;E:9;G:7;H:4;T:36,B:9;C:48;E:215;G:8;H:8;T:53;b:4,4_3,D:3;G:1;H:3;L:1;N:2;R:1;S:2;V:1;W:1;Y:1,B:1;C:7;E:1;T:7,D:0;G:0;H:0;L:0;N:0;R:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;T:0,-99999-99,ARG_100_H_COREBINDING;ASN_103_H_COREBINDING;ASN_33_L_COREBINDING;ASP_108_H_COREBINDING;ASP_56_H_COREBINDING;ASP_58_H_COREBINDING;GLY_96_L_COREBINDING;HIS_102_H_COREBINDING;HIS_31_L_COREBINDING;HIS_98_L_COREBINDING;LEU_101_L_COREBINDING;SER_32_L_COREBINDING;SER_97_L_COREBINDING;TRP_54_H_COREBINDING;TYR_37_L_COREBINDING;VAL_99_L_COREBINDING,DAEFRHDS,0.932297009390042,0.474962429718403,0.617459310400287,-99999-99,ALA_1_Q_C;GLU_2_Q_C;PHE_3_Q_C;ARG_4_Q_C;HIS_5_Q_C;ASP_6_Q_C;SER_7_Q_e,"PFA2 FAB COMPLEXED WITH ABETA18"
2R0Z_LH_Q_4_3.pdb,2R0Z,17895381,2.10,A2NHM3,PF07654_PF07686,2.60.40.10,LH,434,Q,6,-AKFRH-D-,-CBCCC-C-,-41010-3-,4,3,5,-CCCCC-C-,6,0,D:0;G:0;H:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,D:0;G:0;H:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:5;C:1;D:8;E:2;G:6;K:9;L:2;N:3;P:3;Q:6;R:5;S:21;T:3;V:1,A:15;C:8;D:10;E:12;F:15;G:23;H:4;I:15;K:14;L:36;M:3;N:11;P:21;Q:11;R:9;S:41;T:40;V:28;W:9;Y:15,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:24;E:11;G:3;H:4;T:33,B:5;C:47;E:216;G:6;H:7;T:55;b:4,4_3,D:3;G:1;H:4;L:1;N:1;R:1;S:2;T:1;V:2;W:2;Y:1,B:2;C:6;E:3;T:8,D:0;G:0;H:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;T:0,-77555-7-,ARG_100_H_COREBINDING;ASN_33_L_COREBINDING;ASP_108_H_COREBINDING;ASP_56_H_COREBINDING;ASP_58_H_COREBINDING;GLY_96_L_COREBINDING;HIS_102_H_COREBINDING;HIS_31_L_COREBINDING;HIS_52_H_COREBINDING;HIS_98_L_COREBINDING;LEU_101_L_COREBINDING;SER_32_L_COREBINDING;SER_97_L_COREBINDING;THR_103_H_COREBINDING;TRP_54_H_COREBINDING;TRP_55_H_COREBINDING;TYR_37_L_COREBINDING;VAL_30_L_COREBINDING;VAL_99_L_COREBINDING,AKFRHD,0.924754109726607,0.46952772353646,,-99999-9-,ALA_1_Q_C;LYS_2_Q_C;PHE_3_Q_C;ARG_4_Q_C;HIS_5_Q_C;ASP_6_Q_C,"PFA1 FAB COMPLEXED WITH GRIPI PEPTIDE FRAGMENT"
2V17_LH_A_4_45.pdb,2V17,18061582,1.65,,,2.60.40.10,LH,436,A,6,TDHGAE,CCCCCC,421001,4,45,1,CCCCCC,6,0,A:0;D:0;F:0;H:0;N:0;R:0;S:0;Y:0,A:0;D:0;F:0;H:0;N:0;R:0;S:0;Y:0,A:5;D:6;E:4;G:8;K:8;N:3;P:4;Q:5;R:3;S:19;T:5,A:23;C:10;D:10;E:15;F:14;G:24;H:4;I:14;K:14;L:34;M:5;N:13;P:19;Q:10;R:10;S:43;T:40;V:24;W:8;Y:18,C:0;E:0;T:0;b:0,C:0;E:0;T:0;b:0,C:18;E:8;G:8;H:5;T:31,B:4;C:60;E:219;G:13;H:7;T:44;b:5,4_45,A:3;D:1;F:1;H:1;N:1;R:3;S:1;Y:3,C:4;E:1;T:8;b:1,A:0;D:0;F:0;H:0;N:0;R:0;S:0;Y:0,C:0;E:0;T:0;b:0,875445,ALA_104_H_COREBINDING;ALA_105_H_COREBINDING;ALA_107_H_COREBINDING;ARG_106_H_COREBINDING;ARG_30_L_COREBINDING;ARG_52_H_COREBINDING;ASN_92_L_COREBINDING;ASP_93_L_COREBINDING;HIS_91_L_COREBINDING;PHE_32_L_COREBINDING;SER_50_L_COREBINDING;TYR_33_H_COREBINDING;TYR_49_L_COREBINDING;TYR_94_L_COREBINDING,TDHGAE,-1,0.478351013210072,,999999,THR_1_A_C;ASP_2_A_C;HIS_3_A_C;GLY_4_A_C;ALA_5_A_C;GLU_6_A_C,"STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT 2 OF TAU PROTEIN"
2Y07_HL_P_4_44.pdb,2Y07,22266283,2.40,,,2.60.40.10,HL,426,P,6,PPYPAW,CCCCCC,122231,4,44,1,CCCCCC,6,0,A:0;D:0;H:0;N:0;R:0;S:0;T:0;W:0;Y:0,A:0;D:0;H:0;N:0;R:0;S:0;T:0;W:0;Y:0,A:3;D:3;E:5;G:12;H:1;K:6;M:1;N:4;P:8;Q:4;R:3;S:22;T:6;V:1;Y:1,A:28;C:8;D:9;E:12;F:11;G:25;H:6;I:8;K:10;L:30;M:4;N:7;P:20;Q:12;R:6;S:29;T:46;V:36;W:9;Y:16,E:0;T:0,E:0;T:0,C:19;E:15;G:5;H:4;T:37,B:8;C:54;E:199;G:4;H:7;T:55;b:5,4_44,A:1;D:1;H:1;N:1;R:1;S:2;T:1;W:2;Y:4,E:7;T:7,A:0;D:0;H:0;N:0;R:0;S:0;T:0;W:0;Y:0,E:0;T:0,555555,ALA_59_H_COREBINDING;ARG_50_H_COREBINDING;ASN_96_L_COREBINDING;ASP_52_H_COREBINDING;HIS_35_H_COREBINDING;SER_32_L_COREBINDING;SER_95_L_COREBINDING;THR_58_H_COREBINDING;TRP_33_H_COREBINDING;TRP_93_L_COREBINDING;TYR_101_H_COREBINDING;TYR_34_L_COREBINDING;TYR_94_L_COREBINDING;TYR_99_H_COREBINDING,PPYPAWHAPGNI,-1,0.335707493436376,,999999,PRO_1_P_C;PRO_2_P_C;TYR_3_P_C;PRO_4_P_C;ALA_5_P_C;TRP_6_P_C,"CRYSTAL STRUCTURE ANALYSIS OF THE ANTI4HYDROXY3 2 NITROPHENYL ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY 3 BBE612H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY 4 DERIVED DODECAPEPTIDE PPYPAWHAPGNI"
3BAE_LH_A_4_3.pdb,3BAE,18237744,1.59,A2NHM3_Q811U5,PF07686_PF07654,2.60.40.10,LH,437,A,7,-AEFRHDS-,-CBCCCCC-,-4101014-,4,3,5,-CCCCCCC-,7,0,A:0;D:0;E:0;H:0;L:0;N:0;R:0;S:0;V:0;W:0;Y:0,A:0;D:0;E:0;H:0;L:0;N:0;R:0;S:0;V:0;W:0;Y:0,A:4;D:8;E:2;G:7;K:7;L:1;N:2;P:3;Q:3;R:7;S:22;T:6;Y:1,A:14;C:8;D:11;E:14;F:16;G:22;H:6;I:15;K:16;L:34;M:4;N:10;P:21;Q:11;R:11;S:40;T:39;V:31;W:8;Y:15,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:18;E:9;G:6;H:5;T:35,B:7;C:57;E:210;G:12;H:11;T:45;b:4,4_3,A:1;D:2;E:1;H:2;L:2;N:2;R:1;S:2;V:1;W:1;Y:3,B:2;C:4;E:2;T:10,A:0;D:0;E:0;H:0;L:0;N:0;R:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;T:0,-6555568-,ALA_96_L_COREBINDING;ARG_99_H_COREBINDING;ASN_109_H_COREBINDING;ASN_33_L_COREBINDING;ASP_55_H_COREBINDING;ASP_57_H_COREBINDING;GLU_107_H_COREBINDING;HIS_31_L_COREBINDING;HIS_51_H_COREBINDING;LEU_101_L_COREBINDING;LEU_98_L_COREBINDING;SER_32_L_COREBINDING;SER_97_L_COREBINDING;TRP_54_H_COREBINDING;TYR_106_H_COREBINDING;TYR_37_L_COREBINDING;TYR_53_H_COREBINDING;VAL_99_L_COREBINDING,DAEFRHDSGYEVHHQKLVFFAEDVGSNK,0.895308924485126,0.470343291594314,,-9999999-,ALA_1_A_C;GLU_2_A_C;PHE_3_A_C;ARG_4_A_C;HIS_5_A_C;ASP_6_A_C;SER_7_A_C,"CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN 2 OF AMYLOID BETA PEPTIDE 128"
3C2A_IM_Q_4_6.pdb,3C2A,18566514,2.10,P0DOY2,,2.60.40.10,IM,445,Q,13,KSIHLGPGRAFYA,CEEEETTTTCCBC,3000000112333,4,6,3,CCCCCCCCCDDDE,9,4,A:0;D:0;E:0;K:0;R:0;S:0;W:0;Y:0,A:0;D:0;E:0;K:0;R:0;S:0;W:0;Y:0,A:3;D:3;E:5;G:12;K:13;L:1;N:2;P:6;Q:2;R:4;S:16;T:11;V:1,A:25;C:10;D:13;E:9;F:13;G:29;H:4;I:10;K:11;L:32;M:3;N:13;P:20;Q:14;R:7;S:44;T:35;V:38;W:7;Y:14,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,B:1;C:20;E:10;G:10;H:5;T:33,B:9;C:60;E:202;G:13;H:7;T:56;b:4,4_6,A:1;D:2;E:1;K:1;R:1;S:1;W:3;Y:5,C:3;E:8;G:1;T:3,A:0;D:0;E:0;K:0;R:0;S:0;W:0;Y:0,C:0;E:0;G:0;T:0,9887777789999,ALA_98_M_COREBINDING;ARG_50_I_COREBINDING;ASP_112_I_COREBINDING;ASP_56_I_COREBINDING;GLU_111_I_COREBINDING;LYS_52_I_COREBINDING;SER_110_I_COREBINDING;TRP_100_M_COREBINDING;TRP_33_I_COREBINDING;TRP_92_M_COREBINDING;TYR_113_I_COREBINDING;TYR_114_I_COREBINDING;TYR_115_I_COREBINDING;TYR_116_I_COREBINDING;TYR_33_M_COREBINDING,KSIHLGPGRAFYA,0.993303504549222,0.395522356519829,0.774370066570242,9999999999999,LYS_1_Q_C;SER_2_Q_C;ILE_3_Q_C;HIS_4_Q_C;LEU_5_Q_C;GLY_6_Q_C;PRO_7_Q_C;GLY_8_Q_C;ARG_9_Q_C;ALA_10_Q_E;PHE_11_Q_E;TYR_12_Q_E;ALA_13_Q_E,"ANTIBODY FAB FRAGMENT 44752D IN COMPLEX WITH UG1033 PEPTIDE"
3D0L_BA_C_4_1.pdb,3D0L,18824005,2.35,Q6GMX6,PF07686_PF07654,2.60.40.10,BA,431,C,10,---L-----ELDKWASLW,---C-----EETTTGGGC,---2-----320100313,4,1,18,---e-----eCCCCCCdd,6,2,A:0;D:0;F:0;G:0;H:0;L:0;N:0;P:0;Q:0;R:0;V:0;Y:0,A:1;D:1;F:0;G:1;H:0;L:1;N:1;P:0;Q:1;R:1;V:0;Y:0,A:2;D:3;E:6;F:1;G:8;K:11;L:1;N:2;P:7;Q:3;R:4;S:20;T:8;V:1,A:21;C:8;D:13;E:9;F:14;G:20;H:5;I:12;K:9;L:33;M:2;N:9;P:22;Q:15;R:12;S:38;T:37;V:36;W:6;Y:13,C:0;E:0;G:0;T:0,C:2;E:0;G:1;T:4,C:17;E:11;G:9;H:5;T:35,B:5;C:49;E:204;G:13;H:7;T:50;b:6,4_1,A:0;D:1;F:1;G:2;H:2;L:1;N:0;P:1;Q:0;R:2;V:1;Y:2,C:4;E:4;G:1;T:4,A:0;D:0;F:0;G:0;H:0;L:0;N:0;P:0;Q:0;R:0;V:0;Y:0,C:0;E:0;G:0;T:0,---8-----877778999,ALA_1_A_exosite;ARG_100_B_COREBINDING;ARG_101_B_COREBINDING;ARG_107_B_exosite;ASN_111_B_exosite;ASP_50_A_exosite;ASP_56_B_COREBINDING;GLN_27_A_exosite;GLY_102_B_COREBINDING;GLY_108_B_exosite;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_2_A_exosite;LEU_91_A_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_110_B_COREBINDING,GIGALFLGFLGAAGSKKKNEQELLELDKWASLWN,0.967086653407345,0.332437481424986,1.38805547439575,---9-----999999999,LEU_1_C_e;GLU_2_C_e;LEU_3_C_C;ASP_4_C_C;LYS_5_C_C;TRP_6_C_C;ALA_7_C_C;SER_8_C_C;LEU_9_C_e;TRP_10_C_e,"CRYSTAL STRUCTURE OF THE HIV1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN 2 COMPLEX WITH THE GP41 FPMPER HYB3K CONSTRUCT 3 514GIGALFLGFLGAAGS528KKAHX655KNEQELLELDKWASLWN671"
3D0V_BA_C_4_1.pdb,3D0V,18824005,2.05,Q8NF17,PF07654,2.60.40.10,BA,435,C,9,-L-LE-----LDKWAS--,-C-CE-----ETTTTC--,-5-12-----201015--,4,1,18,-e-ee-----CCCCCC--,6,3,A:0;D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,A:1;D:0;F:0;G:0;H:0;L:1;P:0;R:1;V:0;Y:0,A:1;C:1;D:2;E:3;F:2;G:8;K:9;L:1;N:2;P:9;Q:4;R:3;S:21;T:7;V:1,A:22;C:8;D:14;E:12;F:14;G:20;H:5;I:13;K:11;L:34;M:2;N:10;P:20;Q:15;R:12;S:37;T:38;V:37;W:6;Y:13,C:0;E:0;G:0;T:0,C:2;E:1;G:0;T:0,C:18;E:7;G:6;H:3;T:40,B:6;C:50;E:210;G:11;H:8;T:52;b:6,4_1,A:0;D:2;F:1;G:2;H:2;L:1;P:1;R:3;V:1;Y:2,C:7;E:4;G:1;T:3,A:0;D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,C:0;E:0;G:0;T:0,-8-75-----434468--,ALA_1_A_exosite;ARG_100_B_COREBINDING;ARG_101_B_COREBINDING;ARG_113_B_COREBINDING;ARG_60_B_exosite;ASP_56_B_COREBINDING;ASP_58_B_COREBINDING;GLY_102_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_2_A_exosite;LEU_91_A_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,LLELDKWASLW,0.979609700277086,0.326560470148427,3.02121929028662,-9-99-----999999--,LEU_1_C_e;LEU_2_C_e;GLU_3_C_e;LEU_4_C_C;ASP_5_C_C;LYS_6_C_C;TRP_7_C_C;ALA_8_C_C;SER_9_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LLELDKWASLW"
3E8U_LH_P_4_39.pdb,3E8U,19274732,2.10,,,2.60.40.10,LH,429,P,9,VQGSGAFGR,TTTTGGGGC,110000122,4,39,1,CCCCCCCCC,9,0,D:0;E:0;F:0;G:0;H:0;I:0;L:0;N:0;R:0;S:0;T:0;W:0;Y:0,D:0;E:0;F:0;G:0;H:0;I:0;L:0;N:0;R:0;S:0;T:0;W:0;Y:0,A:5;D:7;E:2;G:6;K:11;L:1;M:1;N:4;P:3;Q:2;R:1;S:19;T:4,A:19;C:8;D:13;E:14;F:15;G:23;H:5;I:15;K:13;L:26;M:3;N:17;P:24;Q:16;R:8;S:35;T:35;V:27;W:7;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,C:14;E:11;G:4;H:3;T:34,B:6;C:46;E:212;G:8;H:8;T:55;b:4,4_39,D:1;E:1;F:2;G:2;H:3;I:1;L:1;N:3;R:1;S:2;T:2;W:2;Y:3,C:3;E:7;T:14,D:0;E:0;F:0;G:0;H:0;I:0;L:0;N:0;R:0;S:0;T:0;W:0;Y:0,C:0;E:0;T:0,333334445,ARG_101_H_COREBINDING;ASN_35_H_COREBINDING;ASN_52_H_COREBINDING;ASN_96_L_COREBINDING;ASP_98_L_COREBINDING;GLU_97_L_COREBINDING;GLY_103_H_COREBINDING;GLY_33_H_COREBINDING;HIS_100_H_COREBINDING;HIS_31_H_COREBINDING;HIS_54_H_COREBINDING;ILE_59_H_COREBINDING;LEU_104_H_COREBINDING;PHE_100_L_COREBINDING;PHE_102_H_COREBINDING;SER_95_L_COREBINDING;SER_99_H_COREBINDING;THR_30_H_COREBINDING;THR_53_H_COREBINDING;TRP_47_H_COREBINDING;TRP_50_H_COREBINDING;TYR_31_L_COREBINDING;TYR_32_H_COREBINDING;TYR_36_L_COREBINDING,GVQGSGAFGRG,-1,0.47492277652858,,999999999,VAL_1_P_C;GLN_2_P_C;GLY_3_P_C;SER_4_P_C;GLY_5_P_C;ALA_6_P_C;PHE_7_P_C;GLY_8_P_C;ARG_9_P_C,"CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC 2 FAB 1063 COMPLEXED WITH BNP 513 C10A REVEAL BASIS OF 3 SELECTIVE MOLECULAR RECOGNITION"
3EYF_CD_F_4_18.pdb,3EYF,18772881,2.30,Q6PJF2_Q68CN4,PF07686_PF07654,2.60.40.10,CD,426,F,9,--TIYNTTLKY-,--CCCCCCEEC-,--420210032-,4,18,2,--CCCCDDDDD-,4,5,C:0;D:0;F:0;G:0;K:0;L:0;P:0;R:0;S:0;T:0;W:0;Y:0,C:0;D:0;F:0;G:0;K:0;L:0;P:0;R:0;S:0;T:0;W:0;Y:0,A:4;D:2;E:5;G:9;K:12;L:1;M:1;N:2;P:6;Q:4;R:3;S:16;T:5,A:19;C:8;D:14;E:14;F:15;G:28;H:7;I:11;K:8;L:32;M:5;N:11;P:16;Q:17;R:13;S:36;T:27;V:35;W:6;Y:14,C:0;E:0;T:0,C:0;E:0;T:0,B:1;C:24;E:7;G:5;H:3;T:30,B:4;C:51;E:212;G:13;H:8;T:44;b:4,4_18,C:1;D:1;F:1;G:2;K:1;L:2;P:0;R:1;S:1;T:0;W:0;Y:1,C:4;E:4;T:3,C:1;D:1;F:0;G:1;K:0;L:0;P:1;R:2;S:0;T:1;W:1;Y:1,C:3;E:2;T:4,--764444454-,ARG_106_D_EXOSITE;ARG_59_D_EXOSITE;ARG_92_C_COREBINDING;ASP_113_D_COREBINDING;ASP_57_D_EXOSITE;CYS_102_D_COREBINDING;CYS_107_D_EXOSITE;GLY_100_D_COREBINDING;GLY_103_D_COREBINDING;GLY_110_D_EXOSITE;LEU_111_D_COREBINDING;LEU_47_C_COREBINDING;LYS_101_D_COREBINDING;PHE_50_C_COREBINDING;PRO_96_C_EXOSITE;SER_109_D_COREBINDING;THR_56_D_EXOSITE;TRP_95_C_EXOSITE;TYR_108_D_COREBINDING;TYR_33_C_EXOSITE,ETIYNTTLKY,0.262557077625571,0.444698692333046,0.309273341883843,--999999999-,THR_1_F_C;ILE_2_F_C;TYR_3_F_C;ASN_4_F_C;THR_5_F_E;THR_6_F_E;LEU_7_F_E;LYS_8_F_E;TYR_9_F_E,"CRYSTAL STRUCTURE OF ANTIHUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB 2 PEPTIDE"
3FFD_BA_P_4_22.pdb,3FFD,19346515,2.00,,,2.60.40.10,BA,427,P,18,SIQDLRRRFFLHHLIAEI,HHHHHHHHHHHHHHHHCC,220021022002000212,4,22,1,CCCCCCCCCCCCCCCCCC,18,0,D:0;E:0;F:0;G:0;K:0;M:0;Q:0;S:0;T:0;Y:0,D:0;E:0;F:0;G:0;K:0;M:0;Q:0;S:0;T:0;Y:0,A:4;D:7;E:5;G:8;K:14;L:1;M:1;N:3;P:7;Q:5;R:2;S:17;T:5,A:20;C:8;D:8;E:12;F:15;G:20;H:7;I:12;K:9;L:31;M:6;N:8;P:21;Q:11;R:7;S:40;T:33;V:33;W:7;Y:12,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:27;E:12;G:9;H:6;T:25,B:4;C:47;E:211;G:14;H:9;T:31;b:4,4_22,D:2;E:1;F:1;G:4;K:1;M:1;Q:2;S:4;T:7;Y:5,C:5;E:12;G:1;T:10,D:0;E:0;F:0;G:0;K:0;M:0;Q:0;S:0;T:0;Y:0,C:0;E:0;G:0;T:0,654444344334444556,ASP_49_B_COREBINDING;ASP_96_B_COREBINDING;GLN_52_B_COREBINDING;GLN_99_A_COREBINDING;GLU_34_B_COREBINDING;GLY_33_A_COREBINDING;GLY_54_A_COREBINDING;GLY_55_A_COREBINDING;GLY_95_B_COREBINDING;LYS_51_B_COREBINDING;MET_102_A_COREBINDING;PHE_102_B_COREBINDING;SER_31_A_COREBINDING;SER_52_A_COREBINDING;SER_53_A_COREBINDING;SER_56_A_COREBINDING;THR_100_A_COREBINDING;THR_101_A_COREBINDING;THR_103_A_COREBINDING;THR_30_B_COREBINDING;THR_32_B_COREBINDING;THR_50_A_COREBINDING;THR_97_B_COREBINDING;TYR_104_A_COREBINDING;TYR_31_B_COREBINDING;TYR_32_A_COREBINDING;TYR_57_A_COREBINDING;TYR_59_A_COREBINDING,AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEIRATSEVSPNSKPSPNTKNHPVRFGSDDEGRYLTQETNKVETYKEQPLKTPGKKKKGKPGKRKEQEKKKRRTR,-1,0.393799868309779,,999999999999999999,SER_1_P_C;ILE_2_P_C;GLN_3_P_C;ASP_4_P_C;LEU_5_P_C;ARG_6_P_C;ARG_7_P_C;ARG_8_P_C;PHE_9_P_C;PHE_10_P_C;LEU_11_P_C;HIS_12_P_C;HIS_13_P_C;LEU_14_P_C;ILE_15_P_C;ALA_16_P_C;GLU_17_P_C;ILE_18_P_C,"STRUCTURE OF PARATHYROID HORMONERELATED PROTEIN COMPLEXED TO A 2 NEUTRALIZING MONOCLONAL ANTIBODY"
3G5V_AB_C_4_24.pdb,3G5V,19289842,2.00,,,2.60.40.10,AB,412,C,16,CGADSYEMEEDGVRKC,TTTTCCCEEETTEEEC,0141331322000100,4,24,1,CCCCCCCCCCCCCCCC,16,0,A:0;D:0;F:0;G:0;H:0;N:0;R:0;S:0;W:0;Y:0,A:0;D:0;F:0;G:0;H:0;N:0;R:0;S:0;W:0;Y:0,A:3;D:11;E:4;G:7;I:1;K:8;L:1;N:2;P:6;Q:2;R:1;S:25;T:7,A:14;C:8;D:9;E:10;F:14;G:19;H:5;I:16;K:11;L:28;M:5;N:12;P:16;Q:15;R:8;S:38;T:37;V:27;W:8;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,C:26;E:8;G:7;H:4;T:33,B:6;C:50;E:195;G:5;H:7;T:49;b:4,4_24,A:2;D:1;F:2;G:1;H:1;N:4;R:1;S:2;W:1;Y:3,C:3;E:6;T:9,A:0;D:0;F:0;G:0;H:0;N:0;R:0;S:0;W:0;Y:0,C:0;E:0;T:0,6677766655333323,ALA_34_B_COREBINDING;ALA_99_B_COREBINDING;ARG_59_B_COREBINDING;ASN_30_A_COREBINDING;ASN_32_A_COREBINDING;ASN_53_A_COREBINDING;ASN_57_B_COREBINDING;ASP_32_B_COREBINDING;GLY_100_B_COREBINDING;HIS_50_A_COREBINDING;PHE_33_B_COREBINDING;PHE_94_A_COREBINDING;SER_31_A_COREBINDING;SER_53_B_COREBINDING;TRP_96_A_COREBINDING;TYR_51_B_COREBINDING;TYR_54_B_COREBINDING;TYR_91_A_COREBINDING,CGADSYEMEEDGVRKC,-1,0.459431967652943,,9999999999999999,CYS_1_C_C;GLY_2_C_C;ALA_3_C_C;ASP_4_C_C;SER_5_C_C;TYR_6_C_C;GLU_7_C_C;MET_8_C_C;GLU_9_C_C;GLU_10_C_C;ASP_11_C_C;GLY_12_C_C;VAL_13_C_C;ARG_14_C_C;LYS_15_C_C;CYS_16_C_C,"ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR 2 ASSOCIATED EGFR"
3GGW_CD_F_4_20.pdb,3GGW,19328810,1.70,,,2.60.40.10,CD,428,F,12,-YLEDWIKYNNQK,-HHHHHHHHHHHC,-103101301232,4,20,2,-CCCCddccDDDD,4,4,D:0;E:0;H:0;L:1;N:1;R:0;V:0;W:0;Y:0,D:1;E:0;H:1;L:0;N:0;R:0;V:0;W:0;Y:1,A:3;C:1;D:6;E:4;G:8;K:8;M:1;N:4;P:3;Q:3;R:3;S:20;T:4,A:16;C:8;D:11;E:15;F:13;G:22;H:6;I:16;K:15;L:30;M:6;N:11;P:21;Q:8;R:10;S:42;T:34;V:34;W:8;Y:18,C:1;E:0;G:1;T:0,C:0;E:1;G:0;T:2,C:19;E:10;G:10;H:2;T:27,B:9;C:55;E:209;G:16;H:8;T:43;b:4,4_20,D:0;E:1;H:1;L:1;N:1;R:2;V:1;W:1;Y:1,C:4;E:0;G:0;T:5,D:1;E:0;H:0;L:0;N:0;R:0;V:0;W:0;Y:1,C:1;E:0;G:0;T:1,-677667767998,ARG_101_C_COREBINDING;ARG_52_D_COREBINDING;ASN_31_D_corebinding;ASN_96_C_COREBINDING;ASP_103_D_EXOSITE;ASP_33_C_exosite;GLU_98_C_COREBINDING;HIS_31_C_COREBINDING;HIS_55_C_exosite;LEU_53_D_corebinding;LEU_99_C_COREBINDING;TRP_33_D_COREBINDING;TYR_32_D_EXOSITE;TYR_37_C_COREBINDING;TYR_39_C_exosite;VAL_97_C_COREBINDING,YLEDWIKYNNQK,0.778290993071594,0.486028366473947,0.636183149729698,-999999999999,TYR_1_F_C;LEU_2_F_C;GLU_3_F_C;ASP_4_F_C;TRP_5_F_e;ILE_6_F_e;LYS_7_F_c;TYR_8_F_c;ASN_9_F_E;ASN_10_F_E;GLN_11_F_E;LYS_12_F_E,"CRYSTAL STRUCTURE OF FAB F224 IN COMPLEX WITH A CARBOHYDRATEMIMETIC 2 PEPTIDE"
3GHB_IM_Q_4_6.pdb,3GHB,19913488,2.25,,,2.60.40.10,IM,449,Q,9,KGVRIGPGQ----,CEEEECCCC----,510100012----,4,6,3,CCCCCCCCC----,9,0,A:0;D:0;E:0;K:0;R:0;W:0;Y:0,A:0;D:0;E:0;K:0;R:0;W:0;Y:0,A:4;D:3;E:5;G:11;K:14;L:1;N:3;P:6;Q:2;R:4;S:20;T:14;V:1,A:24;C:10;D:14;E:9;F:13;G:30;H:4;I:10;K:11;L:32;M:3;N:12;P:21;Q:14;R:7;S:41;T:34;V:38;W:7;Y:14,C:0;E:0;T:0,C:0;E:0;T:0,B:1;C:26;E:10;G:14;H:5;T:32,B:9;C:62;E:199;G:13;H:7;T:54;b:4,4_6,A:1;D:1;E:1;K:1;R:1;W:3;Y:5,C:2;E:9;T:2,A:0;D:0;E:0;K:0;R:0;W:0;Y:0,C:0;E:0;T:0,999999999----,ALA_98_M_COREBINDING;ARG_50_I_COREBINDING;ASP_112_I_COREBINDING;GLU_111_I_COREBINDING;LYS_52_I_COREBINDING;TRP_100_M_COREBINDING;TRP_33_I_COREBINDING;TRP_92_M_COREBINDING;TYR_113_I_COREBINDING;TYR_114_I_COREBINDING;TYR_115_I_COREBINDING;TYR_116_I_COREBINDING;TYR_33_M_COREBINDING,KGVRIGPGQA,0.989977728285078,0.392675080425637,,999999999----,LYS_1_Q_C;GLY_2_Q_C;VAL_3_Q_C;ARG_4_Q_C;ILE_5_Q_C;GLY_6_Q_C;PRO_7_Q_C;GLY_8_Q_C;GLN_9_Q_C,"CRYSTAL STRUCTURE OF ANTIHIV1 FAB 44752D IN COMPLEX WITH 2 V3 PEPTIDE W2RW020"
3GHE_HL_P_4_27.pdb,3GHE,19913488,2.40,,,2.60.40.10,HL,436,P,15,RKRIHIGPGRAFYAT,CEEEEEETTEEEEEC,221000000101114,4,27,1,CCCCCCCCCCCCCCC,15,0,D:0;E:0;G:0;L:0;N:0;P:0;V:0;W:0;Y:0,D:0;E:0;G:0;L:0;N:0;P:0;V:0;W:0;Y:0,A:8;D:2;E:4;G:12;K:13;L:1;N:5;P:5;Q:3;R:1;S:17;T:9;V:1,A:23;C:8;D:12;E:8;F:14;G:22;H:6;I:8;K:11;L:29;M:3;N:10;P:18;Q:17;R:9;S:45;T:30;V:38;W:7;Y:15,C:0;E:0;T:0,C:0;E:0;T:0,C:26;E:11;G:8;H:5;T:31,B:9;C:55;E:201;G:13;H:6;T:45;b:4,4_27,D:3;E:2;G:1;L:1;N:2;P:1;V:1;W:1;Y:10,C:1;E:14;T:7,D:0;E:0;G:0;L:0;N:0;P:0;V:0;W:0;Y:0,C:0;E:0;T:0,999755444568999,ASN_30_L_COREBINDING;ASN_50_H_COREBINDING;ASP_105_H_COREBINDING;ASP_112_H_COREBINDING;ASP_57_H_COREBINDING;GLU_108_H_COREBINDING;GLU_99_H_COREBINDING;GLY_31_L_COREBINDING;LEU_107_H_COREBINDING;PRO_98_L_COREBINDING;TRP_47_H_COREBINDING;TYR_103_H_COREBINDING;TYR_109_H_COREBINDING;TYR_110_H_COREBINDING;TYR_111_H_COREBINDING;TYR_113_H_COREBINDING;TYR_114_H_COREBINDING;TYR_34_L_COREBINDING;TYR_59_H_COREBINDING;TYR_93_L_COREBINDING;TYR_99_L_COREBINDING;VAL_100_L_COREBINDING,RKRIHIGPGRAFYAT,-1,0.405921872848965,,999999999999999,ARG_1_P_C;LYS_2_P_C;ARG_3_P_C;ILE_4_P_C;HIS_5_P_C;ILE_6_P_C;GLY_7_P_C;PRO_8_P_C;GLY_9_P_C;ARG_10_P_C;ALA_11_P_C;PHE_12_P_C;TYR_13_P_C;ALA_14_P_C;THR_15_P_C,"CRYSTAL STRUCTURE OF ANTIHIV1 FAB 53710D IN COMPLEX WITH 2 V3 PEPTIDE MN"
3H0T_BA_C_4_21.pdb,3H0T,19553669,1.89,,,2.60.40.10,BA,439,C,22,HFPICIFCCGCCHRSKCGMCCK,CCCCEEEEETTTTTCCEEEEEC,5402021023014130000013,4,21,1,CCCCCCCCCCCCCCCCCCCCCC,22,0,A:0;D:0;E:0;F:0;I:0;K:0;R:0;S:0;V:0;Y:0,A:0;D:0;E:0;F:0;I:0;K:0;R:0;S:0;V:0;Y:0,A:3;C:1;D:2;E:3;G:10;H:1;K:9;M:1;N:4;P:6;Q:5;R:1;S:26;T:6,A:23;C:8;D:10;E:11;F:9;G:19;H:4;I:11;K:12;L:27;M:1;N:12;P:23;Q:18;R:8;S:47;T:35;V:39;W:9;Y:15,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:18;E:11;G:9;H:5;T:35,B:7;C:52;E:211;G:12;H:7;T:48;b:4,4_21,A:1;D:3;E:1;F:2;I:1;K:1;R:2;S:3;V:1;Y:5,B:1;C:1;E:7;T:11,A:0;D:0;E:0;F:0;I:0;K:0;R:0;S:0;V:0;Y:0,B:0;C:0;E:0;T:0,9998888899999998877888,ALA_30_A_COREBINDING;ARG_52_B_COREBINDING;ARG_56_B_COREBINDING;ASP_52_A_COREBINDING;ASP_62_B_COREBINDING;ASP_95_A_COREBINDING;GLU_51_A_COREBINDING;ILE_67_A_COREBINDING;LYS_58_B_COREBINDING;PHE_105_B_COREBINDING;PHE_60_B_COREBINDING;SER_31_A_COREBINDING;SER_57_B_COREBINDING;SER_96_A_COREBINDING;TYR_107_B_COREBINDING;TYR_32_A_COREBINDING;TYR_33_A_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_104_B_COREBINDING,DTHFPICIFCCGCCHRSKCGMCCKT,-1,0.414768203093839,,9999999999999999999999,HIS_1_C_C;PHE_2_C_C;PRO_3_C_C;ILE_4_C_C;CYS_5_C_C;ILE_6_C_C;PHE_7_C_C;CYS_8_C_C;CYS_9_C_C;GLY_10_C_C;CYS_11_C_C;CYS_12_C_C;HIS_13_C_C;ARG_14_C_C;SER_15_C_C;LYS_16_C_C;CYS_17_C_C;GLY_18_C_C;MET_19_C_C;CYS_20_C_C;CYS_21_C_C;LYS_22_C_C,"HEPCIDINFAB COMPLEX"
3HR5_LH_R_4_17.pdb,3HR5,20458139,2.40,,,2.60.40.10,LH,439,R,9,-AQSQ-RAPDR---,-CBCC-CCCCC---,-3201-02103---,4,17,2,-CCCC-CDDDD---,5,4,A:0;D:0;H:0;L:0;N:0;S:0;T:0;V:0;W:0;Y:0,A:0;D:0;H:0;L:0;N:0;S:0;T:0;V:0;W:0;Y:0,A:3;C:2;D:3;E:4;G:10;K:12;N:2;P:2;Q:5;R:4;S:20;T:7,A:23;C:8;D:12;E:11;F:16;G:22;H:4;I:11;K:12;L:32;M:3;N:13;P:20;Q:16;R:9;S:41;T:29;V:37;W:6;Y:17,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:22;E:13;G:4;H:2;T:33,B:7;C:55;E:209;G:9;H:9;T:49;b:4,4_17,A:1;D:2;H:2;L:1;N:3;S:1;T:2;V:1;W:2;Y:2,B:1;C:3;E:3;G:0;T:10,A:1;D:2;H:0;L:1;N:0;S:1;T:0;V:0;W:0;Y:1,B:0;C:0;E:0;G:2;T:4,-7555-44457---,ALA_103_H_COREBINDING;ALA_55_H_EXOSITE;ASN_32_L_COREBINDING;ASN_33_L_COREBINDING;ASN_96_L_COREBINDING;ASP_102_H_COREBINDING;ASP_31_H_EXOSITE;ASP_53_H_EXOSITE;ASP_99_H_COREBINDING;HIS_31_L_COREBINDING;HIS_39_L_COREBINDING;LEU_54_H_EXOSITE;LEU_98_L_COREBINDING;SER_30_H_EXOSITE;SER_52_H_COREBINDING;THR_57_H_COREBINDING;THR_97_L_COREBINDING;TRP_101_H_COREBINDING;TRP_101_L_COREBINDING;TYR_37_L_COREBINDING;TYR_56_H_EXOSITE;TYR_59_H_COREBINDING;VAL_99_L_COREBINDING,SAQSQRAPDRVLCHSGQQQGLPRAAGGSVPHPRCH,0.273348519362187,0.468440658276773,0.418350331659961,-9999-99999---,ALA_1_R_C;GLN_2_R_C;SER_3_R_C;GLN_4_R_C;ARG_5_R_C;ALA_6_R_E;PRO_7_R_E;ASP_8_R_E;ARG_9_R_E,"M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB"
3IDG_BA_C_4_1.pdb,3IDG,19740978,1.86,,,2.60.40.10,BA,441,C,6,----A-----LDKWD---,----C-----BCCCC---,----3-----20102---,4,1,18,----e-----CCCCC---,5,1,A:0;D:0;F:0;G:0;H:0;L:0;P:0;R:0;T:0;V:0;Y:0,A:0;D:0;F:0;G:0;H:0;L:0;P:0;R:0;T:0;V:0;Y:0,A:2;C:2;D:2;E:3;F:1;G:10;K:11;L:1;N:2;P:8;Q:5;R:4;S:21;T:7;V:1,A:21;C:8;D:14;E:12;F:14;G:21;H:5;I:13;K:10;L:35;M:2;N:10;P:22;Q:14;R:13;S:38;T:37;V:37;W:6;Y:13,B:0;C:0;E:0;G:0;T:0;b:0,B:0;C:0;E:0;G:0;T:0;b:0,C:22;E:11;G:7;H:4;T:36,B:6;C:51;E:210;G:13;H:8;T:52;b:5,4_1,A:1;D:2;F:2;G:1;H:2;L:1;P:1;R:2;T:1;V:1;Y:2,B:1;C:5;E:2;G:1;T:6;b:1,A:0;D:0;F:0;G:0;H:0;L:0;P:0;R:0;T:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0;b:0,----6-----65567---,ALA_32_A_COREBINDING;ARG_100_B_COREBINDING;ARG_113_B_COREBINDING;ASP_56_B_COREBINDING;ASP_58_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_32_B_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;THR_30_A_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_116_B_COREBINDING,ALDKWD,0.987048443485938,0.329601936986285,3.16881318477439,----9-----99999---,ALA_1_C_e;LEU_2_C_C;ASP_3_C_C;LYS_4_C_C;TRP_5_C_C;ASP_6_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD"
3IFL_LH_P_4_3.pdb,3IFL,19923222,1.50,,,2.60.40.10,LH,432,P,7,DAEFRHD--,CCBCCCC--,5210103--,4,3,5,eCCCCCd--,5,1,D:0;H:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,D:0;H:0;L:0;N:0;R:0;S:0;T:1;V:0;W:0;Y:0,A:4;D:5;E:3;G:6;K:8;L:1;M:1;N:2;P:4;Q:4;R:4;S:24;T:4,A:16;C:8;D:13;E:11;F:15;G:22;H:4;I:15;K:16;L:34;M:3;N:12;P:22;Q:11;R:8;S:39;T:41;V:30;W:8;Y:16,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:1,C:20;E:11;G:6;H:3;T:30,B:7;C:49;E:216;G:12;H:8;T:48;b:4,4_3,D:3;H:3;L:1;N:1;R:1;S:3;T:0;V:1;W:2;Y:2,B:1;C:3;E:6;T:7,D:0;H:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;T:0,9864568--,ARG_99_H_COREBINDING;ASN_33_L_COREBINDING;ASP_104_H_COREBINDING;ASP_55_H_COREBINDING;ASP_57_H_COREBINDING;HIS_31_L_COREBINDING;HIS_51_H_COREBINDING;HIS_98_L_COREBINDING;LEU_101_L_COREBINDING;SER_32_L_COREBINDING;SER_96_L_COREBINDING;SER_97_L_COREBINDING;THR_101_H_exosite;TRP_48_H_COREBINDING;TRP_53_H_COREBINDING;TYR_37_L_COREBINDING;TYR_59_H_COREBINDING;VAL_99_L_COREBINDING,DAEFRHD,0.932251931274237,0.478578464065933,1.56997898075102,9999999--,ASP_1_P_e;ALA_2_P_C;GLU_3_P_C;PHE_4_P_C;ARG_5_P_C;HIS_6_P_C;ASP_7_P_e,"XRAY STRUCTURE OF AMYLOID BETA PEPTIDEANTIBODY ABETA1712A11 2 COMPLEX"
3IFN_LH_P_4_3.pdb,3IFN,19923222,1.50,,,2.60.40.10,LH,434,P,6,-AEFRH-D-,-CBCCC-C-,-32010-4-,4,3,5,-CCCCC-C-,6,0,D:0;H:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,D:0;H:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:3;D:8;E:2;G:7;K:10;L:1;N:2;P:4;Q:4;R:4;S:23;T:5,A:16;C:10;D:11;E:12;F:15;G:21;H:4;I:15;K:15;L:34;M:4;N:12;P:22;Q:11;R:8;S:39;T:40;V:30;W:9;Y:16,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:16;E:12;G:8;H:4;T:33,B:7;C:55;E:214;G:13;H:7;T:44;b:4,4_3,D:3;H:3;L:1;N:1;R:1;S:3;T:1;V:1;W:1;Y:2,B:1;C:3;E:5;T:8,D:0;H:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;T:0,-85455-8-,ARG_100_H_COREBINDING;ASN_33_L_COREBINDING;ASP_105_H_COREBINDING;ASP_56_H_COREBINDING;ASP_58_H_COREBINDING;HIS_31_L_COREBINDING;HIS_52_H_COREBINDING;HIS_98_L_COREBINDING;LEU_101_L_COREBINDING;SER_32_L_COREBINDING;SER_96_L_COREBINDING;SER_97_L_COREBINDING;THR_102_H_COREBINDING;TRP_54_H_COREBINDING;TYR_37_L_COREBINDING;TYR_60_H_COREBINDING;VAL_99_L_COREBINDING,DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV,0.935697595054037,0.478555802689558,,-99999-9-,ALA_1_P_C;GLU_2_P_C;PHE_3_P_C;ARG_4_P_C;HIS_5_P_C;ASP_6_P_C,"XRAY STRUCTURE OF AMYLOID BETA PEPTIDEANTIBODY ABETA14012A11 2 COMPLEX"
3LEX_BA_C_4_14.pdb,3LEX,20876137,1.97,,,2.60.40.10,BA,431,C,7,-LELDKWA,-CCCCCCC,-1220211,4,14,2,-CCCCCCC,7,0,A:0;D:0;F:0;G:0;H:0;K:0;L:0;N:0;R:0;S:0;W:0;Y:0,A:0;D:0;F:0;G:0;H:0;K:0;L:0;N:0;R:0;S:0;W:0;Y:0,A:2;C:1;D:7;E:5;G:8;K:10;L:1;N:2;P:3;Q:3;R:2;S:21;T:2;V:1;Y:1,A:16;C:8;D:10;E:10;F:13;G:20;H:5;I:16;K:10;L:33;M:3;N:13;P:23;Q:15;R:9;S:40;T:43;V:29;W:10;Y:14,C:0;E:0;T:0,C:0;E:0;T:0,C:20;E:6;G:6;H:4;T:33,B:8;C:45;E:213;G:9;H:7;T:54;b:4,4_14,A:1;D:2;F:1;G:2;H:1;K:2;L:2;N:1;R:1;S:1;W:1;Y:7,C:3;E:8;T:11,A:0;D:0;F:0;G:0;H:0;K:0;L:0;N:0;R:0;S:0;W:0;Y:0,C:0;E:0;T:0,-5555444,ALA_104_A_COREBINDING;ARG_51_B_COREBINDING;ASN_100_A_COREBINDING;ASP_31_B_COREBINDING;ASP_33_B_COREBINDING;GLY_96_B_COREBINDING;GLY_99_A_COREBINDING;HIS_98_B_COREBINDING;LEU_102_A_COREBINDING;LEU_55_B_COREBINDING;LYS_35_B_COREBINDING;LYS_58_B_COREBINDING;PHE_99_B_COREBINDING;SER_32_B_COREBINDING;TRP_101_B_COREBINDING;TYR_101_A_COREBINDING;TYR_105_A_COREBINDING;TYR_33_A_COREBINDING;TYR_37_B_COREBINDING;TYR_51_A_COREBINDING;TYR_54_B_COREBINDING;TYR_98_A_COREBINDING,LLELDKWA,0.953810623556582,0.493772339776364,,-9999999,LEU_1_C_C;GLU_2_C_C;LEU_3_C_C;ASP_4_C_C;LYS_5_C_C;TRP_6_C_C;ALA_7_C_C,"2F5 EPITOPE SCAFFOLD ELICITED ANTIHIV1 MONOCLONAL ANTIBODY 11F10 IN 2 COMPLEX WITH HIV1 GP41"
3LEY_LH_P_4_14.pdb,3LEY,20876137,1.99,,,2.60.40.10,LH,433,P,8,LLELDKWA,CCCCCCCC,40320211,4,14,2,eCCCCCCC,7,1,A:0;D:0;F:0;G:0;K:0;L:0;N:0;S:0;W:0;Y:0,A:0;D:0;F:0;G:0;K:0;L:0;N:0;S:0;W:0;Y:0,A:3;D:6;E:2;F:1;G:9;I:1;K:12;L:2;N:1;P:4;Q:3;R:2;S:21;T:2,A:15;C:10;D:11;E:12;F:12;G:21;H:5;I:16;K:10;L:35;M:3;N:16;P:22;Q:16;R:9;S:36;T:44;V:29;W:10;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,C:22;E:9;G:3;H:4;T:31,B:9;C:52;E:212;G:12;H:7;T:52;b:4,4_14,A:1;D:2;F:2;G:2;K:1;L:1;N:1;S:1;W:1;Y:4,C:4;E:4;T:8,A:0;D:0;F:0;G:0;K:0;L:0;N:0;S:0;W:0;Y:0,C:0;E:0;T:0,98865544,ALA_104_H_COREBINDING;ASN_100_H_COREBINDING;ASP_31_L_COREBINDING;ASP_33_L_COREBINDING;GLY_96_L_COREBINDING;GLY_99_H_COREBINDING;LEU_102_H_COREBINDING;LYS_35_L_COREBINDING;PHE_98_H_COREBINDING;PHE_99_L_COREBINDING;SER_32_L_COREBINDING;TRP_101_L_COREBINDING;TYR_101_H_COREBINDING;TYR_105_H_COREBINDING;TYR_33_H_COREBINDING;TYR_37_L_COREBINDING,LLELDKWA,0.953810623556582,0.488596955618544,3.21606685253898,99999999,LEU_1_P_e;LEU_2_P_C;GLU_3_P_C;LEU_4_P_C;ASP_5_P_C;LYS_6_P_C;TRP_7_P_C;ALA_8_P_C,"2F5 EPITOPE SCAFFOLD ELICITED ANTIHIV1 MONOCLONAL ANTIBODY 6A7 IN 2 COMPLEX WITH HIV1 GP41"
3MLR_HL_P_4_2.pdb,3MLR,20622876,1.80,,,2.60.40.10,HL,445,P,14,T----------KKGIAIGPGRTL----Y-,T----------TTTEEEETTEEE----C-,4----------200000023220----1-,4,2,5,C----------CCCCCCCCCCCC----C-,14,0,A:0;D:0;H:0;I:0;K:0;L:0;N:0;S:0;T:0;W:0;Y:0,A:0;D:0;H:0;I:0;K:0;L:0;N:0;S:0;T:0;W:0;Y:0,A:5;D:4;E:5;F:1;G:11;K:12;L:1;N:3;P:6;Q:6;S:24;T:11;V:1,A:19;C:8;D:11;E:11;F:11;G:29;H:4;I:12;K:16;L:31;M:3;N:5;P:23;Q:17;R:6;S:41;T:28;V:34;W:8;Y:18,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:24;E:17;G:7;H:5;T:36;b:1,B:7;C:56;E:205;G:13;H:6;T:45;b:3,4_2,A:1;D:5;H:1;I:1;K:1;L:3;N:1;S:2;T:1;W:2;Y:2,C:3;E:14;G:1;T:2,A:0;D:0;H:0;I:0;K:0;L:0;N:0;S:0;T:0;W:0;Y:0,C:0;E:0;G:0;T:0,8----------644455457777----7-,ALA_92_L_COREBINDING;ASN_109_H_COREBINDING;ASP_29_L_COREBINDING;ASP_31_H_COREBINDING;ASP_55_H_COREBINDING;ASP_57_H_COREBINDING;ASP_91_L_COREBINDING;HIS_59_H_COREBINDING;ILE_50_H_COREBINDING;LEU_101_H_COREBINDING;LEU_103_L_COREBINDING;LEU_99_H_COREBINDING;LYS_30_L_COREBINDING;SER_107_H_COREBINDING;SER_108_H_COREBINDING;THR_101_L_COREBINDING;TRP_33_H_COREBINDING;TRP_90_L_COREBINDING;TYR_31_L_COREBINDING;TYR_52_H_COREBINDING,NNTKKGIAIGPGRTLYAREK,0.935393258426966,0.373832548164342,,9----------999999999999----9-,THR_1_P_C;LYS_2_P_C;LYS_3_P_C;GLY_4_P_C;ILE_5_P_C;ALA_6_P_C;ILE_7_P_C;GLY_8_P_C;PRO_9_P_C;GLY_10_P_C;ARG_11_P_C;THR_12_P_C;LEU_13_P_C;TYR_14_P_C,"CRYSTAL STRUCTURE OF ANTIHIV1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 2 PEPTIDE"
3MLS_KO_S_4_2.pdb,3MLS,20622876,2.50,,,2.60.40.10,KO,443,S,20,-ACQAFYASSPRKSIHIGAC--------A,-CCEEETTTTGGGCEEEECC--------C,-3211012412200000011--------4,4,2,5,-EDDDDDEEDDCCCCCCCCC--------e,9,10,A:0;D:0;H:0;I:0;K:0;L:0;N:0;Q:0;S:0;T:0;W:0;Y:0,A:0;D:0;H:0;I:0;K:0;L:0;N:0;Q:0;S:0;T:0;W:0;Y:0,A:5;D:2;E:5;G:14;K:11;L:1;N:2;P:9;Q:5;R:1;S:23;T:8;V:2;Y:1,A:19;C:8;D:13;E:11;F:12;G:26;H:4;I:12;K:16;L:31;M:3;N:5;P:20;Q:17;R:5;S:41;T:31;V:33;W:8;Y:17,C:0;E:0;T:0,C:0;E:0;T:0,C:24;E:14;G:6;H:5;T:40,B:8;C:51;E:203;G:9;H:6;T:51;b:4,4_2,A:1;D:5;H:0;I:1;K:1;L:3;N:2;Q:1;S:2;T:0;W:2;Y:2,C:2;E:11;T:7,A:0;D:0;H:1;I:0;K:0;L:0;N:0;Q:0;S:0;T:1;W:0;Y:0,C:0;E:2;T:0,-7643444544444334456--------6,ALA_92_O_COREBINDING;ASN_109_K_COREBINDING;ASN_28_K_COREBINDING;ASP_29_O_COREBINDING;ASP_31_K_COREBINDING;ASP_55_K_COREBINDING;ASP_57_K_COREBINDING;ASP_91_O_COREBINDING;GLN_106_K_COREBINDING;HIS_59_K_EXOSITE;ILE_50_K_COREBINDING;LEU_101_K_COREBINDING;LEU_103_O_COREBINDING;LEU_99_K_COREBINDING;LYS_30_O_COREBINDING;SER_107_K_COREBINDING;SER_108_K_COREBINDING;THR_101_O_EXOSITE;TRP_33_K_COREBINDING;TRP_90_O_COREBINDING;TYR_31_O_COREBINDING;TYR_52_K_COREBINDING,ACQAFYASSPRKSIHIGACA,0.932849316458265,0.373643038669621,0.929789761182604,-9999999999999999999--------9,ALA_1_S_E;CYS_2_S_E;GLN_3_S_E;ALA_4_S_E;PHE_5_S_E;TYR_6_S_E;ALA_7_S_E;SER_8_S_E;SER_9_S_E;PRO_10_S_E;ARG_11_S_C;LYS_12_S_C;SER_13_S_C;ILE_14_S_C;HIS_15_S_C;ILE_16_S_C;GLY_17_S_C;ALA_18_S_C;CYS_19_S_C;ALA_20_S_e,"CRYSTAL STRUCTURE OF ANTIHIV1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV 2 1 GP120 V3 MIMOTOPE"
3MLT_HL_P_4_2.pdb,3MLT,20622876,2.49,,,2.60.40.10,HL,431,P,14,T----------RKSIHLGPGRAF----Y-,T----------TTTEEEETTEEE----C-,4----------200000023221----2-,4,2,5,C----------CCCCCCCCCCCC----C-,14,0,A:0;D:0;H:0;I:0;K:0;L:0;N:0;S:0;T:0;W:0;Y:0,A:0;D:0;H:0;I:0;K:0;L:0;N:0;S:0;T:0;W:0;Y:0,A:5;D:3;E:5;G:14;K:13;L:1;N:3;P:8;Q:5;S:18;T:11;V:1,A:19;C:8;D:12;E:11;F:12;G:24;H:4;I:12;K:14;L:30;M:3;N:5;P:21;Q:18;R:6;S:39;T:27;V:33;W:8;Y:18,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:25;E:15;G:7;H:3;T:37,B:9;C:59;E:193;G:15;H:3;T:43;b:2,4_2,A:1;D:5;H:1;I:1;K:1;L:3;N:1;S:2;T:1;W:2;Y:2,C:6;E:10;G:2;T:2,A:0;D:0;H:0;I:0;K:0;L:0;N:0;S:0;T:0;W:0;Y:0,C:0;E:0;G:0;T:0,6----------665444455556----6-,ALA_92_L_COREBINDING;ASN_109_H_COREBINDING;ASP_29_L_COREBINDING;ASP_31_H_COREBINDING;ASP_55_H_COREBINDING;ASP_57_H_COREBINDING;ASP_91_L_COREBINDING;HIS_59_H_COREBINDING;ILE_50_H_COREBINDING;LEU_101_H_COREBINDING;LEU_101_L_COREBINDING;LEU_99_H_COREBINDING;LYS_30_L_COREBINDING;SER_107_H_COREBINDING;SER_108_H_COREBINDING;THR_99_L_COREBINDING;TRP_33_H_COREBINDING;TRP_90_L_COREBINDING;TYR_31_L_COREBINDING;TYR_52_H_COREBINDING,NNTRKSIHLGPGRAFYATGDIIG,0.9209514306134,0.370884461613113,,9----------999999999999----9-,THR_1_P_C;ARG_2_P_C;LYS_3_P_C;SER_4_P_C;ILE_5_P_C;HIS_6_P_C;LEU_7_P_C;GLY_8_P_C;PRO_9_P_C;GLY_10_P_C;ARG_11_P_C;ALA_12_P_C;PHE_13_P_C;TYR_14_P_C,"CRYSTAL STRUCTURE OF ANTIHIV1 V3 FAB 2557 IN COMPLEX WITH A UG1033 2 V3 PEPTIDE"
3MLV_NM_Q_4_2.pdb,3MLV,20622876,2.48,,,2.60.40.10,NM,438,Q,13,R-----------KRIRVGPGQTV----Y-,C-----------CCEEEETTEEE----C-,3-----------01000023220----2-,4,2,5,C-----------CCCCCCCCCCC----C-,13,0,A:0;D:0;E:0;H:0;I:0;K:0;L:0;N:0;Q:0;S:0;T:0;W:0;Y:0,A:0;D:0;E:0;H:0;I:0;K:0;L:0;N:0;Q:0;S:0;T:0;W:0;Y:0,A:5;E:5;F:1;G:11;K:14;L:2;N:3;P:7;Q:6;S:21;T:8;V:1,A:20;C:8;D:14;E:11;F:11;G:27;H:4;I:12;K:13;L:31;M:3;N:5;P:22;Q:15;R:6;S:42;T:29;V:33;W:8;Y:18,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,B:1;C:23;E:10;G:6;H:8;T:36,B:6;C:59;E:203;G:11;H:9;T:42;b:2,4_2,A:1;D:4;E:1;H:1;I:1;K:1;L:3;N:1;Q:2;S:2;T:1;W:2;Y:2,C:3;E:12;G:1;T:6,A:0;D:0;E:0;H:0;I:0;K:0;L:0;N:0;Q:0;S:0;T:0;W:0;Y:0,C:0;E:0;G:0;T:0,7-----------57454355455----6-,ALA_92_M_COREBINDING;ASN_109_N_COREBINDING;ASP_29_M_COREBINDING;ASP_31_N_COREBINDING;ASP_55_N_COREBINDING;ASP_57_N_COREBINDING;GLN_106_N_COREBINDING;GLN_49_M_COREBINDING;GLU_103_N_COREBINDING;HIS_59_N_COREBINDING;ILE_50_N_COREBINDING;LEU_101_N_COREBINDING;LEU_103_M_COREBINDING;LEU_99_N_COREBINDING;LYS_30_M_COREBINDING;SER_107_N_COREBINDING;SER_108_N_COREBINDING;THR_101_M_COREBINDING;TRP_33_N_COREBINDING;TRP_90_M_COREBINDING;TYR_31_M_COREBINDING;TYR_52_N_COREBINDING,NNTRKRIRVGPGQTVYATNA,0.927148960225087,0.375209479329539,,9-----------99999999999----9-,ARG_1_Q_C;LYS_2_Q_C;ARG_3_Q_C;ILE_4_Q_C;ARG_5_Q_C;VAL_6_Q_C;GLY_7_Q_C;PRO_8_Q_C;GLY_9_Q_C;GLN_10_Q_C;THR_11_Q_C;VAL_12_Q_C;TYR_13_Q_C,"CRYSTAL STRUCTURE OF ANTIHIV1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 2 PEPTIDE"
3MOA_HL_P_4_1.pdb,3MOA,,2.30,,,2.60.40.10,HL,449,P,12,--E----LLELDKWASLW,--T----TTEETTTTTTC,--2----41220100414,4,1,18,--E----EEECCCCCCdd,6,4,A:0;D:0;F:0;G:0;H:0;I:0;L:0;P:0;Q:0;R:0;S:0;V:0;Y:0,A:1;D:0;F:0;G:0;H:0;I:1;L:0;P:1;Q:0;R:0;S:0;V:0;Y:0,A:1;C:1;D:4;E:5;F:1;G:10;K:11;L:1;N:2;P:6;Q:3;R:3;S:21;T:5;V:1,A:22;C:9;D:14;E:9;F:14;G:22;H:5;I:13;K:11;L:34;M:2;N:10;P:23;Q:15;R:13;S:41;T:41;V:37;W:6;Y:13,C:0;E:0;G:0;T:0,C:0;E:3;G:0;T:0,C:18;E:8;G:6;H:3;T:40,B:7;C:54;E:212;G:13;H:8;T:54;b:6,4_1,A:0;D:1;F:2;G:1;H:2;I:0;L:1;P:1;Q:0;R:2;S:0;V:1;Y:2,C:4;E:4;G:1;T:4,A:0;D:0;F:0;G:0;H:0;I:0;L:1;P:0;Q:1;R:1;S:1;V:0;Y:0,C:1;E:1;G:0;T:2,--9----97653334544,ALA_112_H_exosite;ARG_100_H_COREBINDING;ARG_113_H_COREBINDING;ARG_60_H_EXOSITE;ASP_56_H_COREBINDING;GLN_26_L_EXOSITE;GLY_33_H_COREBINDING;HIS_91_L_COREBINDING;HIS_95_L_COREBINDING;ILE_111_H_exosite;LEU_1_L_EXOSITE;LEU_90_L_COREBINDING;PHE_32_H_COREBINDING;PHE_92_L_COREBINDING;PRO_103_H_COREBINDING;PRO_110_H_exosite;SER_25_L_EXOSITE;TYR_54_H_COREBINDING;TYR_93_L_COREBINDING;VAL_116_H_COREBINDING,EKNEQELLELDKWASLW,0.972749901742434,0.329829250185598,0.9715914779371,--9----99999999999,GLU_1_P_E;LEU_2_P_E;LEU_3_P_E;GLU_4_P_E;LEU_5_P_C;ASP_6_P_C;LYS_7_P_C;TRP_8_P_C;ALA_9_P_C;SER_10_P_C;LEU_11_P_e;TRP_12_P_e,"CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT 2 RECOMBINANTLY PRODUCED FAB WITH 17 AA GP41 MPERDERIVED PEPTIDE"
3O6L_LH_C_4_4.pdb,3O6L,21035463,2.10,,,2.60.40.10,LH,435,C,15,E-PVDPK-L---EPWKHPGS----,T-TTTCC-C---TTTTCCCC----,3-32120-0---01002314----,4,4,4,D-EEDDD-C---CCCCCdde----,6,6,D:0;F:0;G:0;H:0;K:0;R:0;S:0;T:0;W:0;Y:0,D:0;F:0;G:1;H:0;K:0;R:0;S:2;T:0;W:0;Y:0,A:5;D:6;E:5;G:8;K:9;L:1;N:3;P:6;Q:4;R:4;S:18;T:4;V:1,A:16;C:9;D:14;E:10;F:13;G:23;H:4;I:13;K:14;L:33;M:5;N:12;P:19;Q:10;R:11;S:41;T:37;V:32;W:7;Y:16,C:0;E:0;T:0,C:0;E:0;T:3,C:20;E:6;G:4;H:4;T:40,B:7;C:55;E:201;G:14;H:7;T:51;b:4,4_4,D:2;F:1;G:2;H:1;K:0;R:1;S:1;T:1;W:2;Y:5,C:2;E:6;T:8,D:1;F:0;G:0;H:0;K:1;R:0;S:0;T:0;W:0;Y:1,C:1;E:1;T:1,9-99876-5---44445677----,ARG_101_L_COREBINDING;ASP_101_H_EXOSITE;ASP_33_H_COREBINDING;ASP_99_H_COREBINDING;GLY_103_H_COREBINDING;GLY_54_H_exosite;GLY_96_L_COREBINDING;HIS_98_L_COREBINDING;LYS_35_L_EXOSITE;PHE_99_L_COREBINDING;SER_50_H_COREBINDING;SER_52_H_exosite;SER_53_H_exosite;THR_97_L_COREBINDING;TRP_47_H_COREBINDING;TRP_94_L_COREBINDING;TYR_100_H_EXOSITE;TYR_102_H_COREBINDING;TYR_31_L_COREBINDING;TYR_37_L_COREBINDING;TYR_57_H_COREBINDING;TYR_59_H_COREBINDING,EPVDPKLEPWKHPGS,0.830651340996169,0.495928320288409,0.506557992731336,9-99999-9---99999999----,GLU_1_C_E;PRO_2_C_E;VAL_3_C_E;ASP_4_C_E;PRO_5_C_E;LYS_6_C_E;LEU_7_C_C;GLU_8_C_C;PRO_9_C_C;TRP_10_C_C;LYS_11_C_C;HIS_12_C_C;PRO_13_C_e;GLY_14_C_e;SER_15_C_e,"ANTITAT HIV 11H6H1 FAB COMPLEXED WITH A 15MER TAT PEPTIDE"
3O6M_LH_C_4_4.pdb,3O6M,21035463,2.40,,,2.60.40.10,LH,434,C,9,-----PK-L---EPWKHP------,-----CC-C---TTTTCC------,-----52-1---010014------,4,4,4,-----dd-C---CCCCCe------,6,2,D:0;F:0;G:0;R:0;S:0;T:0;W:0;Y:0,D:1;F:0;G:0;R:0;S:0;T:0;W:0;Y:1,A:4;D:7;E:4;G:11;K:8;L:1;N:4;P:3;Q:3;R:4;S:18;T:3;V:1,A:17;C:9;D:13;E:11;F:13;G:21;H:5;I:13;K:16;L:33;M:5;N:10;P:22;Q:11;R:11;S:43;T:38;V:32;W:7;Y:16,C:0;E:0;T:0,C:0;E:1;T:1,C:20;E:7;G:6;H:4;T:34,B:7;C:54;E:202;G:12;H:8;T:61;b:2,4_4,D:2;F:1;G:2;R:1;S:1;T:1;W:2;Y:5,C:2;E:6;T:7,D:0;F:0;G:0;R:0;S:0;T:0;W:0;Y:0,C:0;E:0;T:0,-----76-5---555566------,ARG_101_L_COREBINDING;ASP_101_H_exosite;ASP_33_H_COREBINDING;ASP_99_H_COREBINDING;GLY_103_H_COREBINDING;GLY_96_L_COREBINDING;PHE_99_L_COREBINDING;SER_50_H_COREBINDING;THR_97_L_COREBINDING;TRP_47_H_COREBINDING;TRP_94_L_COREBINDING;TYR_100_H_exosite;TYR_102_H_COREBINDING;TYR_31_L_COREBINDING;TYR_37_L_COREBINDING;TYR_57_H_COREBINDING;TYR_59_H_COREBINDING,PKLEPWKHP,0.830262902342991,0.496304157169627,0.503949402222091,-----99-9---999999------,PRO_1_C_e;LYS_2_C_e;LEU_3_C_C;GLU_4_C_C;PRO_5_C_C;TRP_6_C_C;LYS_7_C_C;HIS_8_C_C;PRO_9_C_e,"ANTITAT HIV 11H6H1 FAB COMPLEXED WITH A 9MER TAT PEPTIDE"
3QG6_LH_C_4_42.pdb,3QG6,21454495,2.50,,,2.60.40.10,LH,426,C,6,TCYFIM,CTTTTC,312000,4,42,1,CCCCCC,6,0,A:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;N:0;R:0;S:0;T:0;W:0;Y:0,A:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;N:0;R:0;S:0;T:0;W:0;Y:0,A:1;C:1;D:7;E:4;G:7;K:8;L:1;N:3;P:7;Q:5;R:4;S:22;T:4;Y:1,A:11;C:8;D:10;E:10;F:15;G:22;H:7;I:16;K:13;L:33;M:2;N:12;P:17;Q:13;R:8;S:42;T:41;V:29;W:8;Y:13,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:23;E:9;G:5;H:4;T:34,B:7;C:42;E:203;G:7;H:7;T:60;b:4,4_42,A:1;D:1;E:1;F:2;G:1;H:1;I:1;K:1;L:1;N:2;R:1;S:1;T:2;W:1;Y:4,B:2;C:1;E:8;T:10,A:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;N:0;R:0;S:0;T:0;W:0;Y:0,B:0;C:0;E:0;T:0,964334,ALA_34_H_COREBINDING;ARG_98_H_COREBINDING;ASN_32_H_COREBINDING;ASN_36_H_COREBINDING;ASP_101_H_COREBINDING;GLU_99_H_COREBINDING;GLY_100_H_COREBINDING;HIS_39_L_COREBINDING;ILE_38_H_COREBINDING;LEU_51_L_COREBINDING;LYS_55_L_COREBINDING;PHE_41_L_COREBINDING;PHE_51_H_COREBINDING;SER_53_H_COREBINDING;THR_96_L_COREBINDING;THR_97_H_COREBINDING;TRP_103_H_COREBINDING;TYR_101_L_COREBINDING;TYR_33_H_COREBINDING;TYR_37_L_COREBINDING;TYR_54_L_COREBINDING,YSTCYFIM,-1,0.498014708936669,,999999,THR_1_C_C;CYS_2_C_C;TYR_3_C_C;PHE_4_C_C;ILE_5_C_C;MET_6_C_C,"STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM 2 QUENCHING ANTIBODY"
3SGE_IJ_M_4_19.pdb,3SGE,22069505,1.89,,,2.60.40.10,IJ,436,M,11,E-EEDDDMGFGL-------,C-CCBCCTTTTC-------,3-3012100011-------,4,19,2,D-DDDDDDCCCC-------,4,7,A:0;D:0;G:0;I:0;K:0;L:0;N:0;Q:0;R:0;S:0;T:0;W:0;Y:0,A:0;D:0;G:0;I:0;K:0;L:0;N:0;Q:0;R:0;S:0;T:0;W:0;Y:0,A:4;C:1;D:7;E:5;G:6;I:1;K:12;L:1;M:1;N:3;P:3;Q:5;R:3;S:18;T:5,A:17;C:9;D:14;E:11;F:13;G:22;H:5;I:11;K:12;L:32;M:6;N:11;P:22;Q:11;R:10;S:39;T:34;V:34;W:6;Y:15,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:19;E:10;G:7;H:3;T:36,B:8;C:52;E:196;G:7;H:8;T:59;b:4,4_19,A:0;D:1;G:1;I:0;K:0;L:0;N:2;Q:1;R:3;S:0;T:1;W:2;Y:3,B:0;C:3;E:8;G:0;T:3,A:1;D:0;G:1;I:1;K:1;L:1;N:3;Q:0;R:1;S:1;T:2;W:0;Y:1,B:1;C:3;E:2;G:4;T:3,7-6555554469-------,ALA_33_J_EXOSITE;ARG_100_J_EXOSITE;ARG_50_J_COREBINDING;ARG_51_I_COREBINDING;ARG_52_J_COREBINDING;ASN_30_J_EXOSITE;ASN_32_J_EXOSITE;ASN_35_J_COREBINDING;ASN_39_I_COREBINDING;ASN_56_J_EXOSITE;ASP_31_I_COREBINDING;GLN_95_I_COREBINDING;GLY_101_J_EXOSITE;GLY_96_I_COREBINDING;ILE_55_J_EXOSITE;LEU_55_I_EXOSITE;LYS_35_I_EXOSITE;SER_53_J_EXOSITE;THR_102_J_COREBINDING;THR_103_J_EXOSITE;THR_31_J_EXOSITE;TRP_47_J_COREBINDING;TRP_94_I_COREBINDING;TYR_101_I_COREBINDING;TYR_37_I_COREBINDING;TYR_54_I_EXOSITE;TYR_61_J_COREBINDING,EEEDDDMGFGLFD,0.73394495412844,0.500728407201796,1.10426491386804,9-9999999999-------,GLU_1_M_E;GLU_2_M_E;GLU_3_M_E;ASP_4_M_E;ASP_5_M_E;ASP_6_M_E;MET_7_M_E;GLY_8_M_C;PHE_9_M_C;GLY_10_M_C;LEU_11_M_C,"CRYSTAL STRUCTURE OF MAB 172 IN COMPLEX WITH R13 PEPTIDE"
3U0T_AB_F_4_15.pdb,3U0T,22197375,2.50,,,2.60.40.10,AB,427,F,11,-AIIGLMVGG--------VV,-CTTTTTTTT--------CC,-513012000--------10,4,15,2,-DDDDCCCCC--------dd,5,4,A:0;G:0;H:0;K:0;L:0;N:0;Q:0;R:0;S:0;T:0;V:0;Y:0,A:0;G:0;H:1;K:1;L:0;N:0;Q:0;R:1;S:0;T:1;V:1;Y:2,A:4;C:1;D:5;E:4;G:7;K:10;L:1;N:3;P:6;Q:7;R:4;S:20;T:3;V:1;Y:1,A:20;C:9;D:12;E:14;F:11;G:20;H:5;I:8;K:11;L:31;M:4;N:6;P:20;Q:16;R:11;S:38;T:33;V:40;W:6;Y:15,C:0;E:0;G:0;T:0,C:1;E:2;G:0;T:4,C:23;E:8;G:7;H:3;T:36,B:7;C:52;E:203;G:13;H:8;T:43;b:4,4_15,A:1;G:1;H:0;K:0;L:2;N:1;Q:1;R:1;S:1;T:0;V:0;Y:4,C:3;E:3;G:1;T:5,A:0;G:0;H:0;K:0;L:0;N:0;Q:0;R:0;S:0;T:0;V:0;Y:1,C:0;E:0;G:0;T:1,-876555444--------56,ALA_31_B_COREBINDING;ARG_50_A_COREBINDING;ARG_50_B_exosite;ASN_38_A_COREBINDING;GLN_54_A_COREBINDING;GLY_95_A_COREBINDING;HIS_97_A_exosite;LEU_102_B_COREBINDING;LEU_99_B_COREBINDING;LYS_59_B_exosite;SER_101_B_COREBINDING;THR_96_A_exosite;TYR_100_B_COREBINDING;TYR_28_B_EXOSITE;TYR_30_A_exosite;TYR_32_B_COREBINDING;TYR_36_A_COREBINDING;TYR_53_A_COREBINDING;TYR_98_A_exosite;VAL_100_A_exosite,AIIGLMVGGVV,0.625,0.451518307251328,0.319906236263063,-999999999--------99,ALA_1_F_E;ILE_2_F_E;ILE_3_F_E;GLY_4_F_E;LEU_5_F_C;MET_6_F_C;VAL_7_F_C;GLY_8_F_C;GLY_9_F_C;VAL_10_F_e;VAL_11_F_e,"FABANTIBODY COMPLEX"
3UJI_HL_P_4_5.pdb,3UJI,22164215,1.60,,,2.60.40.10,HL,426,P,18,YNKRKRIHIGPGRAF----YTT,CCGGGCEEEETTTEE----ECC,512112000022300----022,4,5,3,edCCCCCCCCCCCCC----dde,13,3,D:0;E:0;F:0;G:0;I:0;K:0;L:0;N:0;S:0;T:0;W:0;Y:0,D:1;E:0;F:0;G:1;I:0;K:0;L:1;N:0;S:1;T:1;W:1;Y:0,A:6;D:2;E:3;G:12;K:9;M:1;N:2;P:6;Q:3;S:18;T:7;Y:1,A:25;C:8;D:11;E:11;F:12;G:22;H:5;I:12;K:16;L:27;M:3;N:7;P:21;Q:19;R:4;S:41;T:27;V:35;W:7;Y:17,B:0;C:0;E:0;T:0,B:0;C:0;E:4;T:2,B:1;C:21;E:8;G:7;H:5;T:28,B:9;C:51;E:200;G:11;H:7;T:48;b:4,4_5,D:4;E:1;F:1;G:1;I:1;K:1;L:1;N:1;S:3;T:0;W:2;Y:4,B:1;C:2;E:10;T:7,D:0;E:0;F:0;G:0;I:0;K:0;L:0;N:0;S:0;T:0;W:0;Y:0,B:0;C:0;E:0;T:0,965554444455544----479,ASN_31_H_COREBINDING;ASP_104_H_COREBINDING;ASP_28_L_COREBINDING;ASP_55_H_COREBINDING;ASP_57_H_exosite;ASP_90_L_COREBINDING;GLU_102_H_COREBINDING;GLY_107_H_COREBINDING;GLY_94_L_exosite;ILE_50_H_COREBINDING;LEU_93_L_exosite;LEU_99_H_COREBINDING;LYS_29_L_COREBINDING;PHE_101_H_COREBINDING;SER_106_H_COREBINDING;SER_108_H_COREBINDING;SER_59_H_exosite;SER_91_L_COREBINDING;THR_92_L_exosite;TRP_33_H_COREBINDING;TRP_47_H_exosite;TRP_89_L_COREBINDING;TYR_105_H_COREBINDING;TYR_30_L_COREBINDING;TYR_32_H_COREBINDING;TYR_52_H_COREBINDING,YNKRKRIHIGPGRAFYTTKNIIG,0.777777777777778,0.402477558921184,1.0450937756967,999999999999999----999,TYR_1_P_e;ASN_2_P_e;LYS_3_P_C;ARG_4_P_C;LYS_5_P_C;ARG_6_P_C;ILE_7_P_C;HIS_8_P_C;ILE_9_P_C;GLY_10_P_C;PRO_11_P_C;GLY_12_P_C;ARG_13_P_C;ALA_14_P_C;PHE_15_P_C;TYR_16_P_e;THR_17_P_e;THR_18_P_e,"CRYSTAL STRUCTURE OF ANTIHIV1 V3 FAB 2558 IN COMPLEX WITH MN PEPTIDE"
3UJJ_HL_P_4_2.pdb,3UJJ,22164215,2.00,,,2.60.40.10,HL,443,P,17,T----------RKSIRIGPGQA-FYATG-,T----------TTTCEEETTEE-TTTTC-,3----------30101002412-02204-,4,2,5,C----------CCCCCCCCCCC-DDDDc-,12,4,A:0;D:0;E:0;F:0;G:0;K:0;L:0;R:0;S:0;T:0;W:0;Y:0,A:0;D:0;E:0;F:0;G:0;K:0;L:0;R:0;S:0;T:0;W:0;Y:0,A:4;D:2;E:5;G:10;K:13;N:2;P:5;Q:3;R:3;S:25;T:8;W:1,A:28;C:10;D:11;E:11;F:10;G:24;H:4;I:14;K:13;L:24;M:5;N:8;P:24;Q:17;R:3;S:39;T:30;V:35;W:8;Y:19,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:25;E:12;G:4;H:5;T:35,B:9;C:54;E:191;G:15;H:7;T:57;b:4,4_2,A:1;D:2;E:2;F:1;G:4;K:2;L:1;R:1;S:1;T:1;W:1;Y:3,B:1;C:5;E:6;G:2;T:6,A:0;D:0;E:0;F:2;G:1;K:0;L:0;R:1;S:0;T:1;W:0;Y:0,B:0;C:2;E:2;G:0;T:1,7----------54433334443-33335-,ALA_104_H_COREBINDING;ARG_59_H_EXOSITE;ARG_65_L_COREBINDING;ASP_55_H_COREBINDING;ASP_57_H_COREBINDING;GLU_29_L_COREBINDING;GLU_49_L_COREBINDING;GLY_107_H_COREBINDING;GLY_108_H_COREBINDING;GLY_109_H_COREBINDING;GLY_93_L_EXOSITE;GLY_94_L_COREBINDING;LEU_99_H_COREBINDING;LYS_30_L_COREBINDING;LYS_52_L_COREBINDING;PHE_50_H_EXOSITE;PHE_96_L_EXOSITE;PHE_97_L_COREBINDING;SER_31_H_COREBINDING;THR_90_L_COREBINDING;THR_95_L_EXOSITE;TRP_33_H_COREBINDING;TYR_31_L_COREBINDING;TYR_33_L_COREBINDING;TYR_52_H_COREBINDING,NNTRKSIRIGPGQAFYATGDIIG,0.787471783295711,0.389194534648536,0.481432238222582,9----------99999999999-99999-,THR_1_P_C;ARG_2_P_C;LYS_3_P_C;SER_4_P_C;ILE_5_P_C;ARG_6_P_C;ILE_7_P_C;GLY_8_P_C;PRO_9_P_C;GLY_10_P_C;GLN_11_P_C;ALA_12_P_C;PHE_13_P_E;TYR_14_P_E;ALA_15_P_E;THR_16_P_E;GLY_17_P_c,"CRYSTAL STRUCTURE OF ANTIHIV1 V3 FAB 4025 IN COMPLEX WITH CON A 2 PEPTIDE"
3UO1_LH_P_4_13.pdb,3UO1,22753930,1.64,A2NHM3,PF07654,2.60.40.10,LH,434,P,9,EPQAPWMEQ,CTTTGGGCC,420000114,4,13,2,CCCCCCCCd,8,1,G:0;H:0;L:0;N:0;P:0;S:0;T:0;V:0;W:0;Y:0,G:0;H:0;L:0;N:0;P:0;S:0;T:0;V:0;W:0;Y:0,A:3;C:2;D:9;E:6;G:11;I:1;K:8;L:1;N:2;P:2;Q:3;R:3;S:18;T:6,A:16;C:9;D:11;E:12;F:14;G:20;H:5;I:12;K:13;L:33;M:6;N:12;P:20;Q:10;R:10;S:45;T:34;V:34;W:7;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,C:20;E:10;G:8;H:4;T:33,B:9;C:49;E:215;G:16;H:7;T:39;b:4,4_13,G:1;H:2;L:1;N:3;P:1;S:3;T:3;V:1;W:1;Y:4,C:2;E:6;T:12,G:0;H:0;L:0;N:0;P:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;T:0,975454579,ASN_101_H_COREBINDING;ASN_33_L_COREBINDING;ASN_50_H_COREBINDING;GLY_102_H_COREBINDING;HIS_31_L_COREBINDING;HIS_98_L_COREBINDING;LEU_99_H_COREBINDING;PRO_100_L_COREBINDING;SER_32_L_COREBINDING;SER_57_H_COREBINDING;SER_96_L_COREBINDING;THR_100_H_COREBINDING;THR_58_H_COREBINDING;THR_97_L_COREBINDING;TRP_47_H_COREBINDING;TYR_33_H_COREBINDING;TYR_37_L_COREBINDING;TYR_53_H_COREBINDING;TYR_59_H_COREBINDING;VAL_99_L_COREBINDING,EPQAPWMEQ,0.997695852534562,0.49519617995241,1.08374581890774,999999999,GLU_1_P_C;PRO_2_P_C;GLN_3_P_C;ALA_4_P_C;PRO_5_P_C;TRP_6_P_C;MET_7_P_C;GLU_8_P_C;GLN_9_P_e,"STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHCI ANTIGEN"
3UYR_LH_P_4_13.pdb,3UYR,22753930,1.70,A2NHM3,PF07654,2.60.40.10,LH,433,P,8,EPQAPWME-,CTTTGGGC-,40000013-,4,13,2,CCCCCCCC-,8,0,G:0;H:0;L:0;N:0;P:0;S:0;T:0;V:0;W:0;Y:0,G:0;H:0;L:0;N:0;P:0;S:0;T:0;V:0;W:0;Y:0,A:3;C:1;D:7;E:5;G:9;K:8;L:1;N:2;P:2;Q:5;R:4;S:18;T:6;V:1,A:16;C:10;D:13;E:12;F:14;G:22;H:5;I:13;K:13;L:33;M:6;N:12;P:20;Q:8;R:9;S:46;T:34;V:33;W:7;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,C:23;E:5;G:8;H:2;T:34,B:9;C:48;E:214;G:16;H:8;T:43;b:4,4_13,G:1;H:2;L:1;N:3;P:1;S:2;T:3;V:1;W:1;Y:4,C:1;E:6;T:12,G:0;H:0;L:0;N:0;P:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;T:0,99887789-,ASN_100_H_COREBINDING;ASN_33_L_COREBINDING;ASN_49_H_COREBINDING;GLY_101_H_COREBINDING;HIS_31_L_COREBINDING;HIS_98_L_COREBINDING;LEU_98_H_COREBINDING;PRO_100_L_COREBINDING;SER_56_H_COREBINDING;SER_96_L_COREBINDING;THR_57_H_COREBINDING;THR_97_L_COREBINDING;THR_99_H_COREBINDING;TRP_46_H_COREBINDING;TYR_32_H_COREBINDING;TYR_37_L_COREBINDING;TYR_52_H_COREBINDING;TYR_58_H_COREBINDING;VAL_99_L_COREBINDING,EPQAPWME,0.997695852534562,0.495095519915426,,99999999-,GLU_1_P_C;PRO_2_P_C;GLN_3_P_C;ALA_4_P_C;PRO_5_P_C;TRP_6_P_C;MET_7_P_C;GLU_8_P_C,"STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHCI ANTIGEN"
4DGY_HL_A_4_16.pdb,4DGY,22623528,1.80,,,2.60.40.10,HL,438,A,12,Q-LINTNG-------SWHIN--,C-EEEETT-------EEEEC--,2-010230-------10213--,4,16,2,E-DDDDDD-------CCCCC--,5,7,F:0;I:0;L:0;N:0;R:0;S:0;V:0;W:0;Y:0,F:0;I:0;L:0;N:0;R:0;S:0;V:0;W:0;Y:0,A:3;C:1;D:3;E:7;G:10;K:12;L:2;N:3;P:5;Q:2;R:3;S:18;T:7,A:25;C:8;D:14;E:12;F:18;G:21;H:5;I:9;K:10;L:36;M:3;N:14;P:17;Q:18;R:14;S:41;T:30;V:32;W:6;Y:17,C:0;E:0;T:0,C:0;E:0;T:0,C:18;E:6;G:9;H:2;T:40;b:1,B:5;C:56;E:214;G:12;H:9;T:49;b:5,4_16,F:1;I:2;L:1;N:0;R:1;S:1;V:1;W:2;Y:1,C:4;E:2;T:4,F:0;I:0;L:0;N:2;R:0;S:0;V:0;W:0;Y:0,C:0;E:0;T:2,7-456785-------55668--,ARG_91_L_COREBINDING;ASN_57_H_EXOSITE;ASN_93_L_EXOSITE;ILE_108_H_COREBINDING;ILE_95_L_COREBINDING;LEU_102_H_COREBINDING;PHE_107_H_COREBINDING;SER_92_L_COREBINDING;TRP_52_H_COREBINDING;TRP_94_L_COREBINDING;TYR_59_H_COREBINDING;VAL_50_H_COREBINDING,RQLINTNGSWHIN,0.552511415525114,0.422459501286613,0.524065835558854,9-999999-------99999--,GLN_1_A_E;LEU_2_A_E;ILE_3_A_E;ASN_4_A_E;THR_5_A_E;ASN_6_A_E;GLY_7_A_E;SER_8_A_C;TRP_9_A_C;HIS_10_A_C;ILE_11_A_C;ASN_12_A_C,"STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1 C2 3 FORM"
4GAG_LH_P_4_10.pdb,4GAG,22993159,1.80,,,2.60.40.10,LH,427,P,11,-LINTNGSWHVN,-CEEETTEEECC,-01022010224,4,10,2,-CCCCCCCCCCC,11,0,D:0;F:0;I:0;N:0;T:0;V:0;W:0;Y:0,D:0;F:0;I:0;N:0;T:0;V:0;W:0;Y:0,A:2;D:2;E:4;G:7;K:10;N:6;P:4;Q:3;R:6;S:19;T:7;V:2,A:19;C:8;D:16;E:10;F:11;G:19;H:5;I:15;K:10;L:32;M:4;N:12;P:22;Q:14;R:7;S:42;T:40;V:29;W:8;Y:17,C:0;E:0;T:0,C:0;E:0;T:0,C:17;E:13;G:4;H:3;T:35,B:5;C:41;E:221;G:8;H:8;T:53;b:4,4_10,D:1;F:1;I:1;N:3;T:1;V:1;W:1;Y:6,C:3;E:5;T:7,D:0;F:0;I:0;N:0;T:0;V:0;W:0;Y:0,C:0;E:0;T:0,-44344333458,ASN_34_L_COREBINDING;ASN_95_L_COREBINDING;ASN_96_L_COREBINDING;ASP_98_L_COREBINDING;ILE_98_H_COREBINDING;PHE_36_L_COREBINDING;THR_100_H_COREBINDING;TRP_100_L_COREBINDING;TYR_103_H_COREBINDING;TYR_32_L_COREBINDING;TYR_33_H_COREBINDING;TYR_50_H_COREBINDING;TYR_53_H_COREBINDING;TYR_58_H_COREBINDING;VAL_97_L_COREBINDING,LINTNGSWHVN,0.727482678983834,0.482045226184765,,-99999999999,LEU_1_P_C;ILE_2_P_C;ASN_3_P_C;THR_4_P_C;ASN_5_P_C;GLY_6_P_C;SER_7_P_C;TRP_8_P_C;HIS_9_P_C;VAL_10_P_C;ASN_11_P_C,"STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH 2 ITS HCV EPITOPE E2 RESIDUES 412423"
4HHA_BA_P_4_17.pdb,4HHA,,1.60,,,2.60.40.10,BA,438,P,10,ETIYNTT----LKY,CCEECTT----EEC,3120200----031,4,17,2,dCCCCCC----ddd,6,3,D:0;F:0;G:0;H:0;L:0;N:0;P:0;R:0;S:0;T:0;W:0;Y:0,D:0;F:0;G:0;H:3;L:0;N:1;P:1;R:1;S:1;T:0;W:0;Y:1,A:3;C:1;D:2;E:6;G:12;K:10;L:1;M:1;N:2;P:4;Q:3;R:2;S:16;T:3,A:26;C:8;D:12;E:13;F:15;G:23;H:5;I:12;K:11;L:33;M:2;N:12;P:19;Q:19;R:16;S:39;T:28;V:35;W:6;Y:14,C:0;E:0;T:0,C:2;E:2;T:4,C:21;E:6;G:9;H:3;T:27,B:4;C:60;E:207;G:15;H:8;T:48;b:6,4_17,D:2;F:1;G:2;H:0;L:2;N:0;P:0;R:2;S:2;T:2;W:1;Y:2,C:4;E:6;T:6,D:0;F:0;G:0;H:0;L:0;N:0;P:0;R:0;S:0;T:0;W:0;Y:0,C:0;E:0;T:0,8654454----455,ARG_103_B_COREBINDING;ARG_91_A_COREBINDING;ARG_98_B_exosite;ASN_105_B_exosite;ASP_104_B_COREBINDING;ASP_113_B_COREBINDING;GLY_107_B_COREBINDING;GLY_110_B_COREBINDING;HIS_32_B_exosite;HIS_57_B_exosite;HIS_59_B_exosite;LEU_101_B_COREBINDING;LEU_111_B_COREBINDING;PHE_108_B_COREBINDING;PRO_95_A_exosite;SER_102_B_COREBINDING;SER_106_B_COREBINDING;SER_52_B_exosite;THR_109_B_COREBINDING;THR_56_A_COREBINDING;TRP_94_A_COREBINDING;TYR_32_A_COREBINDING;TYR_49_A_COREBINDING;TYR_53_B_exosite,ETIYNTTLKY,0.273348519362187,0.421345382493096,0.215872647642076,9999999----999,GLU_1_P_e;THR_2_P_C;ILE_3_P_C;TYR_4_P_C;ASN_5_P_C;THR_6_P_C;THR_7_P_C;LEU_8_P_e;LYS_9_P_e;TYR_10_P_e,"ANTIHUMAN CYTOMEGALOVIRUS HCMV FAB KE5 WITH EPITOPE PEPTIDE AD2S1"
4HPO_HL_P_4_16.pdb,4HPO,23313589,1.69,,,2.60.40.10,HL,430,P,15,-D------KKQKVHALFYKLDI,-H------HHHHHHHHHCCCCC,-3------11210030011314,4,16,2,-D------DDDDDDDCCCCCdd,5,8,A:0;D:0;G:0;H:0;I:0;K:0;L:0;S:0;T:0;W:0;Y:0,A:0;D:0;G:0;H:0;I:0;K:0;L:0;S:1;T:1;W:0;Y:0,A:4;D:1;E:3;F:1;G:12;H:1;K:12;M:1;N:4;P:8;Q:2;R:3;S:20;T:6;V:1,A:21;C:8;D:11;E:13;F:10;G:20;H:4;I:10;K:11;L:26;M:3;N:7;P:20;Q:18;R:7;S:43;T:30;V:37;W:8;Y:20,C:0;E:0;T:0,C:0;E:0;T:2,B:1;C:24;E:7;G:9;H:5;T:32;b:1,B:6;C:54;E:205;G:12;H:7;T:40;b:3,4_16,A:0;D:2;G:0;H:1;I:1;K:1;L:1;S:1;T:0;W:2;Y:5,C:4;E:8;T:2,A:1;D:3;G:1;H:0;I:0;K:0;L:0;S:2;T:0;W:0;Y:1,C:0;E:0;T:8,-5------34443344334467,ALA_30_L_EXOSITE;ASP_106_H_EXOSITE;ASP_32_L_EXOSITE;ASP_52_L_EXOSITE;ASP_55_H_COREBINDING;ASP_57_H_COREBINDING;GLY_109_H_EXOSITE;HIS_105_H_COREBINDING;ILE_50_H_COREBINDING;LEU_99_H_COREBINDING;LYS_59_H_COREBINDING;SER_107_H_EXOSITE;SER_31_H_exosite;SER_31_L_EXOSITE;SER_97_L_COREBINDING;THR_30_H_exosite;TRP_33_H_COREBINDING;TRP_99_L_COREBINDING;TYR_103_H_COREBINDING;TYR_104_H_COREBINDING;TYR_111_H_COREBINDING;TYR_33_L_EXOSITE;TYR_52_H_COREBINDING;TYR_94_L_COREBINDING,ELRDKKQKVHALFYKLDIV,0.552511415525114,0.406919625850934,0.514847550251526,-9------99999999999999,ASP_1_P_E;LYS_2_P_E;LYS_3_P_E;GLN_4_P_E;LYS_5_P_E;VAL_6_P_E;HIS_7_P_E;ALA_8_P_E;LEU_9_P_C;PHE_10_P_C;TYR_11_P_C;LYS_12_P_C;LEU_13_P_C;ASP_14_P_e;ILE_15_P_e,"CRYSTAL STRUCTURE OF RV144ELICITED ANTIBODY CH58 IN COMPLEX WITH V2 2 PEPTIDE"
4HPY_HL_P_4_34.pdb,4HPY,23313589,1.50,Q6N089_Q8N5F4,PF07654_PF07686,2.60.40.10,HL,432,P,11,KKQKVHALFYK,CCBTTTGGGCC,51110011014,4,34,1,CCCCCCCCCCC,11,0,A:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;N:0;P:0;R:0;S:0;T:0;W:0;Y:0,A:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;N:0;P:0;R:0;S:0;T:0;W:0;Y:0,A:4;D:4;E:5;F:1;G:12;K:10;L:1;N:4;P:7;Q:2;R:3;S:15;T:7;V:2,A:27;C:8;D:8;E:12;F:9;G:20;H:5;I:7;K:11;L:29;M:3;N:10;P:20;Q:15;R:8;S:43;T:27;V:35;W:7;Y:17,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:22;E:11;G:9;H:5;T:30,B:8;C:56;E:193;G:13;H:6;T:43;b:2,4_34,A:2;D:4;E:2;G:4;H:1;I:3;K:1;L:2;N:1;P:2;R:2;S:5;T:1;W:1;Y:3,B:1;C:6;E:12;G:5;T:10,A:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;N:0;P:0;R:0;S:0;T:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,95433345459,ALA_32_H_COREBINDING;ALA_58_H_COREBINDING;ARG_101_H_COREBINDING;ARG_98_L_COREBINDING;ASN_31_L_COREBINDING;ASP_30_H_COREBINDING;ASP_51_L_COREBINDING;ASP_92_L_COREBINDING;ASP_98_H_COREBINDING;GLU_103_H_COREBINDING;GLU_50_L_COREBINDING;GLY_102_H_COREBINDING;GLY_31_H_COREBINDING;GLY_49_H_COREBINDING;GLY_95_L_COREBINDING;HIS_34_H_COREBINDING;ILE_50_H_COREBINDING;ILE_56_H_COREBINDING;ILE_57_H_COREBINDING;LEU_106_H_COREBINDING;LEU_28_L_COREBINDING;LYS_30_L_COREBINDING;PRO_105_H_COREBINDING;PRO_29_L_COREBINDING;SER_51_H_COREBINDING;SER_66_L_COREBINDING;SER_90_L_COREBINDING;SER_93_L_COREBINDING;SER_99_H_COREBINDING;THR_91_L_COREBINDING;TRP_46_H_COREBINDING;TYR_32_L_COREBINDING;TYR_34_L_COREBINDING;TYR_89_L_COREBINDING,ELRDKKQKVHALFYKLDIV,-1,0.408895242827836,,99999999999,LYS_1_P_C;LYS_2_P_C;GLN_3_P_C;LYS_4_P_C;VAL_5_P_C;HIS_6_P_C;ALA_7_P_C;LEU_8_P_C;PHE_9_P_C;TYR_10_P_C;LYS_11_P_C,"CRYSTAL STRUCTURE OF RV144ELICITED ANTIBODY CH59 IN COMPLEX WITH V2 2 PEPTIDE"
4HS6_LH_Y_4_10.pdb,4HS6,23458406,1.53,,,2.60.40.10,LH,433,Y,12,QLINTNGSWHIN,CEEEETTEEEEC,300022010123,4,10,2,dCCCCCCCCCCC,11,1,D:0;F:0;I:0;N:0;T:0;V:0;W:0;Y:0,D:0;F:0;I:0;N:0;T:0;V:0;W:0;Y:0,A:3;C:1;D:3;E:3;G:7;K:11;L:1;N:2;P:4;Q:2;R:4;S:26;T:6,A:21;C:9;D:13;E:13;F:12;G:23;H:5;I:12;K:11;L:35;M:3;N:11;P:20;Q:18;R:8;S:42;T:34;V:33;W:7;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,C:18;E:13;G:8;H:4;T:30,B:5;C:59;E:212;G:7;H:8;T:51;b:4,4_10,D:1;F:1;I:1;N:2;T:1;V:1;W:1;Y:6,C:3;E:4;T:7,D:0;F:0;I:0;N:0;T:0;V:0;W:0;Y:0,C:0;E:0;T:0,655444444459,ASN_95_L_COREBINDING;ASN_96_L_COREBINDING;ASP_98_L_COREBINDING;ILE_98_H_COREBINDING;PHE_36_L_COREBINDING;THR_100_H_COREBINDING;TRP_100_L_COREBINDING;TYR_103_H_COREBINDING;TYR_32_L_COREBINDING;TYR_33_H_COREBINDING;TYR_50_H_COREBINDING;TYR_53_H_COREBINDING;TYR_58_H_COREBINDING;VAL_97_L_COREBINDING,QLINTNGSWHINGSGK,0.727482678983834,0.448054918271916,0.827019346811187,999999999999,GLN_1_Y_e;LEU_2_Y_C;ILE_3_Y_C;ASN_4_Y_C;THR_5_Y_C;ASN_6_Y_C;GLY_7_Y_C;SER_8_Y_C;TRP_9_Y_C;HIS_10_Y_C;ILE_11_Y_C;ASN_12_Y_C,"HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412423 WITH HUMANIZED 2 AND AFFINITYMATURED ANTIBODY MRCT10V362"
4IOI_AB_C_4_31.pdb,4IOI,24101516,1.95,,,2.60.40.10,AB,434,C,12,CQFDLSTRRLKC,CEEETTTTEEEC,120111000012,4,31,1,CCCCCCCCCCCC,12,0,A:0;D:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;V:0;Y:0,A:0;D:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;V:0;Y:0,A:2;C:1;D:6;E:3;F:1;G:11;K:9;N:3;P:2;Q:2;R:2;S:17;T:4;Y:1,A:23;C:8;D:12;E:11;F:13;G:20;H:6;I:11;K:11;L:29;M:3;N:11;P:19;Q:16;R:13;S:41;T:32;V:35;W:7;Y:19,C:0;E:0;T:0,C:0;E:0;T:0,C:13;E:5;G:8;H:3;T:35,B:5;C:47;E:205;G:16;H:8;T:55;b:4,4_31,A:4;D:1;E:1;G:3;I:3;K:1;L:2;N:1;P:2;Q:3;R:1;S:2;T:3;V:1;Y:2,C:10;E:14;T:6,A:0;D:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;V:0;Y:0,C:0;E:0;T:0,454458544456,ALA_100_A_COREBINDING;ALA_175_B_COREBINDING;ALA_84_A_COREBINDING;ALA_92_B_COREBINDING;ARG_39_A_COREBINDING;ASN_41_A_COREBINDING;ASP_85_A_COREBINDING;GLN_112_B_COREBINDING;GLN_38_A_COREBINDING;GLN_39_B_COREBINDING;GLU_165_A_COREBINDING;GLY_101_A_COREBINDING;GLY_113_B_COREBINDING;GLY_42_A_COREBINDING;ILE_83_A_COREBINDING;ILE_9_A_COREBINDING;ILE_93_B_COREBINDING;LEU_10_A_COREBINDING;LEU_115_B_COREBINDING;LYS_103_A_COREBINDING;PRO_174_B_COREBINDING;PRO_41_B_COREBINDING;SER_40_B_COREBINDING;SER_43_A_COREBINDING;THR_102_A_COREBINDING;THR_40_A_COREBINDING;THR_91_B_COREBINDING;TYR_87_A_COREBINDING;TYR_95_B_COREBINDING;VAL_163_A_COREBINDING,CQFDLSTRRLKC,-1,0.450890919917845,,999999999999,CYS_1_C_C;GLN_2_C_C;PHE_3_C_C;ASP_4_C_C;LEU_5_C_C;SER_6_C_C;THR_7_C_C;ARG_8_C_C;ARG_9_C_C;LEU_10_C_C;LYS_11_C_C;CYS_12_C_C,"MEDITOPEENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC"
4JG0_HL_P_4_18.pdb,4JG0,23955275,1.81,,,2.60.40.10,HL,438,P,7,KGNYVV-----T,CCCCCC-----C,422020-----2,4,18,2,ddCCCC-----d,4,2,F:0;G:0;N:0;S:0;T:0;V:0;Y:0,F:0;G:0;N:0;S:0;T:0;V:0;Y:0,A:3;C:1;D:2;E:6;G:10;K:12;L:1;M:1;N:2;P:4;Q:3;R:3;S:20;T:4,A:20;C:9;D:16;E:11;F:15;G:24;H:4;I:9;K:11;L:35;M:4;N:12;P:21;Q:16;R:12;S:41;T:34;V:36;W:6;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,C:19;E:4;G:7;H:2;T:40,B:5;C:58;E:211;G:11;H:9;T:52;b:6,4_18,F:1;G:1;N:1;S:5;T:3;V:1;Y:2,C:3;E:4;T:7,F:0;G:0;N:0;S:0;T:0;V:0;Y:0,C:0;E:0;T:0,987543-----4,ASN_93_L_COREBINDING;GLY_33_H_COREBINDING;PHE_92_L_COREBINDING;SER_102_H_COREBINDING;SER_103_H_COREBINDING;SER_105_H_COREBINDING;SER_52_H_COREBINDING;SER_91_L_COREBINDING;THR_104_H_COREBINDING;THR_53_H_COREBINDING;THR_58_H_COREBINDING;TYR_106_H_COREBINDING;TYR_60_H_COREBINDING;VAL_94_L_COREBINDING,GEKKGNYVVTH,0.262557077625571,0.425088095992556,0.5871328640095,999999-----9,LYS_1_P_e;GLY_2_P_e;ASN_3_P_C;TYR_4_P_C;VAL_5_P_C;VAL_6_P_C;THR_7_P_e,"STRUCTURE OF PHOSPHOSERINETHREONINE PSTAB SCAFFOLD BOUND TO PSER 2 PEPTIDE"
4JO1_MI_Q_4_12.pdb,4JO1,23864637,2.03,,,2.60.40.10,MI,428,Q,10,TRKSIHIGPG,CCCCCCCCCC,4020010025,4,12,2,CCCCCCCCCC,10,0,A:0;C:0;D:0;E:0;F:0;G:0;I:0;L:0;N:0;S:0;W:0;Y:0,A:0;C:0;D:0;E:0;F:0;G:0;I:0;L:0;N:0;S:0;W:0;Y:0,A:7;C:1;D:4;E:1;G:12;K:5;N:2;P:5;Q:4;R:3;S:18;T:16;V:1,A:21;C:14;D:11;E:7;F:14;G:23;H:2;I:9;K:10;L:24;M:2;N:14;P:20;Q:18;R:6;S:32;T:41;V:40;W:6;Y:10,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:23;E:12;G:8;H:1;T:35,B:5;C:58;E:195;G:12;H:4;T:46;b:4,4_12,A:3;C:3;D:4;E:1;F:1;G:2;I:1;L:2;N:2;S:2;W:1;Y:3,C:3;E:13;G:1;T:8,A:0;C:0;D:0;E:0;F:0;G:0;I:0;L:0;N:0;S:0;W:0;Y:0,C:0;E:0;G:0;T:0,8644444468,ALA_101_M_COREBINDING;ALA_35_M_COREBINDING;ALA_60_I_COREBINDING;ASN_33_M_COREBINDING;ASN_99_I_COREBINDING;ASP_101_I_COREBINDING;ASP_33_I_COREBINDING;ASP_51_M_COREBINDING;ASP_94_M_COREBINDING;CYS_100_M_COREBINDING;CYS_50_I_COREBINDING;CYS_95_M_COREBINDING;GLU_52_I_COREBINDING;GLY_91_M_COREBINDING;GLY_92_M_COREBINDING;ILE_51_I_COREBINDING;LEU_47_M_COREBINDING;LEU_90_M_COREBINDING;PHE_100_I_COREBINDING;SER_56_I_COREBINDING;SER_58_I_COREBINDING;TRP_47_I_COREBINDING;TYR_29_M_COREBINDING;TYR_50_M_COREBINDING;TYR_93_M_COREBINDING,NNTRKSIHIGPGRAFYTTGEIIG,0.974299065420561,0.383239774258111,,9999999999,THR_1_Q_C;ARG_2_Q_C;LYS_3_Q_C;SER_4_Q_C;ILE_5_Q_C;HIS_6_Q_C;ILE_7_Q_C;GLY_8_Q_C;PRO_9_Q_C;GLY_10_Q_C,"CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF 2 HIV1 JRFL GP120"
4JO2_MI_Q_4_12.pdb,4JO2,23864637,2.50,,,2.60.40.10,MI,419,Q,10,TRKSIRIGPG,CCCCCCCCCC,4030010024,4,12,2,CCCCCCCCCC,10,0,A:0;C:0;D:0;E:0;F:0;G:0;L:0;N:0;S:0;W:0;Y:0,A:0;C:0;D:0;E:0;F:0;G:0;L:0;N:0;S:0;W:0;Y:0,A:8;C:2;D:4;E:1;G:11;K:6;N:3;P:7;Q:4;S:15;T:12;V:1;W:1,A:20;C:11;D:11;E:7;F:15;G:23;H:2;I:10;K:9;L:24;M:2;N:12;P:17;Q:18;R:9;S:32;T:43;V:40;W:5;Y:10,C:0;E:0;T:0,C:0;E:0;T:0,B:1;C:19;E:8;G:4;H:6;T:37,B:4;C:53;E:202;G:8;H:6;T:43;b:4,4_12,A:3;C:3;D:3;E:1;F:1;G:2;L:2;N:3;S:2;W:1;Y:3,C:4;E:12;T:8,A:0;C:0;D:0;E:0;F:0;G:0;L:0;N:0;S:0;W:0;Y:0,C:0;E:0;T:0,7765444457,ALA_101_M_COREBINDING;ALA_35_M_COREBINDING;ALA_60_I_COREBINDING;ASN_31_I_COREBINDING;ASN_33_M_COREBINDING;ASN_99_I_COREBINDING;ASP_101_I_COREBINDING;ASP_33_I_COREBINDING;ASP_94_M_COREBINDING;CYS_100_M_COREBINDING;CYS_50_I_COREBINDING;CYS_95_M_COREBINDING;GLU_52_I_COREBINDING;GLY_91_M_COREBINDING;GLY_92_M_COREBINDING;LEU_47_M_COREBINDING;LEU_90_M_COREBINDING;PHE_100_I_COREBINDING;SER_56_I_COREBINDING;SER_58_I_COREBINDING;TRP_47_I_COREBINDING;TYR_29_M_COREBINDING;TYR_50_M_COREBINDING;TYR_93_M_COREBINDING,NNTRKSIRIGPGQAFYATGDIIG,0.974299065420561,0.384753237107216,,9999999999,THR_1_Q_C;ARG_2_Q_C;LYS_3_Q_C;SER_4_Q_C;ILE_5_Q_C;ARG_6_Q_C;ILE_7_Q_C;GLY_8_Q_C;PRO_9_Q_C;GLY_10_Q_C,"CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF 2 HIV1 CONSENSUS A GP120"
4N8C_MI_Y_4_28.pdb,4N8C,25609808,1.60,,,2.60.40.10,MI,440,Y,14,LLTEVETPIRNEWG,CCTTTTTCCGGGCC,41100100012104,4,28,1,CCCCCCCCCCCCCC,14,0,A:0;D:0;G:0;H:0;I:0;L:0;N:0;R:0;S:0;T:0;V:0;Y:0,A:0;D:0;G:0;H:0;I:0;L:0;N:0;R:0;S:0;T:0;V:0;Y:0,A:3;C:1;D:4;E:4;G:7;H:1;K:11;N:2;P:3;Q:6;R:4;S:19;T:2;V:2,A:21;C:9;D:17;E:11;F:14;G:22;H:4;I:12;K:16;L:27;M:6;N:10;P:19;Q:14;R:7;S:43;T:38;V:31;W:10;Y:16,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:17;E:7;G:12;H:3;T:30,B:5;C:51;E:215;G:13;H:9;T:50;b:4,4_28,A:1;D:2;G:1;H:1;I:1;L:2;N:3;R:2;S:1;T:2;V:2;Y:6,C:8;E:6;G:2;T:8,A:0;D:0;G:0;H:0;I:0;L:0;N:0;R:0;S:0;T:0;V:0;Y:0,C:0;E:0;G:0;T:0,85433333345556,ALA_33_I_COREBINDING;ARG_101_I_COREBINDING;ARG_99_I_COREBINDING;ASN_55_I_COREBINDING;ASN_57_I_COREBINDING;ASN_59_I_COREBINDING;ASP_102_I_COREBINDING;ASP_103_I_COREBINDING;GLY_52_I_COREBINDING;HIS_35_I_COREBINDING;ILE_51_I_COREBINDING;LEU_102_M_COREBINDING;LEU_38_M_COREBINDING;SER_33_M_COREBINDING;THR_58_I_COREBINDING;THR_99_M_COREBINDING;TYR_100_M_COREBINDING;TYR_31_M_COREBINDING;TYR_32_I_COREBINDING;TYR_34_M_COREBINDING;TYR_97_M_COREBINDING;TYR_98_M_COREBINDING;VAL_104_I_COREBINDING;VAL_50_I_COREBINDING,MSLLTEVETPIRNEWGCRCNDSS,-1,0.475698373318228,,99999999999999,LEU_1_Y_C;LEU_2_Y_C;THR_3_Y_C;GLU_4_Y_C;VAL_5_Y_C;GLU_6_Y_C;THR_7_Y_C;PRO_8_Y_C;ILE_9_Y_C;ARG_10_Y_C;ASN_11_Y_C;GLU_12_Y_C;TRP_13_Y_C;GLY_14_Y_C,"THREEDIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX 2 PROTEIN 2 OF INFLUENZA A VIRUS"
4OJF_LH_A_4_7.pdb,4OJF,24598931,2.00,,,2.60.40.10,LH,438,A,6,DAEFRH,CGGGCC,000022,4,7,3,CCCCCd,5,1,D:0;F:0;G:0;H:0;I:0;M:0;N:0;R:0;S:0;T:0;W:0;Y:0,D:1;F:0;G:0;H:0;I:0;M:0;N:0;R:0;S:0;T:0;W:0;Y:0,A:3;D:4;E:4;G:13;K:14;L:2;N:2;P:3;Q:3;R:2;S:18;T:3;Y:2,A:19;C:9;D:12;E:11;F:13;G:24;H:4;I:7;K:12;L:36;M:2;N:12;P:21;Q:18;R:11;S:45;T:28;V:39;W:5;Y:16,C:0;E:0;T:0,C:0;E:0;T:1,C:15;E:9;G:7;T:42,B:6;C:59;E:196;G:14;T:65;b:4,4_7,D:1;F:1;G:2;H:2;I:1;M:1;N:1;R:2;S:3;T:1;W:2;Y:3,C:4;E:10;T:6,D:0;F:0;G:0;H:0;I:0;M:0;N:0;R:0;S:0;T:0;W:0;Y:0,C:0;E:0;T:0,333346,ARG_101_L_COREBINDING;ARG_51_H_COREBINDING;ASN_39_L_COREBINDING;ASP_31_L_exosite;ASP_33_L_COREBINDING;GLY_32_H_COREBINDING;GLY_96_L_COREBINDING;HIS_100_H_COREBINDING;HIS_98_L_COREBINDING;ILE_50_H_COREBINDING;MET_33_H_COREBINDING;PHE_99_L_COREBINDING;SER_104_H_COREBINDING;SER_105_H_COREBINDING;SER_49_H_COREBINDING;THR_97_L_COREBINDING;TRP_46_H_COREBINDING;TRP_94_L_COREBINDING;TYR_37_L_COREBINDING;TYR_58_H_COREBINDING;TYR_98_H_COREBINDING,DAEFRHDS,0.747716894977169,0.463170707491219,0.776199716567841,999999,ASP_1_A_C;ALA_2_A_C;GLU_3_A_C;PHE_4_A_C;ARG_5_A_C;HIS_6_A_e,"HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 18"
4ONF_LH_P_4_7.pdb,4ONF,25024748,2.00,,,2.60.40.10,LH,430,P,6,DAEFRH,CGGGCC,000023,4,7,3,CCCCCd,5,1,D:0;F:0;G:0;H:0;I:0;M:0;N:0;R:0;S:0;T:0;W:0;Y:0,D:0;F:0;G:0;H:0;I:0;M:0;N:0;R:0;S:0;T:0;W:0;Y:0,A:2;D:7;E:5;G:8;K:12;L:1;N:1;P:3;Q:1;R:3;S:22;T:4;V:1;Y:2,A:16;C:8;D:12;E:11;F:12;G:22;H:4;I:12;K:14;L:34;M:4;N:14;P:20;Q:12;R:12;S:38;T:37;V:32;W:7;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,C:21;E:9;G:7;H:3;T:32,B:6;C:48;E:207;G:11;H:7;T:54;b:4,4_7,D:1;F:1;G:3;H:2;I:1;M:1;N:1;R:2;S:3;T:1;W:2;Y:3,C:4;E:11;T:6,D:0;F:0;G:0;H:0;I:0;M:0;N:0;R:0;S:0;T:0;W:0;Y:0,C:0;E:0;T:0,443448,ARG_101_L_COREBINDING;ARG_52_H_COREBINDING;ASN_39_L_COREBINDING;ASP_100_H_COREBINDING;GLY_104_H_COREBINDING;GLY_33_H_COREBINDING;GLY_96_L_COREBINDING;HIS_101_H_COREBINDING;HIS_98_L_COREBINDING;ILE_51_H_COREBINDING;MET_34_H_COREBINDING;PHE_99_L_COREBINDING;SER_105_H_COREBINDING;SER_106_H_COREBINDING;SER_50_H_COREBINDING;THR_97_L_COREBINDING;TRP_47_H_COREBINDING;TRP_94_L_COREBINDING;TYR_37_L_COREBINDING;TYR_59_H_COREBINDING;TYR_99_H_COREBINDING,DAEFRHD,0.868594032069661,0.496253513487394,0.600924288076294,999999,ASP_1_P_C;ALA_2_P_C;GLU_3_P_C;PHE_4_P_C;ARG_5_P_C;HIS_6_P_e,"FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 17"
4ONG_LH_P_4_7.pdb,4ONG,25024748,2.20,,,2.60.40.10,LH,424,P,5,DAEFR-,CGGGC-,00002-,4,7,3,CCCCC-,5,0,F:0;G:0;H:0;I:0;M:0;N:0;R:0;S:0;T:0;W:0;Y:0,F:0;G:0;H:0;I:0;M:0;N:0;R:0;S:0;T:0;W:0;Y:0,A:3;D:6;E:3;G:9;K:13;L:1;M:1;N:5;P:2;Q:2;R:3;S:20;T:4;Y:1,A:15;C:8;D:14;E:12;F:12;G:21;H:4;I:12;K:13;L:34;M:3;N:9;P:21;Q:11;R:12;S:39;T:36;V:33;W:7;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,C:21;E:10;G:7;H:4;T:31,B:7;C:52;E:205;G:11;H:7;T:46;b:4,4_7,F:1;G:3;H:1;I:1;M:1;N:1;R:2;S:3;T:1;W:2;Y:3,C:3;E:10;T:6,F:0;G:0;H:0;I:0;M:0;N:0;R:0;S:0;T:0;W:0;Y:0,C:0;E:0;T:0,44655-,ARG_101_L_COREBINDING;ARG_52_H_COREBINDING;ASN_39_L_COREBINDING;GLY_103_H_COREBINDING;GLY_33_H_COREBINDING;GLY_96_L_COREBINDING;HIS_98_L_COREBINDING;ILE_51_H_COREBINDING;MET_34_H_COREBINDING;PHE_99_L_COREBINDING;SER_104_H_COREBINDING;SER_105_H_COREBINDING;SER_50_H_COREBINDING;THR_97_L_COREBINDING;TRP_47_H_COREBINDING;TRP_94_L_COREBINDING;TYR_37_L_COREBINDING;TYR_59_H_COREBINDING;TYR_99_H_COREBINDING,DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV,0.865169374535415,0.492857017029988,,55555-,ASP_1_P_C;ALA_2_P_C;GLU_3_P_C;PHE_4_P_C;ARG_5_P_C,"FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 140"
4P3D_BA_C_4_11.pdb,4P3D,25482542,1.95,,,2.60.40.10,BA,436,C,13,FDSAEPWTVRNED-,CTTTTCTTTTTTC-,4131000100123-,4,11,2,dddCCCCCCCCCC-,10,3,A:0;E:0;F:0;G:0;H:0;I:0;K:0;N:0;S:0;T:0;Y:0,A:0;E:0;F:0;G:0;H:0;I:0;K:0;N:0;S:1;T:0;Y:0,A:3;D:5;E:4;G:9;I:1;K:11;L:2;N:4;P:4;Q:3;R:5;S:21;T:5,A:18;C:8;D:12;E:12;F:17;G:23;H:5;I:10;K:11;L:31;M:6;N:10;P:20;Q:11;R:12;S:38;T:33;V:34;W:8;Y:14,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:1,C:17;E:12;G:7;H:3;T:38,B:7;C:53;E:209;G:13;H:8;T:39;b:4,4_11,A:1;E:1;F:1;G:3;H:1;I:2;K:1;N:5;S:4;T:1;Y:5,C:5;E:10;G:1;T:9,A:0;E:0;F:0;G:0;H:0;I:0;K:0;N:0;S:0;T:0;Y:0,C:0;E:0;G:0;T:0,6554444444479-,ALA_33_A_COREBINDING;ASN_100_A_COREBINDING;ASN_31_A_COREBINDING;ASN_33_B_COREBINDING;ASN_35_B_COREBINDING;ASN_57_A_COREBINDING;GLU_99_A_COREBINDING;GLY_102_A_COREBINDING;GLY_53_A_COREBINDING;GLY_96_B_COREBINDING;HIS_31_B_COREBINDING;ILE_51_A_COREBINDING;ILE_58_A_COREBINDING;LYS_55_B_COREBINDING;PHE_105_A_COREBINDING;SER_103_A_COREBINDING;SER_104_A_COREBINDING;SER_32_B_exosite;SER_35_A_COREBINDING;SER_52_A_COREBINDING;THR_50_A_COREBINDING;TYR_101_A_COREBINDING;TYR_101_B_COREBINDING;TYR_32_A_COREBINDING;TYR_37_B_COREBINDING;TYR_59_A_COREBINDING,FDSAEPWTVRNED,0.990888382687927,0.502131271071844,1.17793760445959,9999999999999-,PHE_1_C_e;ASP_2_C_e;SER_3_C_e;ALA_4_C_C;GLU_5_C_C;PRO_6_C_C;TRP_7_C_C;THR_8_C_C;VAL_9_C_C;ARG_10_C_C;ASN_11_C_C;GLU_12_C_C;ASP_13_C_C,"MT1MMPFAB COMPLEX FORM II"
4QXU_LH_K_4_11.pdb,4QXU,25482542,2.30,,,2.60.40.10,LH,439,K,11,---AEPWTVRNEDL,---CCCTTTTTTCC,---31001001223,4,11,2,---CCCCCCCCCCd,10,1,A:0;E:0;G:0;H:0;I:0;K:0;N:0;S:0;T:0;Y:0,A:0;E:0;G:0;H:0;I:0;K:0;N:0;S:0;T:0;Y:0,A:2;C:1;D:7;E:5;G:10;I:1;K:10;L:3;M:1;N:2;P:2;Q:3;R:5;S:19;T:4;V:1,A:18;C:9;D:11;E:12;F:18;G:22;H:5;I:10;K:12;L:30;M:5;N:12;P:22;Q:11;R:12;S:41;T:34;V:33;W:8;Y:14,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:20;E:11;G:10;H:4;T:31,B:6;C:53;E:210;G:13;H:7;T:48;b:2,4_11,A:1;E:1;G:3;H:1;I:2;K:1;N:5;S:4;T:1;Y:5,C:6;E:9;G:1;T:8,A:0;E:0;G:0;H:0;I:0;K:0;N:0;S:0;T:0;Y:0,C:0;E:0;G:0;T:0,---76544566778,ALA_33_H_COREBINDING;ASN_100_H_COREBINDING;ASN_31_H_COREBINDING;ASN_33_L_COREBINDING;ASN_35_L_COREBINDING;ASN_57_H_COREBINDING;GLU_99_H_COREBINDING;GLY_102_H_COREBINDING;GLY_53_H_COREBINDING;GLY_96_L_COREBINDING;HIS_31_L_COREBINDING;ILE_51_H_COREBINDING;ILE_58_H_COREBINDING;LYS_55_L_COREBINDING;SER_103_H_COREBINDING;SER_104_H_COREBINDING;SER_35_H_COREBINDING;SER_52_H_COREBINDING;THR_50_H_COREBINDING;TYR_101_H_COREBINDING;TYR_101_L_COREBINDING;TYR_32_H_COREBINDING;TYR_37_L_COREBINDING;TYR_59_H_COREBINDING,AEPWTVRNEDL,0.990888382687927,0.501797268939081,2.32304563020187,---99999999799,ALA_1_K_C;GLU_2_K_C;PRO_3_K_C;TRP_4_K_C;THR_5_K_C;VAL_6_K_C;ARG_7_K_C;ASN_8_K_C;GLU_9_K_C;ASP_10_K_C;LEU_11_K_e,"NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE 2 SWIVELING CONFORMATIONAL ANTIBODY"
4TQE_LH_A_4_23.pdb,4TQE,,1.60,A2NHM3,PF07686_PF07654,2.60.40.10,LH,438,A,16,LPTPPTREPKKVAVVR,CCCCCCCCCCBCCCCC,4422000100303234,4,23,1,CCCCCCCCCCCCCCCC,16,0,A:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;M:0;N:0;R:0;V:0;W:0;Y:0,A:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;M:0;N:0;R:0;V:0;W:0;Y:0,A:3;D:7;E:5;G:9;K:8;L:2;M:1;N:3;P:6;Q:6;R:5;S:26;T:6,A:20;C:8;D:11;E:11;F:14;G:21;H:6;I:14;K:13;L:28;M:4;N:14;P:19;Q:13;R:6;S:33;T:36;V:32;W:7;Y:14,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:19;E:13;G:8;H:5;T:42,B:7;C:47;E:207;G:13;H:7;T:39;b:4,4_23,A:1;D:3;E:2;F:2;G:3;H:1;I:2;K:2;M:1;N:1;R:1;V:1;W:3;Y:4,B:1;C:6;E:11;G:3;T:6,A:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;M:0;N:0;R:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,9875444444568999,ALA_59_H_COREBINDING;ARG_99_H_COREBINDING;ASN_35_L_COREBINDING;ASP_31_H_COREBINDING;ASP_52_H_COREBINDING;ASP_57_H_COREBINDING;GLU_39_L_COREBINDING;GLU_54_H_COREBINDING;GLY_100_H_COREBINDING;GLY_101_H_COREBINDING;GLY_96_L_COREBINDING;HIS_35_H_COREBINDING;ILE_103_H_COREBINDING;ILE_29_H_COREBINDING;LYS_30_H_COREBINDING;LYS_55_L_COREBINDING;MET_102_H_COREBINDING;PHE_107_H_COREBINDING;PHE_94_L_COREBINDING;TRP_101_L_COREBINDING;TRP_47_H_COREBINDING;TRP_50_H_COREBINDING;TYR_32_H_COREBINDING;TYR_33_H_COREBINDING;TYR_37_L_COREBINDING;TYR_41_L_COREBINDING;VAL_99_L_COREBINDING,LPTPPTREPKKVAVVR,-1,0.492887390802308,,9999999999999999,LEU_1_A_C;PRO_2_A_C;THR_3_A_C;PRO_4_A_C;PRO_5_A_C;THR_6_A_C;ARG_7_A_C;GLU_8_A_C;PRO_9_A_C;LYS_10_A_C;LYS_11_A_C;VAL_12_A_C;ALA_13_A_C;VAL_14_A_C;VAL_15_A_C;ARG_16_A_C,"STRUCTURE OF TAU PEPTIDE IN COMPLEX WITH TAU5 ANTIBODY FAB FRAGMENT"
4TUJ_DC_F_4_30.pdb,4TUJ,26179345,1.89,,,2.60.40.10,DC,418,F,13,RCNPNMEPPRCWA,CCTTTTTTTTTCC,3002100024032,4,30,1,CCCCCCCCCCCCC,13,0,D:0;E:0;G:0;H:0;K:0;L:0;M:0;N:0;P:0;S:0;V:0;Y:0,D:0;E:0;G:0;H:0;K:0;L:0;M:0;N:0;P:0;S:0;V:0;Y:0,A:4;D:4;E:3;G:10;I:1;K:11;L:4;M:1;N:3;P:5;Q:4;R:4;S:20;T:3;V:1;Y:1,A:16;C:8;D:13;E:11;F:12;G:19;H:6;I:12;K:13;L:28;M:4;N:11;P:17;Q:12;R:7;S:40;T:37;V:32;W:8;Y:13,C:0;E:0;T:0,C:0;E:0;T:0,C:20;E:10;G:5;H:4;T:40,B:4;C:63;E:193;G:4;H:7;T:43;b:5,4_30,D:1;E:1;G:1;H:3;K:1;L:1;M:1;N:2;P:2;S:2;V:1;Y:4,C:3;E:5;T:12,D:0;E:0;G:0;H:0;K:0;L:0;M:0;N:0;P:0;S:0;V:0;Y:0,C:0;E:0;T:0,5545544465687,ASN_28_C_COREBINDING;ASN_33_D_COREBINDING;ASP_47_C_COREBINDING;GLU_100_C_COREBINDING;GLY_98_C_COREBINDING;HIS_31_D_COREBINDING;HIS_39_D_COREBINDING;HIS_54_D_COREBINDING;LEU_51_D_COREBINDING;LYS_55_D_COREBINDING;MET_99_C_COREBINDING;PRO_100_D_COREBINDING;PRO_48_C_COREBINDING;SER_54_C_COREBINDING;SER_96_D_COREBINDING;TYR_27_C_COREBINDING;TYR_37_D_COREBINDING;TYR_41_D_COREBINDING;TYR_49_C_COREBINDING;VAL_99_D_COREBINDING,RCNPNMEPPRCWAAEGD,-1,0.488384084472827,,9999999999999,ARG_1_F_C;CYS_2_F_C;ASN_3_F_C;PRO_4_F_C;ASN_5_F_C;MET_6_F_C;GLU_7_F_C;PRO_8_F_C;PRO_9_F_C;ARG_10_F_C;CYS_11_F_C;TRP_12_F_C;ALA_13_F_C,"CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA 2 ASSOCIATED ANTIGEN"
4TUK_LH_I_4_4.pdb,4TUK,26179345,1.60,,,2.60.40.10,LH,425,I,15,-V-----CNPLTGALLC---SAAE,-C-----CTTTTTTTTT---GGGC,-1-----2020001000---3303,4,4,4,-D-----DDDDDCCCCC---DDDD,5,6,A:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:2;D:6;E:2;G:9;I:1;K:11;L:2;M:1;N:3;P:5;Q:5;R:4;S:20;T:2;V:1;Y:2,A:17;C:8;D:10;E:12;F:13;G:19;H:6;I:11;K:13;L:30;M:4;N:11;P:19;Q:11;R:7;S:45;T:36;V:32;W:7;Y:13,C:0;E:0;T:0,C:0;E:0;T:0,C:20;E:12;G:8;H:4;T:32,B:7;C:51;E:205;G:10;H:7;T:40;b:4,4_4,A:1;D:1;E:0;G:1;H:1;I:1;K:0;L:0;M:0;N:2;R:0;S:2;T:1;V:1;W:1;Y:1,C:2;E:6;T:5,A:0;D:0;E:1;G:2;H:2;I:0;K:1;L:1;M:1;N:1;R:1;S:0;T:0;V:0;W:0;Y:2,C:0;E:4;T:8,-5-----5444435446---7779,ALA_49_H_COREBINDING;ARG_32_L_EXOSITE;ASN_32_H_COREBINDING;ASN_33_L_EXOSITE;ASN_34_H_COREBINDING;ASP_51_H_COREBINDING;GLU_100_H_EXOSITE;GLY_30_H_EXOSITE;GLY_56_H_COREBINDING;GLY_98_H_EXOSITE;HIS_31_L_COREBINDING;HIS_39_L_EXOSITE;HIS_54_L_EXOSITE;ILE_50_H_COREBINDING;LEU_51_L_EXOSITE;LYS_55_L_EXOSITE;MET_99_H_EXOSITE;SER_58_H_COREBINDING;SER_96_L_COREBINDING;THR_57_H_COREBINDING;TRP_46_H_COREBINDING;TYR_31_H_EXOSITE;TYR_37_L_COREBINDING;TYR_41_L_EXOSITE;VAL_99_L_COREBINDING,VCNPLTGALLCSAAEGD,0.829654777743504,0.484627043846234,0.69092546631312,-9-----9999999999---9999,VAL_1_I_E;CYS_2_I_E;ASN_3_I_E;PRO_4_I_E;LEU_5_I_E;THR_6_I_E;GLY_7_I_C;ALA_8_I_C;LEU_9_I_C;LEU_10_I_C;CYS_11_I_C;SER_12_I_E;ALA_13_I_E;ALA_14_I_E;GLU_15_I_E,"CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA 2 ASSOCIATED ANTIGEN"
4TUL_LH_I_4_4.pdb,4TUL,26179345,1.40,,,2.60.40.10,LH,424,I,11,-V-----CNPLTGALLC-------,-C-----CBTTTBTTCC-------,-1-----2020002002-------,4,4,4,-D-----DDDDDCCCCC-------,5,6,A:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;S:0;T:0;V:0;W:0;Y:0,A:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;S:0;T:0;V:0;W:0;Y:0,A:2;C:1;D:6;E:1;G:8;I:1;K:9;L:2;M:1;N:3;P:5;Q:6;R:3;S:20;T:2;W:1;Y:2,A:17;C:8;D:10;E:13;F:13;G:19;H:7;I:11;K:15;L:30;M:4;N:12;P:19;Q:10;R:9;S:44;T:36;V:33;W:6;Y:13,C:0;E:0;T:0,C:0;E:0;T:0,C:16;E:13;G:6;H:5;T:33,B:7;C:51;E:203;G:9;H:7;T:48;b:4,4_4,A:1;D:1;E:0;G:1;H:0;I:1;K:0;L:0;M:0;N:2;S:1;T:1;V:1;W:1;Y:1,C:3;E:6;T:2,A:0;D:0;E:1;G:2;H:2;I:0;K:1;L:1;M:1;N:0;S:1;T:0;V:0;W:0;Y:2,C:0;E:4;T:7,-7-----6555556556-------,ALA_49_H_COREBINDING;ASN_32_H_COREBINDING;ASN_34_H_COREBINDING;ASP_51_H_COREBINDING;GLU_100_H_EXOSITE;GLY_30_H_EXOSITE;GLY_56_H_COREBINDING;GLY_98_H_EXOSITE;HIS_39_L_EXOSITE;HIS_54_L_EXOSITE;ILE_50_H_COREBINDING;LEU_51_L_EXOSITE;LYS_55_L_EXOSITE;MET_99_H_EXOSITE;SER_58_H_COREBINDING;SER_96_L_EXOSITE;THR_57_H_COREBINDING;TRP_46_H_COREBINDING;TYR_31_H_EXOSITE;TYR_37_L_COREBINDING;TYR_41_L_EXOSITE;VAL_99_L_COREBINDING,VCNPLTGALLCSAAEGD,0.829654777743504,0.484070011184579,0.902826672180213,-9-----9999999999-------,VAL_1_I_E;CYS_2_I_E;ASN_3_I_E;PRO_4_I_E;LEU_5_I_E;THR_6_I_E;GLY_7_I_C;ALA_8_I_C;LEU_9_I_C;LEU_10_I_C;CYS_11_I_C,"CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA 2 ASSOCIATED ANTIGEN"
4WHT_YX_x_4_19.pdb,4WHT,25473061,2.22,,,2.60.40.10,YX,409,x,12,-Q------LINTNGSWHVN,-T------TTTTTTTTTBC,-3------10012030124,4,19,2,-d------CCCCDDDDDEE,4,7,A:0;D:0;E:0;F:0;G:0;H:0;L:0;M:0;N:0;P:0;R:0;S:0;T:0;W:0;Y:0,A:0;D:0;E:0;F:0;G:0;H:0;L:0;M:0;N:0;P:0;R:0;S:1;T:0;W:0;Y:0,A:6;D:7;E:5;G:9;K:9;M:1;N:2;P:6;Q:1;R:3;S:19;T:9;V:1,A:17;C:8;D:10;E:8;F:11;G:21;H:4;I:11;K:8;L:35;M:4;N:9;P:13;Q:13;R:11;S:37;T:34;V:35;W:5;Y:13,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:1,C:25;E:9;G:8;T:36,B:9;C:52;E:190;G:10;T:44;b:2,4_19,A:0;D:2;E:2;F:0;G:0;H:0;L:1;M:1;N:1;P:0;R:2;S:0;T:3;W:1;Y:3,B:0;C:2;E:4;T:10,A:1;D:0;E:0;F:1;G:1;H:1;L:0;M:0;N:0;P:1;R:0;S:1;T:0;W:0;Y:1,B:1;C:1;E:2;T:3,-4------33333343347,ALA_99_Y_EXOSITE;ARG_56_X_COREBINDING;ARG_97_X_COREBINDING;ASN_39_Y_COREBINDING;ASP_33_Y_COREBINDING;ASP_99_X_COREBINDING;GLU_31_Y_COREBINDING;GLU_60_Y_COREBINDING;GLY_55_X_EXOSITE;HIS_98_Y_EXOSITE;LEU_51_Y_COREBINDING;MET_98_X_COREBINDING;PHE_57_X_EXOSITE;PRO_100_Y_EXOSITE;SER_49_X_EXOSITE;SER_55_Y_exosite;THR_51_X_COREBINDING;THR_96_Y_COREBINDING;THR_97_Y_COREBINDING;TRP_46_X_COREBINDING;TYR_32_X_COREBINDING;TYR_37_Y_COREBINDING;TYR_54_Y_COREBINDING;TYR_58_X_EXOSITE,QLINTNGSWHVN,0.73394495412844,0.465526954332398,0.13639281506003,-9------99999999999,GLN_1_x_e;LEU_2_x_C;ILE_3_x_C;ASN_4_x_C;THR_5_x_C;ASN_6_x_E;GLY_7_x_E;SER_8_x_E;TRP_9_x_E;HIS_10_x_E;VAL_11_x_E;ASN_12_x_E,"STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 311 P1 3 CRYSTAL FORM"
4WY7_HL_P_4_9.pdb,4WY7,25787074,2.10,,,2.60.40.10,HL,432,P,15,NWFDITNWLWYIKKK-,CGGGHHHHHHHHHHC-,100100030121234-,4,9,2,CCCCCCCCCCCCCCC-,15,0,A:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:2;D:3;E:3;G:9;K:8;L:1;N:4;P:9;Q:4;R:6;S:20;T:5;W:2,A:28;C:8;D:9;E:14;F:14;G:25;H:5;I:7;K:10;L:31;M:1;N:8;P:16;Q:17;R:12;S:36;T:31;V:37;W:5;Y:15,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:19;E:13;G:9;H:4;T:31,B:7;C:55;E:198;G:14;H:8;T:43;b:4,4_9,A:1;E:1;G:4;I:3;K:2;L:3;N:1;P:1;Q:2;S:3;T:2;V:1;W:1;Y:2,C:2;E:14;G:1;T:10,A:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,544444556577999-,ALA_32_H_COREBINDING;ASN_58_H_COREBINDING;GLN_90_L_COREBINDING;GLN_94_L_COREBINDING;GLU_98_H_COREBINDING;GLY_107_H_COREBINDING;GLY_111_H_COREBINDING;GLY_49_H_COREBINDING;GLY_93_L_COREBINDING;ILE_110_H_COREBINDING;ILE_51_H_COREBINDING;ILE_56_H_COREBINDING;LEU_106_H_COREBINDING;LEU_33_H_COREBINDING;LEU_54_H_COREBINDING;LYS_108_H_COREBINDING;LYS_33_L_COREBINDING;PRO_109_H_COREBINDING;SER_34_H_COREBINDING;SER_95_L_COREBINDING;SER_97_L_COREBINDING;THR_30_H_COREBINDING;THR_57_H_COREBINDING;TRP_46_H_COREBINDING;TYR_31_H_COREBINDING;TYR_92_L_COREBINDING;VAL_50_H_COREBINDING,NWFDITNWLWYIKKKK,0.97737556561086,0.409113235616012,,999999959999999-,ASN_1_P_C;TRP_2_P_C;PHE_3_P_C;ASP_4_P_C;ILE_5_P_C;THR_6_P_C;ASN_7_P_C;TRP_8_P_C;LEU_9_P_C;TRP_10_P_C;TYR_11_P_C;ILE_12_P_C;LYS_13_P_C;LYS_14_P_C;LYS_15_P_C,"CRYSTAL STRUCTURE OF RECOMBINANT 4E10 EXPRESSED IN ESCHERICHIA COLI 2 WITH EPITOPE BOUND"
4XBE_LH_P_4_8.pdb,4XBE,26777395,1.76,,,2.60.40.10,LH,430,P,15,N-WF----DITNWLWYIKKK,C-GG----GHHHHHHHHHCC,1-00----100030121234,4,8,3,d-dd----CCCCDDDDEEDD,4,8,A:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:0;E:0;G:3;I:0;K:0;L:0;N:1;P:0;Q:1;S:3;T:1;V:1;W:1;Y:1,A:2;D:3;E:5;G:11;K:8;L:1;N:2;P:8;Q:4;R:8;S:18;T:7,A:28;C:8;D:9;E:13;F:14;G:22;H:5;I:7;K:10;L:31;M:1;N:9;P:17;Q:19;R:10;S:37;T:29;V:37;W:5;Y:15,C:0;E:0;G:0;T:0,C:0;E:7;G:0;T:5,C:21;E:10;G:6;H:3;T:37,B:7;C:55;E:199;G:12;H:8;T:41;b:4,4_8,A:1;E:1;G:0;I:3;K:2;L:1;N:1;P:1;Q:0;S:0;T:1;V:0;W:0;Y:1,C:1;E:5;G:2;T:4,A:0;E:0;G:1;I:0;K:0;L:2;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;G:1;T:2,5-44----444444556899,ALA_33_H_COREBINDING;ASN_31_L_COREBINDING;ASN_59_H_exosite;GLN_94_L_exosite;GLU_99_H_COREBINDING;GLY_105_H_EXOSITE;GLY_109_H_exosite;GLY_50_H_exosite;GLY_93_L_exosite;ILE_108_H_COREBINDING;ILE_52_H_COREBINDING;ILE_57_H_COREBINDING;LEU_104_H_EXOSITE;LEU_54_H_EXOSITE;LEU_55_H_COREBINDING;LYS_106_H_COREBINDING;LYS_33_L_COREBINDING;PRO_107_H_COREBINDING;SER_35_H_exosite;SER_95_L_exosite;SER_97_L_exosite;THR_31_H_COREBINDING;THR_58_H_exosite;TRP_47_H_exosite;TYR_32_H_COREBINDING;TYR_92_L_exosite;VAL_51_H_exosite,NWFDITNWLWYIKKK,0.875597545219638,0.439828318312989,0.346880382841123,9-99----999955999999,ASN_1_P_e;TRP_2_P_e;PHE_3_P_e;ASP_4_P_C;ILE_5_P_C;THR_6_P_C;ASN_7_P_C;TRP_8_P_E;LEU_9_P_E;TRP_10_P_E;TYR_11_P_E;ILE_12_P_E;LYS_13_P_E;LYS_14_P_E;LYS_15_P_E,"CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE 2 EPITOPE ON HIV1 GP41 CRYSTALS CRYOPROTECTED WITH SPHINGOMYELIN 3 020 SM D18120"
4XCF_LH_P_4_8.pdb,4XCF,26777395,1.43,,,2.60.40.10,LH,432,P,15,N-WW----DITNWLWYIKKK,C-GG----GHHHHHHHHHHC,1-00----000030122334,4,8,3,d-dd----CCCCDDDDEEDD,4,8,A:0;E:0;F:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:0;E:0;F:1;G:3;I:1;K:0;L:0;N:1;P:0;Q:2;S:2;T:1;V:1;W:1;Y:1,A:2;D:3;E:5;G:11;K:10;N:2;P:7;Q:5;R:5;S:21;T:6,A:28;C:8;D:9;E:13;F:13;G:22;H:5;I:7;K:9;L:33;M:1;N:9;P:18;Q:17;R:13;S:37;T:30;V:37;W:5;Y:15,C:0;E:0;G:0;T:0,C:0;E:9;G:0;T:5,C:26;E:8;G:7;H:3;T:33,B:7;C:57;E:201;G:15;H:8;T:37;b:4,4_8,A:1;E:1;F:0;G:0;I:2;K:2;L:1;N:1;P:1;Q:0;S:0;T:1;V:0;W:0;Y:1,C:1;E:4;G:2;T:4,A:0;E:0;F:0;G:1;I:0;K:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:1,6-44----444445565999,ALA_33_H_COREBINDING;ASN_31_L_COREBINDING;ASN_59_H_exosite;GLN_90_L_exosite;GLN_94_L_exosite;GLU_99_H_COREBINDING;GLY_104_H_EXOSITE;GLY_108_H_exosite;GLY_50_H_exosite;GLY_93_L_exosite;ILE_107_H_COREBINDING;ILE_52_H_COREBINDING;ILE_57_H_exosite;LEU_55_H_COREBINDING;LYS_105_H_COREBINDING;LYS_33_L_COREBINDING;PHE_110_H_exosite;PRO_106_H_COREBINDING;SER_95_L_exosite;SER_97_L_exosite;THR_31_H_COREBINDING;THR_58_H_exosite;TRP_47_H_exosite;TYR_32_H_COREBINDING;TYR_92_L_exosite;VAL_51_H_exosite,NWWDITNWLWYIKKKK,0.876157407407407,0.44116148850464,0.399963748357274,9-99----999959955999,ASN_1_P_e;TRP_2_P_e;TRP_3_P_e;ASP_4_P_C;ILE_5_P_C;THR_6_P_C;ASN_7_P_C;TRP_8_P_E;LEU_9_P_E;TRP_10_P_E;TYR_11_P_E;ILE_12_P_E;LYS_13_P_E;LYS_14_P_E;LYS_15_P_E,"CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE 2 EPITOPE ON HIV1 GP41 CRYSTALS CRYOPROTECTED WITH 3 PHOSPHATIDYLCHOLINE 030 PC"
4XH2_AB_a_4_26.pdb,4XH2,26087144,2.00,,,2.60.40.10,AB,430,a,16,GSATRELDELMASLSD,TTTHHHHHHHHHHCCC,2300210120022043,4,26,1,CCCCCCCCCCCCCCCC,16,0,F:0;H:0;I:0;K:0;P:0;Q:0;R:0;S:0;T:0;W:0;Y:0,F:0;H:0;I:0;K:0;P:0;Q:0;R:0;S:0;T:0;W:0;Y:0,A:2;D:1;E:5;G:11;K:13;L:1;M:1;N:2;P:5;Q:2;R:3;S:22;T:5,A:27;C:9;D:13;E:10;F:13;G:21;H:4;I:9;K:11;L:29;M:1;N:10;P:16;Q:18;R:9;S:45;T:29;V:38;W:5;Y:17,C:0;E:0;T:0,C:0;E:0;T:0,C:19;E:9;G:8;H:4;T:33,B:5;C:61;E:198;G:10;H:8;T:48;b:4,4_26,F:2;H:1;I:1;K:2;P:1;Q:1;R:1;S:5;T:1;W:2;Y:6,C:4;E:8;T:11,F:0;H:0;I:0;K:0;P:0;Q:0;R:0;S:0;T:0;W:0;Y:0,C:0;E:0;T:0,7654544444444567,ARG_88_B_COREBINDING;GLN_89_B_COREBINDING;HIS_36_A_COREBINDING;ILE_93_B_COREBINDING;LYS_87_B_COREBINDING;LYS_90_B_COREBINDING;PHE_105_A_COREBINDING;PHE_86_B_COREBINDING;PRO_92_B_COREBINDING;SER_32_A_COREBINDING;SER_34_A_COREBINDING;SER_45_B_COREBINDING;SER_53_A_COREBINDING;SER_56_A_COREBINDING;THR_100_A_COREBINDING;TRP_101_A_COREBINDING;TRP_48_A_COREBINDING;TYR_102_A_COREBINDING;TYR_103_A_COREBINDING;TYR_33_A_COREBINDING;TYR_51_A_COREBINDING;TYR_58_A_COREBINDING;TYR_60_A_COREBINDING,WGGSATRELDELMASLSD,-1,0.425156652825521,,9999999999999999,GLY_1_a_C;SER_2_a_C;ALA_3_a_C;THR_4_a_C;ARG_5_a_C;GLU_6_a_C;LEU_7_a_C;ASP_8_a_C;GLU_9_a_C;LEU_10_a_C;MET_11_a_C;ALA_12_a_C;SER_13_a_C;LEU_14_a_C;SER_15_a_C;ASP_16_a_C,"CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB 2 FRAGMENT"
4XXD_DE_F_4_8.pdb,4XXD,25880481,2.41,P01834_P01857,PF07654,2.60.40.10,DE,423,F,9,-K--LVFFAEDV--------,-C--CCCCGGGC--------,-1--11000202--------,4,8,3,-D--DDDDCCCC--------,4,5,D:0;F:0;G:0;H:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,D:0;F:0;G:0;H:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:4;D:5;E:5;G:10;K:13;L:2;N:3;P:3;Q:5;R:4;S:21;T:5;V:2,A:20;C:8;D:9;E:9;F:13;G:23;H:5;I:9;K:10;L:32;M:3;N:12;P:21;Q:15;R:9;S:37;T:26;V:38;W:5;Y:14,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:21;E:12;G:5;H:4;T:40,B:7;C:53;E:193;G:6;H:7;T:48;b:4,4_8,D:1;F:0;G:0;H:0;L:0;Q:0;R:1;S:3;T:1;V:1;W:0;Y:3,C:3;E:0;G:1;T:6,D:1;F:2;G:1;H:1;L:1;Q:1;R:0;S:2;T:0;V:1;W:1;Y:2,C:2;E:6;G:0;T:5,-6--55555669--------,ARG_30_E_COREBINDING;ASP_33_D_COREBINDING;ASP_99_E_EXOSITE;GLN_49_E_EXOSITE;GLY_98_E_EXOSITE;HIS_39_D_EXOSITE;LEU_51_D_EXOSITE;PHE_26_E_EXOSITE;PHE_41_D_EXOSITE;SER_32_E_COREBINDING;SER_34_E_EXOSITE;SER_52_E_COREBINDING;SER_96_D_COREBINDING;SER_97_E_EXOSITE;THR_97_D_COREBINDING;TRP_101_D_EXOSITE;TYR_100_E_EXOSITE;TYR_31_D_COREBINDING;TYR_31_E_COREBINDING;TYR_37_D_COREBINDING;TYR_54_D_EXOSITE;VAL_1_E_EXOSITE;VAL_99_D_COREBINDING,VHHQKLVFFAEDVGSNK,0.75869939707149,0.470317870887529,0.524562674996996,-9--99999999--------,LYS_1_F_E;LEU_2_F_E;VAL_3_F_E;PHE_4_F_E;PHE_5_F_E;ALA_6_F_C;GLU_7_F_C;ASP_8_F_C;VAL_9_F_C,"CRYSTAL STRUCTURE OF MIDREGION AMYLOID BETA CAPTURE BY SOLANEZUMAB"
4YO0_DC_F_4_33.pdb,4YO0,26872787,1.56,,,2.60.40.10,DC,407,F,11,VAMPGAEDDVV,CCTTTTTTTCC,31000021013,4,33,1,CCCCCCCCCCC,11,0,A:0;F:0;G:0;H:0;I:0;K:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;F:0;G:0;H:0;I:0;K:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:2;D:6;E:7;G:10;K:9;M:1;N:5;P:6;Q:2;R:5;S:13;T:3;V:1,A:21;C:8;D:11;E:8;F:13;G:21;H:5;I:10;K:10;L:28;M:4;N:11;P:16;Q:14;R:9;S:32;T:38;V:34;W:6;Y:15,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:22;E:11;G:9;H:6;T:21;b:1,B:6;C:51;E:201;G:11;H:6;T:36;b:3,4_33,A:1;F:1;G:3;H:1;I:2;K:1;N:2;R:1;S:5;T:1;V:1;W:1;Y:3,C:3;E:10;G:1;T:9,A:0;F:0;G:0;H:0;I:0;K:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,74333344447,ALA_53_C_COREBINDING;ARG_101_C_COREBINDING;ASN_31_C_COREBINDING;ASN_31_D_COREBINDING;GLY_33_C_COREBINDING;GLY_54_C_COREBINDING;GLY_96_D_COREBINDING;HIS_91_D_COREBINDING;ILE_51_C_COREBINDING;ILE_97_D_COREBINDING;LYS_57_C_COREBINDING;PHE_104_C_COREBINDING;SER_100_C_COREBINDING;SER_50_C_COREBINDING;SER_52_C_COREBINDING;SER_94_D_COREBINDING;SER_95_D_COREBINDING;THR_99_C_COREBINDING;TRP_47_C_COREBINDING;TYR_32_C_COREBINDING;TYR_59_C_COREBINDING;TYR_93_D_COREBINDING;VAL_102_C_COREBINDING,EGGVAMPGAEDDVV,-1,0.388195206782011,,99599999999,VAL_1_F_C;ALA_2_F_C;MET_3_F_C;PRO_4_F_C;GLY_5_F_C;ALA_6_F_C;GLU_7_F_C;ASP_8_F_C;ASP_9_F_C;VAL_10_F_C;VAL_11_F_C,"CRYSTAL STRUCTURE OF MONOCLONAL ANTIHUMAN PODOPLANIN ANTIBODY NZ1 2 WITH BOUND PA PEPTIDE"
4YR6_ED_F_4_36.pdb,4YR6,,2.38,,,2.60.40.10,ED,424,F,10,KLRGVLQGHL,CCCCGGGCCC,3301230002,4,36,1,CCCCCCCCCC,10,0,D:0;F:0;G:0;H:0;L:0;N:0;S:0;T:0;W:0;Y:0,D:0;F:0;G:0;H:0;L:0;N:0;S:0;T:0;W:0;Y:0,A:7;D:4;E:3;G:7;K:10;M:1;N:2;P:6;Q:4;R:2;S:21;T:4;Y:1,A:17;C:8;D:13;E:9;F:15;G:21;H:5;I:15;K:14;L:32;M:3;N:15;P:19;Q:14;R:8;S:35;T:38;V:30;W:8;Y:15,C:0;E:0;T:0,C:0;E:0;T:0,C:16;E:9;G:8;H:4;T:35,B:5;C:50;E:208;G:7;H:7;T:53;b:4,4_36,D:1;F:2;G:1;H:1;L:1;N:2;S:1;T:5;W:2;Y:2,C:3;E:6;T:9,D:0;F:0;G:0;H:0;L:0;N:0;S:0;T:0;W:0;Y:0,C:0;E:0;T:0,4444444344,ASN_33_D_COREBINDING;ASN_56_D_COREBINDING;ASP_93_E_COREBINDING;GLY_58_D_COREBINDING;HIS_52_D_COREBINDING;LEU_54_D_COREBINDING;PHE_60_D_COREBINDING;PHE_91_E_COREBINDING;SER_106_D_COREBINDING;THR_102_D_COREBINDING;THR_103_D_COREBINDING;THR_104_D_COREBINDING;THR_105_D_COREBINDING;THR_94_E_COREBINDING;TRP_92_E_COREBINDING;TRP_96_E_COREBINDING;TYR_30_E_COREBINDING;TYR_32_E_COREBINDING,KLRGVLQGHL,-1,0.465000408150346,,9999999999,LYS_1_F_C;LEU_2_F_C;ARG_3_F_C;GLY_4_F_C;VAL_5_F_C;LEU_6_F_C;GLN_7_F_C;GLY_8_F_C;HIS_9_F_C;LEU_10_F_C,"FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE"
